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CANCER
B2-2:
Diffusion of New Technologies for Patients With
Prostate Cancer
Ramzi G. Salloum,1 Matthew N. Nielsen,2 Mark C.
Hornbrook,3 Maureen O’Keefe Rosetti,3 Paul A.
Fishman,4 Jennifer Elston Lafata,5 Debra P. Ritzwoller6
University of South Carolina; 2University of North
Carolina at Chapel Hill; 3Kaiser Permanente Northwest;
4
Group Health Cooperative; 5Virginia Commonwealth
University; 6Kaiser Permanente Colorado

1

Background/Aims: Prostate cancer is the most common and
costly cancer among U.S. men and offers a portfolio of case
studies and clinical problems. Among these, the documented
increases in use of robotic radical prostatectomy (RRP) and
intensity-modulated radiotherapy (IMRT) are illustrative of
rapid diffusion of costly, unproven technological innovations.
Evidence of these case studies has been limited to the
traditional Medicare fee-for-service (FFS) aged population
and may provide a potentially biased view of the universe
of cancer care in the United States. To address this issue, we
examine treatment patterns among prostate cancer patients
enrolled in two integrated health care delivery systems.
Methods: The sample included a retrospective cohort
of patients diagnosed with nonmetastatic prostate cancer
between 2000 and 2008 at the Northwest and Colorado
regions of Kaiser Permanente. Choice of radiation therapy was
defined as the receipt of external beam radiotherapy (threedimensional [3D] conformal radiation therapy vs. IMRT)
as primary treatment within one year of diagnosis. Choice
of prostatectomy was defined as the receipt of surgery as
primary treatment (open radical prostatectomy vs. minimallyinvasive/robotic radical prostatectomy). A pooled time-series
cross-section design was used to analyze the medical care
resource use for treating prostate cancer.
Results: Both RRP and IMRT were introduced in the two
health systems in 2003, and their use has been steadily
increasing since then. Use of traditional treatments has either
remained stable: open radical prostatectomy; or decreased:
3D conformal radiation therapy.
Discussion: We hypothesize that diffusion rates of RRP and
IMRT have been slower among HMO enrollees compared
with FFS patients. This study improves our understanding
of patterns of prostate cancer care in the United States by
using a large sample of managed care enrollees across the
age spectrum, including men younger than 65 relative to men
older than 65 years.
Keywords: prostate, technology
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B2-4:
An Economic Evaluation of Colorectal Cancer
Screening in Primary Care Practice
Richard T. Meenan,1 Jessica Chubak,2 Sally W. Vernon,3
Sharon Fuller,2 Ching-Yun Wang,4 Beverly B. Green2
Kaiser Permanente Northwest; 2Group Health
Cooperative; 3University of Texas; 4Fred Hutchinson
Cancer Research Center
1

Background/Aims: This study evaluated the costeffectiveness of interventions using electronic health records
(EHR), automated mailings, and stepped increases in support
to improve two-year colorectal cancer screening adherence.
Methods: Analyses are based on a parallel-design, randomized
trial in which three stepped interventions (EHR-linked
mailings [“automated”], automated plus telephone assistance
[“assisted”], or automated and assisted plus nurse navigation to
testing completion or refusal [“navigated”]) were compared to
usual care. Data were collected over August 2008–November
2011 with analysis in 2012–2013. Implementation resources
were micro-costed; research and registry development costs
were excluded. Incremental cost-effectiveness ratios (ICERs)
were based on number of participants current for screening
per guidelines over two years. Robustness of results was
examined through bootstrapping.
Results: Intervention delivery cost per participant current for
screening ranged from $21 (automated) to $27 (navigated).
When induced testing costs (e.g. screening colonoscopy) were
included, automated (ICER: -$159) and assisted (ICER: -$36)
were cost-saving relative to usual care. Savings arose from
increased fecal occult blood testing, substituting for more
expensive colonoscopies in usual care. Results were broadly
consistent across demographic subgroups. More intensive
interventions were consistently likely to be cost-effective
relative to less intensive interventions with willingness to
pay values of $600–$1,200 for a 1% increase in the rate of
screening adherence yielding probability of cost-effectiveness
of at least 80%.
Discussion: The cost-effectiveness was demonstrated of a
stepped approach to colorectal cancer screening promotion,
especially one using automated data systems linked to
electronic health records.
Keywords: colorectal cancer screening, cost-effectiveness
B2-5:
Randomized Trial of In-Home Cervical Cancer
Screening in Underscreened Women
Rachel L. Winer,1 Jasmin A. Tiro,2 Diana L. Miglioretti,1
Chris Thayer,1 Jane A. Dimer,1 John Lin,3 Hongyuan
Gao,1 Diana S. Buist1
Supplement

Group Health Cooperative; 2University of Texas
Southwestern; 3University of Washington
1

Background/Aims: Over half of cervical cancers in the
United States are diagnosed in unscreened or underscreened
women. Innovative strategies that move primary screening
out of the clinic could be highly effective in improving
screening compliance while maintaining high-quality
care. Internationally, there is growing interest in a primary
screening strategy of self-collected, in-home high-risk
human papillomavirus (hrHPV) screening followed by triage
of hrHPV-positive results to clinician-collected cytology
or colposcopy. The need for in-clinic screening could be
eliminated for a majority of women in organized screening
programs if hrHPV screening can be seamlessly integrated
with in-clinic follow-up.
Methods: In March 2014, we launched a large, pragmatic
randomized controlled trial within Group Health to compare
effectiveness of two programmatic approaches for increasing
cervical cancer screening among 17,000 women aged 30–64
years who are overdue (≥3.4 years since last Pap test or never
had a Pap test). The control arm is usual care at Group Health,
consisting of an organized program of patient invitation
and reminders and electronic medical record (EMR)-based
alerts to providers about patients who are not up-to-date with
recommended screening. The intervention arm includes usual
care plus a mailed in-home hrHPV screening kit. Women
mail their screening kits directly to our centralized laboratory,
and hrHPV test results are documented in our EMR to notify
women’s provider teams of appropriate follow-up care.
Primary outcomes are early detection and treatment of cervical
neoplasia. Secondary outcomes are cervical cancer screening
uptake and screening predictors, and patient experiences and
attitudes towards in-home hrHPV testing and follow-up of
hrHPV-positive results. We are surveying 100 responders
and 100 nonresponders to the in-home hrHPV screening
invitation, and interviewing 50 women with hrHPV-positive
results (including those with timely versus late completion of
clinical follow-up).
Results: As of September 2014, 6,194 eligible women were
identified and randomized. We will highlight the study design
and lessons learned from implementing a pragmatic trial.
Discussion: This pragmatic trial will generate evidence-based
data on the impact of an in-home hrHPV screening program in
a real-world clinical setting. Findings will interest organized
programs considering implementing in-home screening and
low-resource countries caring for populations with limited
access to primary care.
Keywords: cervical cancer, cancer screening
B3-1:
The CRN Scholars Program: Career Development
Within CRN
Matthew P. Banegas,1 Diana S. Buist,2 Mara M. Epstein,3
Terry S. Field,3 Grace Clarke Hillyer,4 Jason P. Lott,5
Pamala A. Pawloski6

Supplement

National Cancer Institute; 2Group Health Cooperative;
University of Massachusetts Medical School; 4Columbia
University; 5Yale School of Medicine; 6HealthPartners
1

3

Background/Aims: The Cancer Research Network (CRN)
Scholars Program was launched during the third cycle of the
collaborative grant to increase research capacity within the
CRN. Specific goals of the program include: (1) becoming
a principal investigator on a successful investigator-initiated
grant within the CRN, and (2) primary author on peerreviewed, published manuscripts reporting original research
from the CRN. In addition to developing research expertise
utilizing CRN resources, the CRN Scholars Program fosters
development of skills difficult to acquire in other training
environments, including the initiation of collaborative
research proposals involving stakeholders in integrated
health care delivery systems, use and analysis of complex
clinical, claims and pharmaceutical data, and strategic grant
proposal development tailored to the unique resources and
opportunities afforded by the CRN.
Methods: The 26-month program facilitates individualized
mentorship, creation of research advisory teams for each
scholar comprised of investigators from their home institution
and collaborating CRN sites. Monthly one-on-one mentoring
meetings and quarterly mentoring team meetings enable
scholars to gain familiarity with the CRN landscape to develop
novel, investigator-initiated projects with CRN collaborators.
Additionally, scholars attend semiannual in-person meetings
and conduct bimonthly group conference calls examining
academic career development, writing and review of research
proposals, analytic design, discussing available funding
opportunities, execution of multisite research studies, and
media training.
Results: The first two Scholars Program cohorts included
CRN-affiliated junior investigators, while the current iteration
of the Scholars Program (CRN4) has shifted focus to include
external junior investigator researchers pursuing training in
the conduct of multisite, multidisciplinary population-based
studies. Members of the CRN4 cohort have successfully
received career development awards and independent grants
to support their CRN work, published several first-authored
manuscripts and received awards honoring their research.
Discussion: The CRN Scholars Program is working to
expand the scope and scale of investigators conducting cancer
research within integrated health care delivery systems, a goal
of significant importance given nationwide shifts in policy and
practice in the organization of medical care and emphasis on
population health. Accordingly, the CRN Scholars Program is
well positioned to produce future leaders in cancer research
and, ultimately, improve the lives of patients.
Keywords: scholarship, training
C2-5:
Using Natural Language Processing to Identify
Health Plan Beneficiaries With Pulmonary Nodules
Farhood Farjah,1 Scott Halgrim,2 Steven B. Zeliadt,3
Michael K. Gould,4 David S. Carrell,2 Elizabeth T.
Loggers,5 David R. Flum,1 Diana S. Buist2
www.aurora.org/jpcrr
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University of Washington; 2Group Health Cooperative;
Veterans Administration Puget Sound Health Care
System; 4Kaiser Permanente Southern California;
5
Seattle Cancer Care Alliance

National Cancer Institute; 2Kaiser Permanente
Northwest; 3Kaiser Permanente Colorado; 4Group
Health Cooperative; 5University of South Carolina;
6
Virginia Commonwealth University

Background/Aims: The development of a portable,
automated method for identifying individuals with lung
nodules will facilitate the efficient conduct of populationbased studies of nodule care and associated outcomes. We
evaluated the performance of a previously developed natural
language processing (NLP) algorithm for identifying health
plan beneficiaries with pulmonary nodules.
Methods: A cross-sectional study was performed of 500
randomly selected adult, in-network health plan beneficiaries
with continuous enrollment at Group Health Cooperative who
underwent a computed tomography (CT) of the chest in 2012,
had no history of lung cancer and had not undergone a CT
between 2009 and 2011. An NLP algorithm originally developed
at Kaiser Permanente Southern California assessed electronic
radiology reports using keywords and qualifiers relating to
pulmonary nodules ranging in size from 5 to 30 mm among
individuals who had undergone CT and had an International
Classification of Diseases (ICD-9-CM) diagnostic code for a
lung nodule. This algorithm was applied to our patient population
and modified to identify pulmonary nodules regardless of size. A
trained chart abstractor reviewed radiology reports to determine
whether the radiologist reported a lung nodule. An experienced,
board-certified thoracic surgeon adjudicated radiology reports
with unclear documentation of a nodule.
Results: The true prevalence of pulmonary nodules among
individuals undergoing CT in 2012 — median age 65 years,
43% men, 84% white, 51% smokers — was 34%. Median
nodule size was 6 mm (range 2–87 mm). NLP identified 218
(44%) individuals with a nodule. The accuracy of NLP was as
follows: sensitivity 91%, specificity 81%, positive predictive
value 72% and negative predictive value 95%.
Discussion: An automated method of using NLP and electronic
radiology text reports — originally developed at one Cancer
Research Network (CRN) site — reasonably identifies health
plan members with pulmonary nodules at another CRN site.
This finding supports the notion that automated methods are
portable across integrated health systems and institutions using
electronic medical records. Ongoing work seeks to determine
whether modifications to the NLP algorithm can improve
performance. Given its current performance characterized
by a high negative predictive value, NLP could be used to
decrease the burden of chart abstraction in population-based
studies of nodule care.
Keywords: pulmonary nodule, natural language processing

Background/Aims: The rising economic burden of cancer in
the United States has become a significant public policy issue.
Current knowledge of cancer care costs is largely limited to
Medicare fee-for-service patients age ≥ 65 years, based on
linked Surveillance, Epidemiology, and End Results (SEER)
Medicare data. Accordingly, estimates that reflect care costs
across the cancer experience, from diagnosis to end-of-life and
among individuals < 65 years of age, are needed. This study
estimated total and incremental long-term costs of care for
individuals age ≥ 18 years diagnosed with breast, colorectal,
lung and prostate cancer in integrated health care settings.
Methods: We used administrative and electronic medical
record data linked with tumor registry information for
individuals who were enrolled in one of four nonprofit
integrated health care systems and diagnosed with primary
breast, colorectal, lung or prostate cancer between 1/1/2000–
12/31/2008 (cases). We also identified age-/sex-matched
cancer-free individuals (controls). Participating health systems
included Group Health Cooperative, Henry Ford Health
System, Kaiser Permanente Northwest and Kaiser Permanent
Colorado. Long-term costs (at 5, 10 and 20 years) of care were
based on the Phases-of-Care approach (Initial, Continuing and
End-of-life phases) and measured using the Kaplan-Meier
Sample Average estimator, incorporating cost data from the
standardized relative resource cost algorithm and cancer site-,
age- and stage-specific survival probabilities from SEER.
Costs were calculated for both cases and controls to estimate
total and incremental care costs, stratified by cancer site, age
group (<65 vs. ≥65 years) and stage at diagnosis (advanced
vs. not advanced).
Results: Total and incremental long-term costs of cancer
care were significantly higher among individuals age < 65
years at diagnosis compared to those ≥ 65 years. There was
considerable variability in total and incremental long-term
costs by cancer site and stage at diagnosis.
Discussion: Estimates reported in this study improve our
understanding of the magnitude of long-term economic
resources needed to provide cancer care in the United States
by describing cancer care costs among patients in integrated
care settings and those age < 65 years. Our results will be
directly applicable to future analyses of cancer care costs,
serving as a foundation for cost comparisons across different
health care systems.
Keywords: cost of care, cancer

D3-5:
Long-Term Medical Care Costs of Breast, Prostate,
Lung and Colorectal Cancer for HMO Members

ECI-3:
Disparities in Colorectal Cancer Screening Rates
Among Asian Subgroups in a Large Managed Care
Organization

1
3

Matthew P. Banegas,1 K. Robin Yabroff,1 Maureen
O’Keefe Rosetti,2 Debra P. Ritzwoller,3 Paul A. Fishman,4
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Christopher D. Jensen,2 Joanne E. Schottinger,1 Ann G.
Zauber,4 Theodore R. Levin,2 Virginia P. Quinn1

Supplement

Kaiser Permanente Southern California; 2Kaiser
Permanente Northern California; 3University of
Pennsylvania; 4Memorial Sloan Kettering Cancer Center
1

Background/Aims: Colorectal cancer (CRC) is the second
leading cause of cancer death in the United States. CRC
screening allows for early detection of CRC or its precursors,
and leads to a decrease in CRC incidence and mortality.
National guidelines recommend screening with either an
annual fecal immunochemical test (FIT), a colonoscopy
every 10 years, or a flexible sigmoidoscopy every 5 years
for individuals age 50–75 years. Nationally, the overall
age-adjusted combined CRC screening rates increased from
52.3% to 65.4% between 2002 and 2010; however, screening
rates among Asian Americans were 11% lower compared with
whites, but differences among Asian subgroups is unknown.
Thus, we examined CRC screening rates among Asian
subgroups in a large managed care setting.
Methods: We used electronic data to characterize CRC
screening among Asian subgroups (Japanese, Korean,
Filipino, Asian-Indian, Chinese, Vietnamese, Other Asian)
compared with white non-Hispanics (WNHs). Using
descriptive and multivariable models, we evaluated 408,242
screening-eligible members of Kaiser Permanente Southern
California aged 50–89 years as of January 1, 2010.
Results: Compared with WNHs over the past 3 years,
Japanese were least likely and Koreans were most likely to
have had any CRC screening exam (odds ratio [OR] 0.89,
95% confidence interval [CI] 0.84–0.95; and OR 1.84, 95%
CI 1.68–2.02, respectively). Of those screened, compared
with WNHs, Japanese men were older (mean age 65.2 vs.
62.6). Screened Asian-Indians and Vietnamese had an equal
distribution of men and women, while the other subgroups
had more females. In the previous 3 years, Japanese were
less likely to have had a FIT (41%, 1,742 of 4,301), and
Vietnamese were more likely (56%, 2,248 of 4,018). In the
previous 10 years, Koreans were more likely to have had a
colonoscopy (56%, 1,797 of 3,189) and Filipinos were least
likely (42%, 9,135 of 21,688).
Discussion: CRC screening rates and choice of screening
test differ among Asian subgroups in an insured population.
Further research is needed to understand the reasons for the
differences among Asian subgroups, particularly the Japanese
population.
Keywords: colorectal cancer screening, health care disparities
PD2-1:
Trends in Estrogen Receptor Testing and Tamoxifen
Initiation After Ductal Carcinoma in Situ During
1996–2011
Hazel B. Nichols,1 Erin J. Bowles,2 Diem-Thy Tran,2
Diana S. Buist2

was FDA-approved as adjuvant endocrine therapy for
DCIS patients. We assessed tamoxifen initiation after DCIS
diagnosis according to calendar year, tumor characteristics
and concurrent treatment within Group Health Cooperative
(GHC).
Methods: We identified female GHC enrollees aged 18–89
years with an incident DCIS diagnosis during 1996–2011.
Eligibility criteria required 12 months continuous enrollment
before and after DCIS diagnosis. Tamoxifen initiation was
identified through pharmacy records. Tumor characteristics
and treatment information were captured from the virtual
data warehouse. Relative risks (RR) and 95% confidence
intervals (CI) for tamoxifen initiation were calculated with
multivariable generalized linear models adjusted for age,
calendar year, estrogen receptor (ER) status, radiation therapy
and grade.
Results: We identified 727 women with a DCIS diagnosis,
including 163 (22%) who initiated endocrine therapy within
12 months. Fourteen women filled aromatase inhibitor
prescriptions and were analyzed with tamoxifen users. ER
testing increased from 4% of DCIS cases in 2001 to 71%
in 2011. Women diagnosed with DCIS during 1996–2000
were 43% less likely to use tamoxifen as those diagnosed in
2001–2005 (RR: 0.6, CI: 0.4–0.9). However, tamoxifen use
did not vary significantly across calendar years after 2001.
Among ER-positive tumors, 58% (18 of 31) used tamoxifen
in 2001–2005 compared to 39% (47 of 122) in 2006–2011.
Among women with unknown ER status, 24% (47 of 194)
used tamoxifen in 2001–2005 compared to 15% (21 of 140)
in 2006–2011. Younger women were more likely to use
tamoxifen (RR: 1.7, 95% CI: 1.1–2.6 for age 45–54 compared
to 65–74; P-trend=0.0002). Compared to breast conserving
surgery (BCS) with radiation, women who had BCS without
radiation (RR: 0.5, CI: 0.2–0.9) or mastectomy (RR: 0.6, CI:
0.4–0.8) were less likely to use tamoxifen. Six percent (n=47)
of women had a bilateral mastectomy; of these, < 5 used
tamoxifen.
Discussion: Increasing ER testing since 2001 has not
corresponded to parallel increases in tamoxifen use.
Tamoxifen use after DCIS was more common among younger
women and those who had BCS and radiation therapy.
Keywords: tamoxifen, DCIS
PD2-3:
Tamoxifen and Antidepressant Drug Interactions in
a Large Cohort of Breast Cancer Survivors
Reina Haque,1 Jiaxiao Shi,1 Suzanne Fletcher,2 Joanne
E. Schottinger,1 Syed A. Ahmed,1 T. Craig Cheetham,1
Joanie Chung,1 Chantal Avila,1 Laurel A. Habel,3 Marilyn
L. Kwan3

University of North Carolina; 2Group Health Cooperative

Kaiser Permanente Southern California; 2Harvard
Pilgrim Health Care; 3Kaiser Permanente Northern
California

Background/Aims: Ductal carcinoma in situ (DCIS), a stage
0 breast cancer usually detected on mammogram, accounts
for 24% of all breast cancer diagnoses. In 2000, tamoxifen

Background/Aims: Considerable controversy exists
on whether certain antidepressants reduce tamoxifen’s
effectiveness in lowering recurrence or subsequent breast

1
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cancer. Previous studies have been limited by small sample
sizes, poor measurement of medication use, or inadequate
statistical analysis. Our goal was to determine whether taking
tamoxifen and antidepressants concomitantly is associated
with an increased risk of subsequent breast cancer in survivors.
Methods: We assembled a cohort of 16,887 women who
were diagnosed with their first primary breast cancer (Stage
0–II) from 1996 to 2007 and treated with tamoxifen and
followed through 12/31/2009 at Kaiser Permanente Southern
and Northern California. We collected demographic, tumor,
pharmacy and cancer treatment information. The outcome
measure was risk of subsequent breast cancer. The main
independent variables were fractions of overlap when both
tamoxifen and antidepressant treatments were prescribed.
Hazard ratios (HR) and 95% confidence intervals (CI) were
estimated using Cox regression models.
Results: Overall, 2,946 women (17%) developed subsequent
breast cancer during the 14-year study period. We observed
a small nonsignificant increased risk of subsequent breast
cancer in women who concurrently used paroxetine in the
first full year of tamoxifen use. For every 25% increase in
percent days overlap of tamoxifen and paroxetine use, the risk
increased insignificantly by 6% (HR: 1.06, 95% CI: 0.98–
1.14). However, the risk attenuated with longer tamoxifen
duration.
Discussion: We observed a slight increased risk of subsequent
breast cancer in women who concurrently used paroxetine
in the first year of endocrine therapy. Nevertheless, taking
tamoxifen for a longer duration mitigated such risks.
Keywords: breast cancer, medical treatment
PD2-6:
Data Mining via the Electronic Medical Record to
Identify Inherited Colorectal Cancer in an HMO
Patient Population
Monica Alvarado,1 Hilary Kershberg,1 George Tiller,1
Patty Miller,1 Ivan Lizarraga,1 John Goff,1 Carl Taganas1
Kaiser Permanente Southern California

1

Background/Aims: A family history of colorectal cancer
(CRC) and/or endometrial cancer, especially under age 50,
is suggestive of Lynch syndrome, the most common form
of inherited colorectal cancer. Limited family history (FH)
data are currently collected on our members by nongenetics
providers and recorded in the FH tab of our electronic medical
record (EMR). We used these data as a potential “screening
tool” for inherited CRC.
Methods: We queried our EMR (Epic, Verona, WI) system
to identify individuals meeting the following criteria: 1) age
25–50 years, 2) no personal history of CRC, 3) FH of at least
two relatives with CRC, and 4) accessed our electronic patient
portal at least once in the last year. We identified 444 members
who met all criteria and had not already had a genetics
consultation. All received a secure email requesting additional
personal and FH via a secure electronic questionnaire (created
by using HP Process Automation). Survey respondents
provided information on: a) known mutation in a cancer
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susceptibility gene in the family, b) FH of colon, endometrial
and other cancers, and c) personal/FH of polyps. Based on
their responses, members were informed that: a) genetics
would schedule a consultation to discuss their FH, or b) they
do not appear to be in increased risk for a cancer syndrome.
Results: At present 106 (24%) of those contacted completed
the survey, and 96 (91%) of them meet our moderate/highrisk criteria. Over half have been scheduled/seen and genetic
testing is in progress for some. Males and Hispanic/Latino
members were underrepresented in both the original cohort
and in the group of respondents. Non-Hispanic Caucasians
were overrepresented in both groups.
Discussion: The underrepresentation of males and Hispanics
in both the original cohort and the group of respondents
suggests that gender and racial/ethnic background play a role
in the likelihood of the patient reporting a FH of cancer. The
high proportion of high-/moderate-risk responses suggests that
those with more suspicious histories may be more motivated
to complete the survey. Our results will help us determine if
mining limited FH data in the EMR is an effective method for
identifying inherited CRC syndromes.
Keywords: family history colorectal cancer, data mining
electronic medical record
PD2-7:
Use of Imaging for Staging of Localized Breast
Cancer in Two Integrated Health Care Systems:
Adherence to a Choosing Wisely Recommendation
Erin E. Hahn,1 Tania Tang,1 Janet S. Lee,1 Corrine
Munoz-Plaza,1 Joyce O. Adesina,1 Ernest Shen,1 Braden
Rowley,2 Jared L. Maeda,3 David M. Mosen,4 John C.
Ruckdeshel,2 Michael K. Gould1
1
Kaiser Permanente Southern California; 2Intermountain
Healthcare; 3Mid-Atlantic Permanente Research
Institute; 4Kaiser Permanente Northwest

Background/Aims: The initial American Society of Clinical
Oncology “Top 5” list, created as part of the Choosing
Wisely campaign, recommends against use of imaging for
staging of localized breast cancer in asymptomatic women
at low risk for metastasis. The objective of this study was to
measure and compare use of imaging for staging in two large
integrated health care systems, Kaiser Permanente (KP) and
Intermountain Healthcare (IH). We also sought to distinguish
whether imaging was used for routine staging or for diagnostic
purposes.
Methods: We identified stage 0–IIB breast cancer patients
diagnosed between January 1, 2010, and December 31,
2012, with first primary malignancy from tumor registries
in three KP regions (Southern California, Northwest, and
Mid-Atlantic) and IH. Using the KP and IH electronic
health records, we identified use of imaging tests (positron
emission tomography, computerized tomography [CT], bone
scan) during the staging window, defined as 30 days prior to
diagnosis up to initial cancer-directed surgery. We performed
chart abstraction on a stratified random sample of patients
who received an imaging test to identify clinical indication.

Supplement

Results: For the total sample of 10,014, mean age at diagnosis
was 60 years (range 22–99), with 21% stage 0, 47% stage I
and 32% stage II. Overall, 8% of patients (n=792) received at
least one imaging test during the staging window, including
8% at KP and 6% at IH (P=0.0005). The most commonly
used service was CT, with 82% of imaging services. Chart
abstraction (n=129) revealed that overall, almost half of all
imaging tests (48%) were performed to evaluate a symptom,
sign or prior imaging finding, including 55% at KP and 32%
at IH. Symptoms and signs included chest pain, weight loss
and palpable masses.
Discussion: Use of imaging for staging of low-risk breast
cancer was very low in both health care systems, with
clinically trivial differences between them. Approximately
half of imaging services were in response to a sign or
symptom. Strategies to reduce use of imaging for staging of
localized breast cancer within these health care systems are
unlikely to yield meaningful improvement.
Keywords: breast cancer, diagnosis, staging
PD2-8:
Implementing a Multisite, Transdisciplinary CaseControl Study to Assess Effectiveness of Screening
Colonoscopy for Preventing Death From Colorectal
Cancer (SCOLAR)
Tracy A. Becerra,1 Virginia P. Quinn,1 Douglas A. Corley,2
Michael Goodman,3 Ann G. Zauber,4 Christopher D.
Jensen,2 Alexis Zebrowski,5 Chyke A. Doubeni5
Kaiser Permanente Southern California; 2Kaiser
Permanente Northern California; 3Emory University;
4
Memorial Sloan-Kettering Cancer Center; 5University
of Pennsylvania

patient screening history for a minimum of 10 years prior to
cancer diagnosis (or reference date for controls). In addition
to data quality safeguards, i.e. inter-rater validation or
teleconferences among chart abstractors, expert reviewers
perform adjudication of indications to differentiate screening
from diagnostic procedures, a key methodological strength to
assess true CRC prevention.
Results: To date, 4,753 chart abstractions have been performed,
of which 48.8% of subjects were women, 35.3% were 55–64
years of age, 9.5% were Hispanic, and 70.9% were white. We
found a high level of accuracy using electronic data to capture
receipt of colonoscopy. We are currently performing reviews
and adjudication of data to create indication. Preliminary
results show that 43% had a screening fecal occult blood test
within 2 years of the reference date, 39.7% had a flexible
sigmoidoscopy, and 32% had at least one colonoscopy.
Discussion: We believe SCOLAR provides a model for
overcoming methodological issues affecting case-control
studies of the effectiveness of colorectal cancer screening.
Keywords: colorectal, cancer, screening
PD2-9:
Using Tumor Registry and Electronic Medical
Record Databases to Determine Incidence of
Uterine Sarcoma and Occult Malignancy Within an
Integrated Health Care System
Ted E. Palen,1 Kimberly J. Bishoff,1 Lue-Yen Tucker,2
Tina R. Raine-Bennet2
Kaiser Permanente Colorado;
Northern California

2

Kaiser Permanente

1

1

Background/Aims: Colorectal cancer (CRC) is the second
leading cause of cancer death in the United States. There is
a need for observational studies that assess effectiveness of
“screening” colonoscopy by carefully defining indication
for exam. “Screening for Colorectal Cancer in Average-Risk
Adults (SCOLAR),” is a transdisciplinary study to determine
if colonoscopy is as effective as believed, filling a critical
void in the evidence on effectiveness of CRC screening
interventions in reducing the risk of death in real-world
practice.
Methods: We describe implementation of SCOLAR, an
ongoing case-control study at Kaiser Permanente Northern
and Southern California conducted by investigators from
seven institutions. All subjects had 5 years minimum prior
health plan enrollment, no personal or strong family history of
CRC, or diagnosis of inflammatory bowel disease. Cases are
subjects who died from invasive colorectal adenocarcinoma
(2006–2012) and were 55–90 years old on date of death.
Controls were individually matched to cases on service area,
sex, birth date and enrollment years. SAS programs were
centrally developed and adapted locally for sampling patients
and extracting electronic data to populate a standardized
data collection tool. Data collection involves chart reviews
of electronic medical records and paper charts to identify

Background/Aims: There are currently no reliable estimates
of uterine sarcoma incidence and occult malignancy at
hysterectomy to aid decision-making about surgical route and
policy formulation.
Methods: We identified women 18 years or older who
underwent a hysterectomy and had a new diagnosis of uterine
sarcoma in 2006–2013 in a large integrated health care system.
Clinical presentation including when the diagnosis was not
suspected or known preoperatively was assessed. Age- and
race-specific total and annual incidence of uterine sarcoma
and leiomyosarcoma and occult malignancy were calculated
and evaluated for trends over time.
Results: From 2006 to 2013 there were 93,153 hysterectomies,
of which 49,314 (52.9%) were for leiomyoma or abnormal
bleeding. There were 298 new cases of uterine sarcoma,
more than half (58%) of which were suspected or known
preoperatively. The incidence of occult uterine sarcoma and
leiomyosarcoma among women having hysterectomies for
presumed benign leiomyoma and abnormal bleeding was
2.51 and 1.66 per 1,000 hysterectomies, respectively. The
incidence was significantly higher for women over age 50;
however, there was no significant difference in incidence by
race/ethnicity. The annual incidence of uterine sarcoma did
not increase over the 8-year period.
Discussion: Data from a large, diverse, community-based
U.S. population confirms that uterine sarcomas are rare. The
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risk of occult malignancy must be weighed against the known
benefits of minimally invasive hysterectomy. Our estimates of
the risk of occult malignancy add important information for
discussions between patients and clinicians when considering
minimally invasive surgery and power morcellation and
providing informed consent.
Keywords: leiomyosarcoma, hysterectomy
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PS1-1:
Quality Measures in Early Stage Oral Cavity
Squamous Cell Carcinoma
Steven S. Chang1
Henry Ford Health System
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Background/Aims: Head and neck cancer treatment
practices and outcomes vary from institution to institution.
Other than survival data, there has been no established
method to evaluate an institution’s quality of cancer care.
To address this issue, the American Head and Neck Society
(AHNS) developed quality guidelines for head and neck
cancer care based on systematic literature review and expert
opinion. These guidelines represent critical aspects of
accepted standards of oral cancer care, and the presence or
absence of these measures is most likely to affect the overall
outcome regardless of patient comorbidity. The purpose of
this study is to evaluate the quality of oral tongue cancer
care at our institution and validate these established quality
measures.
Methods: A retrospective chart review of 73 patients treated
at Henry Ford Health System with stage I–III oral tongue
squamous cell carcinoma from 1991 to 2012 was performed,
using 26 clinical measures based on AHNS quality guidelines.
Correlations between parameters and endpoints were assessed
by the Pearson chi-square test or, when there were < 10
subjects in any cell of a 2 × 2 grid, by the two-tailed Fisher
exact test.
Results: Of the 26 measures, 4 major measures were
established. These were postoperative TNM staging (95.2%
compliance rate), documentation of margin status in
pathology reporting (93.6%), appropriate referral for radiation
postoperatively based on NCCN guidelines (96.8%), and neck
dissection based on > 4 mm depth of invasion of the primary
(performed in 84.5% of the qualifying patients). Overall 5-year
survival for patients evaluated before 2007 was 58%. Of the
26 clinical endpoints, a majority of demographic and social
history information was present with a compliance of 95%.
However, other clinical endpoints such as preoperative speech
pathology evaluation or dental evaluation had compliance
rates of < 20%.
Discussion: We were able to successfully review our own
practice, validate the AHNS quality measures and identify
areas that require improvement. This provides support to
the validity of the major measures of quality head and neck
cancer care established by the AHNS.
Keywords: head and neck cancer, quality
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Background/Aims: Despite recent reductions in incidence
and mortality, colorectal cancer remains the third most
commonly diagnosed cancer and the third leading cause
of cancer death among both men and women in the United
States. Accordingly, research supported by initiatives such as
the Cancer Research Network (CRN) is of utmost importance
in further reducing the burden of this disease. The CRN is a
consortium funded by the National Cancer Institute to support
cancer research among a subset of HMORN sites. The data
collected and maintained by the nine funded and six affiliate
CRN sites facilitate a variety of colorectal cancer research
opportunities.
Methods: Data from nine funded and two affiliate CRN sites
were included in this analysis. Counts and characteristics
of primary malignant colorectal tumors diagnosed during
2004–2012 were obtained from the CRN Cancer Counter, an
informatics tool that provides aggregated counts to facilitate
study planning. Site-specific descriptive analyses included
annual counts of incident cases as well as distributions of
demographic characteristics and American Joint Committee
on Cancer (AJCC) stage. Additional information — including
updated diagnoses through 2013 and availability of treatment
and site-specific factor data — will be obtained from a
centrally developed SAS program to be run against the virtual
data warehouse at participating sites in early 2015.
Results: From 2004 to 2012, more than 42,000 colorectal
cancers were diagnosed among patients of 11 CRN sites;
two Kaiser Permanente health plans (Northern and Southern
California) accounted for more than 60% of all diagnoses.
The majority (57%) of diagnoses occurred in persons aged
65+ years, although that proportion ranged from 36% to 76%
across sites. AJCC stage was available for > 90% of total
diagnoses with a range of 67% to 98% across sites. White
persons comprised the majority (76%) of cases, although the
proportion varied considerably (from 32% to 96%) by site.
Discussion: The CRN supports the infrastructure to
maintain high-quality data (from local tumor registries as
well as internal health plan systems) on patients diagnosed
with cancer at participating sites. Furthermore, CRN sites
encompass a wide distribution of geographic locations and
patient characteristics. Thus, the CRN provides a uniquely
data-rich setting in which to pursue colorectal cancer research.
Keywords: colorectal cancer, virtual data warehouse
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Background/Aims: Neutropenia, an extreme reduction in
infection-fighting white blood cells, is a dangerous side effect of
cytotoxic chemotherapy for cancer treatment, especially when
accompanied by fever. Neutropenia and febrile neutropenia
are associated with treatment delays, chemotherapy dose
reductions, hospitalizations, antibiotic use, death and high
costs. The granulocyte-colony stimulating factors (G-CSFs),
filgrastim, pegfilgrastim and tbo-filgrastim, reduce the risk of
neutropenia and febrile neutropenia; however, they are also
associated with additional patient visits, side effects and high
treatment-related costs. G-CSF use was found to be inconsistent
with recommended clinical guidelines (overuse among those at
low risk and underuse among those at high risk for neutropenia),
thus making it part of the Choosing Wisely campaign. Individual
patient factors are associated with increased risk for neutropenia
and febrile neutropenia beyond that of the prescribed
chemotherapy. No study has investigated the effect of providing
medical oncologists with neutropenia risk predictions in real
time to optimize the use of G-CSF and reduce neutropenia/febrile
neutropenia outcomes among patients. The ongoing work will
assess the feasibility of applying an existing patient neutropenia
risk model developed by Lyman et al. to existing electronic data
files. This work builds upon feasibility work currently being
conducted at HealthPartners Institute, Minneapolis, MN, and
adds two more CRN sites (Group Health Research Institute,
Seattle, WA, and Henry Ford Health System, Detroit, MI).
Methods: We will investigate the applicability of an adapted
risk model to readily available electronic data (excluding
clinical oncology treatment modules). We will adapt Lyman’s
model to work with available data, provide external validation
and calibrate the adapted model for our patient population.
Results: To date, we have obtained IRB approval to conduct
the study and are developing a distributed modular program
for extraction of clinical and administrative data variables
available in the HMORN’s virtual data warehouse.
Discussion: This presentation will report preliminary data
on neutropenia and febrile neutropenia rates, chemotherapy
treatment variations and G-CSF use among racially and
geographically diverse sites. The current CRN study will
provide a necessary foundation for a planned external proposal
designed to test and implement a real-world risk assessment
tool intended for use by clinicians at the point of care.
Keywords: neutropenia, risk model
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Background/Aims: Surgical treatment for rectal cancer can
result in an intestinal ostomy that requires lifelong adaptation
and investment of physical, cognitive and financial resources.
However, little is known about the prevalence of functional
limitation related to ostomies among long-term cancer
survivors.
Methods: In 2010–2011, we mailed questionnaires to 313
long-term rectal cancer survivors with ostomies (≥5 years
postdiagnosis) from two Kaiser regions, Northern California
and Northwest. Potential participants (KP members age ≥18
years) were identified through tumor registries. The response
rate was 66% (183/277). Data from the electronic medical
record included hernia diagnoses and comorbidity score.
Results: Of respondents with ostomy who reported wearing
a pouch (not irrigating), 64% (103/160) were male. Mean age
at survey was 75 years. Health status: Health problems that
could affect ostomy care capacity were fairly common. Mean
body mass index (BMI) at time of survey was 26.76 (standard
deviation 5.42), with 70% (105/150) of respondents reporting
a significant change (+/-) in BMI since time of surgery; 28%
(45/160) of respondents had a hernia diagnosis at some time
after their surgery. Adaptive resources: Of participants who
reported paying for their ostomy supplies, 55% (39/71)
had at least some difficulty paying the cost. Women were
significantly more likely to report difficulty than men
(P=0.011). Fifteen percent (23/155) reported receiving help
with their ostomy care. While 63% (100/160) of respondents
were partnered at time of survey, women were significantly
less likely to be partnered than men (p< 0.001). Functional
limitations related to ostomy: 27% (39/147) of respondents
reported changing their ostomy wafer or appliance more often
than every 3 days, 27% (41/154) had problems with ostomy
leakage, 25% (39/155) had problems with the skin around the
ostomy, and 21% (33/155) reported having difficulty caring
for their ostomy.
Discussion: Most rectal cancer survivors have health
conditions that can worsen impairment and undermine
adaptive capacity related to ostomy care and report difficulty
paying for their ostomy supplies. Approximately 25% of
survivors experienced limitations across multiple domains of
ostomy-related functioning, yet only 14% reported receiving
assistance with ostomy care. Further research should explore
whether/how gender and partnered status influence resources
or unmet needs for ostomy care assistance.
Keywords: survivorship, ostomy
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Background/Aims: Granulocyte-colony stimulating factors
(G-CSFs) are indicated to decrease the incidence of infections
associated with chemotherapy-induced neutropenia (a severe
reduction in white blood cells) in cancer patients receiving
myelosuppressive chemotherapy. Severe neutropenia or febrile
neutropenia occurs in 25–40% of treatment-naïve patients
and are associated with increased infection rates, treatment
delays, dose reductions, hospitalizations, deaths and increased
costs. In addition to the chemotherapy treatment regimen,
patient-specific factors influence neutropenic risk. Current
guideline recommendations do not include a mechanism
to quantify patient risk when determining need to G-CSF
support. Studies report over- and underuse of G-CSF among
those at low and high risk for neutropenia. A neutropenia risk
model developed by Lyman et al. showed prior chemotherapy,
relative dose intensity (RDI), abnormal liver and renal
function, and low white cell count are major risk factors. We
are testing the feasibility of using readily available clinical
and administrative data from the HealthPartners electronic
medical record and Oncology Treatment Module to apply the
Lyman model to data from adult cancer patients receiving first
cycle chemotherapy.
Methods: We included breast, colorectal, lymphoid, lung and
ovarian cancer patients to compare abstracted chart data to
electronically extracted data. We will adapt the Lyman model
to predict neutropenia risk using our database. We also will
extract electronic data from our site’s virtual data warehouse
(VDW) for comparison with sites participating in a separate
CRN-funded pilot project to evaluate the feasibility of using
VDW data to predict neutropenic risk.
Results: We identified and abstracted data on 235 patients
who received one of 60 treatment regimens. The median age at
diagnosis was 61 (range 30–86) and 32% were male. Of those,
92 (39%) received G-CSF. The most commonly administered
chemotherapy included cyclophosphamide, etoposide,
5-fluorouracil and doxorubicin. Manually abstracted data
will be used to validate the electronically extracted data.
Data validation, including inter-rater reliability and RDI, is
ongoing.
Discussion: G-CSF use among chemotherapy patients can be
identified in electronic oncology treatment records. Validation
of key variables to determine the feasibility of using electronic
data for risk determination is ongoing.
Keywords: neutropenia, risk model
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Background/Aims: The treatment for ductal carcinoma
in situ (DCIS) is similar to invasive breast cancer despite
evidence of low 10-year recurrence rates and mortality.
Patient preferences and involvement with decision-making
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should play a key role in treatment decisions; however, little
are known about how decision-making about the type of
treatment influences patient-reported outcomes. The objective
is to review the recent literature to determine how decisionmaking for treatment of DCIS influences patient-reported
outcomes and to make recommendations on future studies to
improve decision-making practices.
Methods: A search of PubMed database was conducted for
manuscripts published 2009–2014. Search terms included
“ductal carcinoma in situ” and “satisfaction with treatment”
(n=33), “decisional conflict” (n=1) or “patient decision
making” (n=137). Only articles that included patient-reported
decision-making were included in the review. Articles
were excluded if they aggregated patients with invasive or
metastatic breast cancer.
Results: There were a total of 11 articles included in the
review. We found that decisional conflict among patients
was common. Physicians play an important role in women
understanding the disease; however, there is controversy
about treatment of DCIS among experts. Decisional conflict
was related to a lack of knowledge about the disease,
which led to confusion, anxiety, fear and depression. The
studies showed that conflicting messages from health care
professionals negatively impacted patient’s abilities to make
informed treatment decisions and patient-reported outcomes.
In terms of health disparities, one study found that a lack of
understanding about DCIS was greater in women from nonEnglish speaking backgrounds. Recommendations for future
research include: 1) improve knowledge of DCIS and its
complexities among health care professionals and patients,
2) address knowledge gaps by developing and testing the
efficacy of “decision aids” to improve patients comfort in
making informed treatment choices, 3) evaluate why various
messages about DCIS exist among health care professionals,
and 4) address the need to establish consensus on guidelines.
Discussion: The literature suggests that patients often have
a lack of knowledge and experience adverse psychological
outcomes associated with a diagnosis of DCIS. More research
is needed to improve informed treatment decisions about the
disease for patients diagnosed with DCIS.
Keywords: DCIS, treatment, decision-making
PS1-16:
The Effects of a Nonclinical Caregiver’s Presence
When a Cancer Patient Is Receiving Highly
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Background/Aims: A cancer diagnosis not only affects the
patient but also affects the patient’s family and friends. The
primary treatment of cancer is chemotherapy. Nausea is the
side effect of chemotherapy most patients fear. The study
aimed at examining another aspect of helping patients cope
with chemotherapy side effects.
Methods: Medical records of patients currently receiving
chemotherapy were reviewed to determine eligibility.
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Participants had to be able to speak, read and understand
English, and their chemotherapy protocol must have included
at least one highly emetogic-classified chemotherapy drug
from the following: Carboplatin, Cytoxan, Adriamycin or
Cisplatin. Forty-one participants agreed to be part of the
study. Participants were classified into two groups. Group A
included 23 participants who had a family or friend caregiver
present during their treatment session. Group B included 16
participants who were alone during their treatment session.
Twenty-four hours postchemotherapy the participant was
asked to rate their nausea on a 5-point Likert scale (0=none,
4=symptoms associated with life-threatening consequences).
They also were asked to report if they had taken any antinausea medication (Compazine), and specifically how many
pills in the last 24 hours. Seventy-two hours postchemotherapy
the participant was asked to complete the Functional Living
Index-Emesis; responses to each question were on a 7-point
Likert scale.
Results: The study examined the possibility of a relationship
between a nonclinical caregiver’s presence, their level of
nausea symptoms and their quality of life. The study showed
that a nonclinical caregiver’s presence did not affect the
patient’s symptoms of nausea or their need to take less antinausea medications. The study supports the idea that a cancer
patient’s quality of life can be improved by the presence of
a nonclinical caregiver during a patient’s treatment session.
Discussion: The study’s findings suggest there is a benefit to
an improved quality of life if a cancer patient receiving highly
emetogenic chemotherapy medication has a nonclinical
caregiver with them during the time of administration.
Although, cancer patients having a nonclinical caregiver
present at their side while they receive chemotherapy seems
to have no effect on a patient’s reported nausea levels.
Keywords: caregiver, chemotherapy
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Background/Aims: In studies of cancer incidence, it is often
desirable to exclude individuals with any prior cancer. While
the virtual tumor registry (VTR) can be a valuable tool in
identifying cancer cases, these data may be incomplete. In
particular, cancers diagnosed prior to health plan enrollment,
or diagnosed out of network, may not be captured in the
VTR. Further, data in the VTR may lag several months
behind, so recently diagnosed cases may be missed. As part
of a new study, we needed to identify cancer-free adults in
the current Kaiser Permanente Colorado member population.
To accomplish this, we developed an algorithm using our
electronic medical record (EMR) data to identify individuals
who have never had cancer.
Methods: Kaiser Permanente Colorado members between the
ages of 40–75 years who were continuously enrolled during
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2013 were included. We used administrative and EMR data,
including the VTR, chemotherapy files, and inpatient and
outpatient claims, to identify those with a high likelihood of
prior cancer.
Results: A total of 203,888 members met our initial inclusion
criteria. The algorithm flagged 31,885 (15.6%) people as
having a history of cancer. Of these, 10,494 (33%) cancer cases
were identified by the VTR, 9,125 (29%) were identified with
only a diagnosis code of cancer, and 7,812 (25%) had only a
receipt of chemotherapy. Having at least 2 visits to oncology
accounted for 1,324 (4%) cases. The remaining 3,130 (10%)
cases were a combination of the aforementioned categories.
Most cases, 29,126 (91%), were identified as having cancers
prior to 2013. Of those with prior cancer, 61% were women.
Those flagged as having cancer were significantly older,
with mean age 61 (9.2 standard deviation) compared to 56
(9.4 standard deviation) for those without cancer (P<0.0001).
Chart reviews for 100 patients identified as not having cancer
are underway to determine the algorithm’s specificity.
Discussion: It is important to consider data sources outside
the VTR to capture all health plan members with a history
of cancer. Casting a wide net will help ensure that anyone
with a history of cancer, whether diagnosed recently or prior
to joining the health plan, will be identified.
Keywords: cancer, tumor registry
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Background/Aims:
Atherosclerotic
cardiovascular
disease (ASCVD) accounts for 1 in every 3 deaths in the
United States, and studies show that the precursors of
atherosclerosis are apparent early in life. The correlation
between childhood cardiovascular risk factors and the extent
of atherosclerosis in adulthood has led to the development
of guidelines aimed at attenuating ASCVD risks in youth.
One major ASCVD risk factor is dyslipidemia, including
both familial hypercholesterolemia (FH) and lifestyle-related
hyperlipidemia. Currently, few studies have investigated
temporal lipid screening and treatment trends in youth and
guideline adherence before and after the 2011 update, which
includes universal lipid screening and targeted screening
recommendations. The purpose of this study is to identify
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lipid screening and treatment trends and guideline adherence
in a diverse population of children and adolescents across
multiple health care systems participating in the Pediatric
Cardiovascular Risk Network (P-CVRN) study. This data is
also essential to provide up-to-date cost-effective analyses
(CEA).
Methods: Institutional Review Board approval was obtained
for this study. This retrospective database study includes >
600,000 youth age 2 to 21 years with at least one outpatient visit
captured across five P-CVRN sites between 2001 and 2013.
The following de-identified data was captured and extracted
at an individual patient level from inpatient and outpatient
claims data: patient demographics, diagnoses, pretreatment
laboratory values, initial lipid-lowering medications and
doses, initial posttreatment laboratory values and presence of
other risk factors or conditions.
Results: The data collected was used to analyze trends in
pediatric lipid management and inform contemporaneous
CEA related to pediatric lipid screening and treatment. Our
data revealed that screening rates declined at most sites
and varied from a peak of ~25% to a low of ~5% of youth.
Lipid-lowering medications were prescribed in 0.02–0.19%
of all youth, and prescribing did not generally increase over
time. Lipid-lowering medication and dose initiation, pre- and
posttreatment laboratory values, and medication possession
ratio were analyzed using logistic regression. CEA did not
support the benefit of universal lipid screening in youth.
Discussion: Current screening trends indicate that health care
providers are nonadherent with guideline recommendations,
and CEA reveals that universal screening in youth is not costeffective.
Keywords: lipid management, youth
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Background/Aims: Aromatase inhibitors (AIs) reduce
breast cancer incidence in primary prevention trials (MAP3,
IBIS2). However, controversy regarding AI’s influence on
cardiovascular disease (MI, angina and cardiac failure) (Amir
et al., J Natl Cancer Inst., 2011) could limit use in prevention
settings.
Methods: We assembled a cohort of 13,273 postmenopausal
breast cancer patients initially cardiovascular disease (CVD)free at diagnosis in a large managed care organization. Women
were diagnosed 1991–2010, and followed through 2012. The
outcome, CVD risk, was compared across endocrine treatments
(AI, tamoxifen [TAM], both, or neither). Information on
demographics, comorbidity (diabetes, hypertension, etc.) and
covariate medications (antihyperlipidemics, antihypertensives
and other CVD drugs) were available from electronic medical
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records. We conducted Cox models using time-dependent
endocrine drug use variables adjusted for age, demographics,
comorbidity, CVD drug use, cancer treatment, tumor
characteristics and tumor laterality.
Results: Among the 13,273-patient cohort, postmenopausal
women who used AIs exclusively had a similar risk of ischemic
disease (hazard ratio [HR]: 0.97, 95% confidence interval [CI]:
0.78–1.22) and stroke (HR: 0.97, 95% CI: 0.70–1.33) versus
those who used TAM only (HR: 1.00, reference). However,
women who used AIs only had a higher risk of other CVD
disease combined (congestive heart failure, cardiomyopathy,
dysrhythmia, valvular dysfunction, pericarditis) (HR: 1.26,
95% CI: 1.11–1.43) than those exposed to TAM only. The risk
of other CVD disease was greater among women exposed
to sequential TAM and AI treatment. The results are based
on 3,711 CVD events occurring in 72,886 woman-years of
follow-up. Based on a subset of 7,982 patients who underwent
breast irradiation, the risk of CVD overall was greater among
women who used AIs only and received left-sided irradiation
(HR: 1.21, 95% CI: 1.02–1.44).
Discussion: Results indicate that variation exists in the type
of CVD events that occur in breast cancer patients receiving
AIs compared to tamoxifen users. For example, the risk of
ischemic disease or stroke was not elevated in those who used
AIs only versus TAM users. However, overall CVD events
were greater in women who used AIs only (or sequentially
after TAM), especially if they received left-sided breast
irradiation. While these observational study results require
cautious interpretation, they provide a basis for comparing the
benefits and risks of endocrine treatments.
Keywords: breast cancer, cardiovascular disease
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Background/Aims: Guidelines have been established
for the care of type 2 diabetes (T2DM) patients. However,
~50% of adult patients receive the recommended care.
Factors contributing to the low rate may include shortage
of primary care physicians (PCP) and lack of knowledge
and compliance at the patient level. To close this care gap,
Kaiser Permanente Southern California (KPSC) initiated
proactive panel management (PPM). PPM is a standardized
and centralized process in which a health care team supports
physicians by proactively identifying and evaluating patients
with key and actionable care gaps, and providing patientspecific recommendations to help close the gaps. Patients with
glycated HbA1c ≥ 9% were eligible. The purpose of this study
was to evaluate clinical comparative effectiveness of PPM in
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achieving HbA1c control (defined as glycated HbA1c < 9%).
Methods: Data for 10,581 adult T2DM patients who had
glycated HbA1c ≥ 9% in 2011 (baseline) but had not received
PPM in that year were extracted from electronic medical
records. Logistic regression was used to evaluate effectiveness
of PPM in 2012 (follow-up) on HbA1c control.
Results: Among the 10,581 patients, 6,728 (63.6%) received
PPM during 2012. At baseline, receivers were more likely
to be 45–64 years of age, female, and had more years of
education than nonreceivers. The two groups were similar
in race/ethnicity and household income. During follow-up,
the PPM group had a greater reduction in HbA1c (mean
[standard deviation]: -2.0 [2.2] vs. -1.6 [2.1], P<0.0001) and
a higher percentage of patients achieved HbA1c control (63%
[4,232 of 6,728] vs. 54% [2,079 of 3,853], P<0.0001) than
the non-PPM group. The differences were not explained by
social demographics, baseline service utilization and HbA1c.
More patients in the PPM group had a PCP visit and used an
antidiabetic medication than the non-PPM group during 2012;
these two factors explained the majority of the association
between PPM and HbA1c control. PPM was most effective
for patients with higher educational attainment, no PCP visit
or use of any antidiabetic medication at baseline.
Discussion: PPM using patient-level information in electronic
medical records and technology within a prepaid health care
delivery system can effectively increase diabetic control for
high-risk T2DM patients.
Keywords: diabetes, care improvement

to VVA diagnosis and treatment in their practice. A list of
potential barriers and an open-ended response option were
provided.
Results: The response rate was 34% (120/353). Knowledge
about VVA was good; 67% (641/953) of responses were
correct. Only 39.5% (47/119) of clinicians were likely
to assess VVA in a postmenopausal patient if she did not
mention symptoms. Most clinicians rated their confidence
in counseling their patients as medium or less regarding
menopause-related vaginal discomfort (56.1%; 67/118) and
the risks/benefits of vaginal estrogen therapy (58%; 69/119).
Commonly reported barriers were lack of time during the visit
(75.4%; 86/114), lack of patient education materials (45.6%;
52/114) and clinical tools (18.4%; 21/114), patient discomfort
with discussing vulvovaginal concerns (41.2%; 47/114),
warnings about risks of estrogen medication in elderly women
(36.8%; 42/114), and the clinicians’ lack of knowledge about
VVA (32.5%; 37/114).
Discussion: Provider knowledge about VVA symptoms and
treatment is generally good. Barriers to patient care such as time,
lack of clinical support tools, and patient-provider discomfort
with discussion of VVA may explain why this easily treated
condition is frequently underdiagnosed and undertreated. Our
second abstract describes the intervention phase of our study,
which includes the design and implementation of a clinicianfocused intervention to improve diagnosis and management
of symptomatic VVA.
Keywords: patient care improvement, postmenopause

B1-6:
Design and Implementation of a Clinician-Focused
Intervention to Improve Diagnosis and Management
of Symptomatic Vulvovaginal Atrophy: ClinicianReported Barriers

B4-1:
Problematic Events in Critically Ill Patients: The
Perspectives of Surrogate Decision-Makers

Kimberly K. Vesco,1 Joanna Bulkley,1 Amanda Clark,1
Kate Beadle,1 Ashley Borin,1 Michael Leo1
1

Kaiser Permanente Northwest

Background/Aims: Nearly 50% of postmenopausal women
experience symptoms related to vulvovaginal atrophy
(VVA) including vulvovaginal dryness and irritation, painful
intercourse, dysuria, urinary urgency and incontinence,
and recurrent urinary tract infection. Effective treatment
options are available, however few women seek treatment
for these symptoms and few providers ask women if they
are symptomatic. As part of the development of a clinicianfocused intervention to improve diagnosis and management
of symptomatic VVA among Kaiser Permanente Northwest
patients, we conducted a survey of primary care and OB/
GYN clinicians to assess provider knowledge about VVA and
barriers to its diagnosis and treatment.
Methods: We sent an email invitation to take a short online
survey to all 353 Kaiser Permanente Northwest primary
care and OB/GYN clinicians with valid email addresses.
The survey included VVA knowledge questions related to
symptoms, diagnosis and treatment, and practice assessment
questions. We asked clinicians to report all potential barriers

Supplement

Kimberly A. Fisher,1 Sumera Ahmad,1
Jackson,2 Kathleen M. Mazor2

Madeline

University of Massachusetts Medical School; 2Meyers
Primary Care Institute
1

Background/Aims: Critically ill patients are particularly
vulnerable to breakdowns in medical care due to the severity
and complexity of their illness. Although many critically ill
patients are unable to communicate or participate in their own
care, their surrogate decision-makers (SDMs) are likely to
have important insights regarding preventable problematic
events that may occur in the intensive care unit (ICU). We
describe the perspective of SDMs of critically ill patients with
such events.
Methods: We enrolled SDMs of adult critically ill patients
with respiratory failure in any of the 7 ICUs at a single
tertiary medical center in central Massachusetts. Participating
SDMs were contacted by telephone approximately 4 weeks
after the patient’s discharge and screened for those who
identify a problematic event. Problematic events are defined
as something that “went wrong,” that could have been
prevented, and that had a deleterious impact on the patient
or SDM. Participants who identify an event that meets the
above criteria were invited to undergo an in-depth qualitative
interview.
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Results: Of the 127 SDMs we approached for participation,
91 (72%) agreed to participate, and complete follow-up is
available on 70 of the 91 participants (77%). Of those with
complete follow-up, 43% (30 of 70) identified at least one
eligible problematic event, with many SDMs identifying
multiple events. Problematic events included breakdowns
in medical care (delay in diagnosis, misdiagnosis, delayed
or inadequate treatment, preventable complications, and
premature discharge) and major lapses in communication
(insufficient information, inadequate access to health care
providers, problems with communication regarding end-oflife preferences, and episodes of rude or dismissive treatment
by health care providers). These problems had a significant
negative impact on patients and their families leading to
physical harm, prolonged hospitalization, rehospitalization,
severe emotional distress, life disruption, and provision of
medical care inconsistent with patients’ wishes.
Discussion: SDMs frequently identify preventable problems
in the care of critically ill patients with significant adverse
consequences for both patients and SDMs. These findings
highlight the importance of the perspective of SDMs of
critically ill patients in understanding breakdowns in care and
may identify targets for preventing such events.
Keywords: patient safety, qualitative

other vaccines because “they make it up fresh each year” as
compared to a vaccine where “it has been given for years.”
The majority of participants cited relationships of family,
friends or coworkers as influencing their own vaccination
decision. While some participants cited concern for others’
health as a reason to get vaccinated (“it’s not fair if you get
sick and spread it to everybody else”), others voiced concerns
that care-giving responsibilities could be compromised if
the vaccine induced illness. Several participants had not
previously heard of the pneumococcal vaccine. Preferred
modes of information on vaccination included verbal and
electronic; hard-copy handouts were preferred by slightly
fewer patients. When asked about effective messaging, some
responded unfavorably to message components perceived to
be condescending or intrusive (“our records indicate that you
haven’t yet gotten this vaccine”).
Discussion: We identified several potential barriers to
vaccination for patients who were not up to date with
influenza or pneumococcal vaccination. Based on these
findings, we are developing patient messages that include
references to protecting the health of friends and family but
which minimize language implying that the sender has been
monitoring vaccination behavior.
Keywords: flu vaccine, qualitative

B4-4:
System Alignment for VaccinE Delivery (SAVED):
Qualitative Interviews Inform a Technology-Based
Intervention to Improve Influenza and Pneumococcal
Vaccination Rates

B4-5:
An In-Depth Interview Study of Immunization
Providers to Understand Practice Patterns, Barriers
and Facilitators for Administering the 3-Dose HPV
Vaccine Series

Sarah L. Cutrona,1 Larry Garber,2 Lloyd Fisher,1 Peggy
Preusse,3 Sarah L. Goff,4 Meera Sreedhara,2 Madeline
Jackson,2 Devi Sundaresan,3 Kathleen M. Mazor2

Melissa Preciado,1 Sharon M. Hudson,1 June Rondinelli,1
Beth A. Glenn,2 Chun Chao1

University of Massachusetts Medical School; 2Meyers
Primary Care Institute; 3Reliant Medical Group; 4Baystate
Medical Center
1

Background/Aims: Influenza and pneumococcal vaccines
are beneficial but underutilized. Patient interviews may help
identify effective outreach strategies and increase vaccination
rates.
Methods: We conducted in-depth qualitative interviews with
a purposive sample of adults whose primary care physicians
were part of a large multispecialty group practice in central
Massachusetts. Interviews occurred between April and
October 2014, with individuals who were not up to date on
either influenza or pneumococcal vaccines. The goal of the
interviews was to: (a) understand barriers to influenza and
pneumococcal vaccination, and (b) inform development of
provider educational materials and patient outreach materials.
Results: We interviewed 14 people, 57% under age 65 (8 out
of 14); 64% female (9 out of 14) (additional interviews are
in process). Major themes included trust, influence of family
and friends, and impact of vaccination choice on others.
Many participants trusted their doctor’s recommendations but
did not trust vaccine safety and efficacy. In some cases, the
safety of influenza vaccines was compared unfavorably with
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Kaiser Permanente Southern California; 2University of
California Los Angeles
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Background/Aims: Vaccination with the quadrivalent human
papillomavirus (HPV) vaccine presents an opportunity to
reduce the burden of conditions caused by HPV types 6,
11, 16 and 18. Despite increases in HPV vaccine initiation
since its introduction in 2006, the 3-dose series completion
rate among age-eligible males and females remains low.
Provider recommendation has been identified as one of the
strongest influences on HPV vaccine initiation. However,
limited research has examined the contribution of provider
factors to HPV vaccine completion. The purpose of this study
was to gain an understanding of barriers and facilitators to
HPV vaccine series completion from the perspective of
immunization providers.
Methods: Rates of HPV vaccination were examined for 201
pediatrics and family medicine clinics serving adolescent
members in Southern California. These clinics were ranked
with regard to the proportion of age-eligible males and
females who completed the 3-dose HPV vaccine series in
order to identify the three highest and three lowest performing
clinics. Data were collected through semistructured telephone
interviews within three subsets of immunization providers:
pediatricians, family practice physicians, and immunization
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nurses. Our goal was to interview at least 10 providers
from each subset within the highest and lowest ranked
clinics in order to reach thematic saturation. Providers were
recruited through presentations at staff meetings and via
email and telephone. The Health Behavior Framework and
the Competing Demands Model were used to develop the
interview guide.
Results: Sixty-two interviews were conducted from
December 2013 to August 2014; 30 providers were recruited
from clinics with the lowest completion rates and 32 from
the highest-performing clinics. Interviews were recorded and
transcribed verbatim. Interviews focused on the following
themes: 1) provider knowledge, attitudes and behaviors,
2) perceptions of patient knowledge and attitudes, and 3)
system-level influence on vaccination. Data analysis using
Nvivo software is ongoing. It is anticipated that final theme
generation will be completed by December 2014. Additional
results will be discussed.
Discussion: We expect that the results of this study will help
guide the design of multilevel interventions targeting the
provider and health care system to improve HPV vaccine
series completion.
Keywords: HPV vaccine, adherence

Results: Among 7,026 patients (69% KA, 31% PT-only),
27% had partial/total knee replacement surgery during
follow-up. PT-only patients were older and more likely to be
female, have greater comorbidity and utilize health services
more frequently than patients with KA. After accounting for
differences between groups, KA patients were no better off than
PT-only patients in terms of time to knee replacement surgery;
cumulative incidence of knee surgery was significantly higher
for those who received KA vs. PT-only (hazard ratio: 1.30,
95% confidence interval: 1.16–1.46). No differences in
utilization for knee pain, narcotic medication dispenses or
knee injections were observed between the groups.
Discussion: For patients with meniscal damage complicated
by OA, treatment with KA does not result in better clinical
outcomes than PT-alone. Considering Choosing Wisely and
Kaiser Permanente organizational goals, reduction in KA
procedures performed for these patients may be warranted.
Keywords: orthopedic surgery, comparative effectiveness
D3-1:
Value of Primary Care Diabetes Bundle Management:
Long-Term Impact on Cost
Daniel D. Maeng,1 Yan Xiaowei,1 Thomas R. Graf1

C1-5:
Evaluation of Knee Arthroscopy as a Low-Value
Intervention for Treatment of Meniscal Damage in
Patients With Osteoarthritis
Mary Helen Black,1 Ronald A. Navarro,1 Annette L.
Adams1
Kaiser Permanente Southern California

1

Background/Aims: Patients presenting to their physicians
with knee pain are often evaluated for osteoarthritis (OA)
and/or meniscal damage. To alleviate pain and delay/prevent
more invasive knee surgery, meniscal damage is typically
treated with knee arthroscopy (KA) even if mild/moderate
OA is present. However, recent randomized trials suggest that
KA for meniscal damage in the setting of OA does not result
in improved physical functioning and/or greater pain relief
than treatment with physical therapy (PT) alone. Given these
data, our aims were: 1) determine the demographic/clinical
patient factors that lead to treatment with KA or PT-only, and
2) assess differences in clinical outcomes for KA vs. PT-only.
Methods: The cohort is comprised of patients aged > 45 years,
with > 2 years membership, no prior knee surgery and recent
history of OA at the time of meniscal tear diagnosis (2003–
2006). Patients were followed from date of surgery (KA) or
first PT visit (PT-only) until partial/total knee replacement
surgery, death, disenrollment or end of study (12/31/2013),
whichever occurred first. Cox proportional hazards and
robust Poisson models were used to estimate the risk of knee
replacement surgery and greater utilization/medication use,
respectively, associated with KA vs. PT-alone. Demographic/
clinical characteristics were used to derive a propensity
score, and inverse probability of treatment weights applied to
individual observations in the estimation of model parameters.
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1

Geisinger Health System

Background/Aims: In 2006, Geisinger’s primary care clinics
implemented an all-or-none diabetes bundle system of care,
which has been shown to be associated with reduced risk of
retinopathy, stroke and myocardial infarction (Bloom et al.,
2014). This follow-up study estimates long-term cost savings
associated with patients’ exposure to the all-or-none bundle of
measures for primary care management of diabetes.
Methods: Claims data from Geisinger Health Plan were used
to identify those who met Healthcare Effectiveness Data and
Information Set criteria for diabetes and had two or more
diabetes-related encounters on different dates before 2006.
A cohort of 2,426 members exposed to the diabetes bundle
was then compared against a propensity score-matched
comparison cohort of 1,836 members from January 1, 2006,
through June 30, 2013. A set of generalized linear models
with log link and gamma distribution was estimated. The key
explanatory variable was each member’s bundle exposure
measured in month. The dependent variables were inpatient
and outpatient facility costs, professional cost and total
medical cost measured on a per-member-per-month (PMPM)
basis.
Results: During the first year of exposure, the total cost
of care including prescription drugs rose 1.5% ($9/$604;
P=0.67) PMPM. Also during the first year of the diabetes
bundle exposure, there were statistically significant increases
in the outpatient (12.6% [$19/$150]) and professional (10%
[$15/$153]) PMPM costs (P<0.05). However, in the third
and fifth years, there were approximately 10% ($67/$666)
and 16% ($118/$764) PMPM total cost savings, respectively
(P<0.05). Over the entire study period, the estimated total
medical cost saving was 6.8% ($44/$650; P<0.05) PMPM.
The main source of the savings was reductions in inpatient
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facility cost, which accounted for approximately half of the
total cost reductions.
Discussion: A system of care with an all-or-none bundled
measure used in primary care for patients with diabetes
may reduce long-term cost of care while improving health
outcomes.
Keywords: diabetes care, cost of care
ECI-1:
Use of Low-Value Surveillance Services for Early
Stage Breast Cancer Survivors
Erin E. Hahn, Tania Tang, Janet S. Lee, Corrine
Munoz-Plaza,1 Joyce O. Adesina,1 Ernest Shen,1 Braden
Rowley,2 Jared L. Maeda,3 David M. Mosen,4 John C.
Ruckdeshel,2 Michael K. Gould1
1

1

1

1
Kaiser Permanente Southern California; 2Intermountain
Healthcare; 3Mid-Atlantic Permanente Research
Institute; 4Kaiser Permanente Northwest

Background/Aims: Guidelines from the National
Comprehensive Cancer Network and the American Society
of Clinical Oncology recommend against aggressive
surveillance for early stage breast cancer survivors. However,
breast cancer survivors commonly receive nonrecommended
services, including advanced imaging and biomarker tests. The
objective of this study was to measure use of posttreatment
breast cancer surveillance services including carcinogenic
antigen biomarker tests and advanced imaging in two
integrated health care systems, Kaiser Permanente (KP) and
Intermountain Healthcare (IH), and to identify potential target
areas for de-implementation of low-value services.
Methods: We identified stage 0–IIB breast cancer patients
diagnosed with first primary malignancy between January
1, 2009, and December 31, 2010, from tumor registries in
three KP regions and all four IH regions. Using the KP and
IH electronic health records, we identified use of advanced
imaging tests (positron emission tomography [PET],
computerized tomography [CT], bone scan) and biomarker
tests over 18 months, starting one year after diagnosis. We
excluded services performed in the emergency department or
inpatient setting. We performed chart abstraction on a stratified
random sample of patients who received an imaging or
biomarker test to identify clinical indication: diagnostic (used
in response to a clinical sign or symptom) or surveillance.
Results: Of the total sample of 7,217 patients, 23% received
at least one imaging test during the surveillance period,
including 25% at KP and 20% at IH (P<0.05), and 27% of
patients received at least one biomarker test, 36% at KP and
12% at IH (P<0.05). Chart abstraction (n=155) revealed that
the majority of imaging services (90%) were diagnostic,
while the majority of biomarker (96%) tests were used for
surveillance in absence of documented signs or symptoms.
Discussion: There is substantial use of imaging services and
biomarker tests during posttreatment care of early stage breast
cancer patients. Review of health records revealed that the
majority of imaging services were performed in response to
clinical signs or symptoms, while the overwhelming majority
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of biomarker tests were performed for surveillance. Next
steps include developing a tailored strategy that incorporates
input from oncology clinicians to reduce use of surveillance
biomarker tests as a care improvement project.
Keywords: breast cancer surveillance, low-value services
PD1-1:
Providing an Upstream Discussion in the Ambulatory
Setting to Assist Chronic Kidney Disease Patients
Considering Dialysis
Craig M. Nelson,1 Tuan K. Le,1 Mi Chang,1 Pushkar
Chand,1 Julie Sortais,1 Karen Tallman2
Kaiser Permanente Southern
Permanente Northern California

1

California;

2

Kaiser

Background/Aims: Extensive discussion with renal patients
about treatment intensity is not systematically integrated
into their care. These discussions are often time-consuming,
involve family, and require multiple discussions. The
discussion often takes place during an acute hospitalization.
We conducted a “test of change” pilot to assess the utility of
providing an upstream discussion in the ambulatory setting
as an additional nephrology consult to assist renal patients
with chronic kidney disease considering treatment choice.
We believed our pilot would show this additional nephrology
consult would help our chronic kidney disease patients to be
more informed about choosing or not choosing dialysis, and
would also assist us in resource stewardship.
Methods: We randomly assigned nephrology patients at
Kaiser Permanente South Bay Medical Center with stage 4 or
5 chronic kidney disease who had not yet begun dialysis. The
test group received the additional nephrology consult and was
seen by an interdisciplinary team comprised of a nephrologist,
a social worker and a clinical ethicist.
Results: Those who received the additional nephrology
consult experienced help in forming a treatment plan, felt
well-understood, and had the opportunity to thoroughly
discuss questions. The control group that did not receive the
additional nephrology consult had a 26% increased probability
of beginning dialysis, had a statistical increase for dialysis and
clinic visits (P<0.10 and P<0.05), and were more likely to be
admitted to the hospital (control 0.5 vs. test 0.2 admissions
per patient), spend more days hospitalized (control 2.8 vs. test
0.5 bed days per patient), and be seen in the emergency room
(control 0.73 vs. test 0.66 visits per patient) and clinic (control
6.6 vs. test 3.6 visits per patient).
Discussion: We attempted to review the utility of providing an
upstream discussion in the ambulatory setting for renal patients
considering treatment plan decision-making. Interdisciplinary
consultations in the ambulatory setting allows us to begin a
helpful conversation that can include helping patients and
families better understand the possibilities of medicine,
patients’ treatment goals, and lived values from the patients’
context.
Keywords: advance care planning, shared decision-making
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PD1-4:
Minimizing Medication Histories Errors for Patients
Admitted to the Hospital Through the Emergency
Department: A Three-Arm Pragmatic Randomized
Controlled Trial of Adding Admission Medication
History Interviews by Pharmacists or PharmacistSupervised Pharmacy Technicians to Usual Care
Joshua M. Pevnick,1 Caroline B. Nguyen,1 Cynthia
A. Jackevicius,2 Katherine A. Palmer,1 Rita Shane,1
Catherine Bresee,1 Mackenzie E. Bear,1 Olga Zaitseva,1
David Seki,1 Anish Desai,1 Brian Doyle,3 Douglas S. Bell3
Cedars-Sinai Health System, 2Western University of
Health Sciences; 3University of California Los Angeles
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Background/Aims: Meta-analysis shows hospitalized U.S.
patients suffer 106,000 fatal adverse drug events (ADE)
annually. Errors in admission medication histories (AMH)
frequently cause preventable ADEs. There is also concern that
electronic health records (EHR) propagate AMH errors into
ADEs by making AMHs easily orderable. We hypothesized
that for patients with complex AMHs, pharmacist-supervised
pharmacy technician (PSPT) and pharmacist AMH interviews
would reduce AMH errors.
Methods: At a large university-affiliated hospital, we
conducted an IRB-approved, pragmatic randomized trial with
informed consent waived. Inclusion criteria, accessed via
EHR, were: ≥ 10 chronic prescription medications, history
of acute myocardial infarction or congestive heart failure,
admission from skilled nursing facility, history of transplant,
or active anticoagulant, insulin or narrow therapeutic index
medications; patients were excluded if admitted to pediatric
or trauma services or transplant services with pharmacists.
All arms received usual care for patients admitted from the
emergency department. This included registered nurses
obtaining AMHs, and natural variation in checking, correcting
and ordering from these AMHs by admitting providers. In the
two intervention arms, PSPTs and pharmacists obtained initial
AMHs. They contacted family, pharmacies and/or providers to
resolve questions. As per prior studies, we obtained reference
standard AMHs from all patients (usually one day after
admission), and initial AMH errors were independently rated
by ≥ 2 pharmacists as significant, serious or life-threatening.
Three error severities were assigned –– 1, 4 and 9 points,
respectively. We calculated weighted error scores for each
patient, and mean scores/patient for each arm. We had 80%
power to identify arms with higher/lower scores of ≥ 11.2/
patient.
Results: Of 311 patients enrolled, 28 patients were later
excluded (most not ultimately admitted, or discharged
before reference standard AMH obtained). Median age and
number of medications were 76 and 14 (interquartile ranges:
63–84 and 10–19), respectively. Patients in the usual care,
pharmacist and PSPT arms had 7.4, 1.4 and 1.5 AMH mean
errors/patient, respectively (P<0.0001); mean error scores
were 21.2, 3.9 and 3.9 per patient, respectively (P<0.0001).
Physician scoring of admission medication order errors due to
AMH errors is ongoing.
Discussion: Pharmacists and PSPTs substantially reduced
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AMH errors and weighted error scores, and thus show
promise for reducing ADEs. Limitations include our single
site, and using intermediate endpoints.
Keywords: adverse drug events, medication reconciliation
PD1-5:
Comparing Implementation Models Across Two
Kaiser Permanente Regions to Improve Outcomes
for Patients With Comorbid Depression and Diabetes
Mark Dreskin,1 Arne Beck,2 Gabrielle F. Beaubrun,1
Nancy E. Brace,2 Alisa Aunskul,1 Jennifer M. Boggs,2
Karen J. Coleman1
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Permanente Colorado

1

California;

2

Kaiser

Background/Aims: The Care for Mental, Physical, and
Substance-use Syndromes (COMPASS) initiative was funded
by the Centers for Medicare & Medicaid Services (CMS)
to implement collaborative care in primary care settings for
patients with comorbid depression and diabetes, coronary
artery disease and/or substance-use disorders. Here we
compare implementation strategies in Kaiser Permanente
Colorado (KPCO) and Southern California (KPSC) to inform
potential dissemination strategies across other HMO sites.
Methods: COMPASS patients are enrolled if they have
PHQ9 scores > 10 and poorly controlled diabetes (HbA1c >
8.0). The proposed collaborative care model requires a team
with a consulting psychiatrist, consulting physician and care
manager. The care manager provides both behavioral health
interventions and medical care, and facilitates a weekly
structured case review to determine treatment intensification.
The program lasts at least six months with six months
of maintenance. COMPASS implementation at KPCO
included a dedicated, centralized nurse care manager and
therapist working together who telephonically outreached
and followed patients. COMPASS implementation at KPSC
used an existing depression care management program in
primary care at four medical center service regions, requiring
care managers to change their scope of practice to address
diabetes. Both KPCO and KPSC held weekly structured case
reviews. KPCO was centralized and KPSC was done by teams
at each participating medical center.
Results: The initiative began in 2012. To date, KPCO has
enrolled 303 patients and KPSC 712. Remission rates for
depression are 26% in KPCO and 39% in KPSC patients.
Control rates for diabetics are 39% for KPCO and 38% for
KPSC.
Discussion: Centralized care management may increase
uniformity and fidelity of implementation, but limit reach and
compromise outcomes without additional local primary care
support. Conversely, adding care management tasks to existing
staff may increase reach but attenuate outcomes without
adequate staff training in co-management of psychological and
medical care needs. Funded by the U.S. Department of Health
and Human Services via CMS (#1C1CMS331048-01-00), the
contents of this publication are solely the responsibility of the
authors and do not necessarily represent the official views of
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the U.S. Department of Health and Human Services or any of
its agencies.
Keywords: collaborative care, depression
PD1-6:
Medically Complex Pediatric Patient Care Model:
Coordinated Team-Based Care With Supporting
Health Information Technology to Implement Best
Practices and Address Care Gaps of Transitioning
Age Patients and Family Caregivers
Susan R. Snyder,1 Thomas W. Davis,1 Rebecca A.
Stametz,1 Deseraé N. Clarke,1 Amanda C. Bengier,1
Jonathan D. Darer1
Geisinger Health System

1

Background/Aims: Medically complex pediatric patients
have multiple severe chronic conditions consuming
disproportionate health care resources. The top 1% of
Geisinger’s pediatric population uses health care representing
20% of total costs. Nationally, their needs are largely
underserved by current delivery systems as they involve
multiple specialists and settings, are challenging to coordinate,
and place a tremendous burden on family caregivers. Providing
effective care for children with special health care needs
(CSHCN) requires a system that is integrated, comprehensive,
coordinated and family-centered to foster positive experiences
between families and providers. Advancing integrated
systems of care for CSHCN and their families is a national
priority and reflected in the Healthy People goals. Geisinger
has developed a new innovative approach to CSHCN starting
with ages 15 and over: the Medically Complex Pediatric
Patient (MCPP) care model. Its objective is to address patient
and family caregiver needs along with drivers of poor quality
and unnecessarily high costs of care. This approach includes:
(1) a comprehensive care clinic with an enhanced professional
care team to provide and coordinate health care supported by
(2) care bundles for reliable delivery of best practices and (3)
advanced health information technology using Geisinger’s
patient portal and web-based applications to efficiently
document and facilitate timely care, planning, management
and coordination and promote good communication between
families and providers.
Methods: Development and implementation of the MCPP care
model and an evaluation plan are occurring simultaneously.
The evaluation plan begins with newly developed patient and
family caregiver assessment questionnaires administered to all
eligible families to collect baseline and postimplementation
measures, with questions corresponding to multiple nationally
validated surveys (National Survey of CSHCN, GAD-7,
PHQ-9, Caregiver Strain Index).
Results: Survey results of approximately 300 families will
establish intensity of caregiving needs, caregiver challenges
and ability to meet needs effectively, service quality and
gaps consistent with national measures including CSHCN
core outcomes that facilitate integrated systems of care for
CSHCN such as care coordination, partners in decisionmaking, and medical home to assess preimplementation gaps
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and postimplementation performance.
Discussion: Baseline results will be used to inform MCPP
care model implementation and to assess its progress and
performance over time consistent with national priorities.
Keywords: children with medical complexity, caregivers
PD1-10:
Bridging the Gap: Evaluating Osteoporosis Therapy
Medication Orders Versus Pharmacotherapy
Prescription Fills Following an Osteoporotic
Fracture
Jane R. Grafton1
Group Health Cooperative

1

Background/Aims: Pharmacotherapy following osteoporotic
fracture is a primary intervention strategy to prevent future
fractures. Multiple effective pharmacotherapies are available,
but postfracture treatment rates remain low. Osteoporosis
treatment is defined as a prescription fill for oral or injectable
bisphosphonate therapy. When a physician orders treatment
but the patient does not fill, there is potential to address this
gap by following up at patient level. If the physician does not
order treatment, then appropriate intervention might be at
physician level. This poster aims to identify gaps in treatment
at Group Health Cooperative, whether they occur at patient or
provider level.
Methods: The Post Fracture Care Study examines factors
associated with nonreceipt of care following osteoporotic
fracture between 2006 and 2012 in a cohort of 5,237
women aged ≥ 55 years at fracture, with no osteoporosis
pharmacotherapy in the 12 months preceding index fracture
date. Information on treatment was captured from Group
Health automated pharmacy data, which includes fills at
Group Practice pharmacies as well as claims for fills at
external pharmacies. Medication orders were considered if
they occurred within 12 months on/after index fracture date.
Treatment was operationalized as: a fill between 45 days prior
to medication order and 45 days after order, and within 12
months after fracture date.
Results: 10.4% (543/5,237) were ordered a bisphosphonate;
12.3% (643/5,237) received treatment (filled an oral or
injectable bisphosphonate); 0.8% (40/5,237) were ordered
bisphosphonate but did not receive treatment; 2.7%
(140/5,237) received treatment, without record of order in
EMR; and 87.0% (4,554/5,237) had neither medication order
nor treatment.
Discussion: The gap of women with an osteoporotic fracture
who had medication order but did not receive treatment offers
a group of patients to target for intervention. For patients
with neither medication order nor treatment, the provider
or patient might be targeted. For future analysis, consider
collecting standard documentation by physician of offer to
prescribe osteoporosis therapy and patient response. This may
offer additional patient subgroups to target for appropriate
interventions that increase treatment rates in this vulnerable
population.
Keywords: osteoporosis, fracture
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PS1-23:
Participation in Quality Improvement: Provider
Perceptions Regarding Documentation Audits

Erin E. Hahn,1 Robert M. Cooper,1 Hugo Danilo,1 Alice
H. Park,1 Elizabeth P. Bell,1 Iman A. Abdalla,1 Kien Vuu,1
Luis M. Moreta-Sainz,1 Michael K. Gould1
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Background/Aims: Effective communication within health
care depends on accurate documentation of assessments, plans
and delivered care. Use of electronic medical records (EMRs)
requires relearning and evaluating documentation processes
for providers, and problems can arise when consistent use
of entry fields is not maintained. At each phase of obstetric
care, providers require accurate information. In shared
practices, prenatal care consists of multiple office visits with
multiple providers, focused on maternal/fetal status, accurate
dating, and risk factor identification. Information accuracy
is important at all phases, but especially so when laboring
women present. In our HMO, all providers receive training on
EMR use with further training following technology updates.
Nevertheless, considerable variability exists in documentation
practices. The EMR’s comprehensive nature leads to different
tabs, fields and pages where same information can be entered.
Data entered into one tab/field may not automatically populate
other fields as the provider expects (e.g. problem identified
during visit does not make it to the list of patient problems
entered on initial visit). Currently, there is no assessment
of provider documentation skills or EMR completeness.
This quality improvement project (QIP) aims for better
documentation, with a secondary goal of mutual learning
through peer auditing.
Methods: Our midwifery group, members of an obstetrical
team in Southern California, initialized peer audits for initial
prenatal care visits. Provider perceptions of reluctance, time
involvement and learning (from the Conscious Competence
Learning Model) are currently being evaluated before/after
the initial cycle of peer audit process. All eligible midwifery
service members are participating. The Fall 2014 QIP has
two components: pre/post surveys and two rounds of EMR
audits. Surveys will assess perceptions of time required for
audits, attitudes about the effectiveness of audits and ideas for
improving the audit process. Group meetings after each audit
cycle will focus on concepts of shared learning and ideas for
improving documentation.
Results: Comparison of audit composite objective ratings will
detect changes in overall documentation behaviors. Survey
results will determine whether the group’s perceptions change
and whether value is seen in ongoing audit cycles.
Discussion: This project will demonstrate whether using
audit cycles enhance documentation and shared learning
among participating midwives.
Keywords: peer documentation audits, perceptions of peer
audits
PS1-26:
Application of Performance Improvement Methods
to Improve Timeliness of Lung Cancer Care
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Kaiser Permanente Southern California

Background/Aims: Timeliness, an essential element of
high-quality care as defined by the Institute of Medicine, is
critical in cancer care delivery. Timeliness of diagnosis and
treatment is associated with improved outcomes for some
cancers. A Kaiser Permanente Southern California (KPSC)
organizational goal is to achieve optimal timeliness of cancer
care to ensure best possible outcomes for KPSC members.
Methods: A working group at the KPSC Los Angeles
Medical Center (LAMC), led by the physician director of the
cancer program, the director of performance improvement
and the director of oncology services, convened a series of
multidisciplinary meetings focused on improving timeliness
of lung cancer care. Participants included LAMC physicians,
nurses and administrators as well as KPSC researchers.
Alignment of physician education time and education credits
was facilitated by administrative leaders. Performance
improvement activities included review of current state of
LAMC lung cancer care, definition of key metrics, iterative
development of specialty-based process maps, chart
abstraction and identification of potential interventions.
Physicians participated in all activities, facilitated by group
leaders. Data sources included medical records and tumor
registry data.
Results: Review of LAMC baseline data for patients newly
diagnosed with lung cancer in 2012 (N=60) showed that the
median number of days from initial imaging to date of diagnosis
is 21 days (range: 0–112). Median days from postdiagnosis
physician consultation to initial treatment varied by physician
specialty: 4 (radiology), 12 (radiation oncology), 24 (medical
oncology) and 27 days (surgery). Chart review revealed that
patients diagnosed in the inpatient setting had shorter time to
receipt of services. Root cause analysis revealed several target
areas for improvement interventions including: development
of a lung cancer protocol for radiology, a closed-loop system
with pulmonology, improved integration of palliative and
hospice care, a rapid results system for genetic studies, and
increased frequency of lung tumor board. A new position of
lung cancer coordinator was proposed to oversee activities, and
standardized “smart phrases” were created for documentation
of encounters.
Discussion: Multidisciplinary groups with clinician,
performance improvement and research participation
can achieve significant progress in identifying areas
for improvement using robust methods. Next steps will
include implementation and evaluation of the proposed
improvements.
Keywords: performance improvement, lung cancer timeliness
PS1-28:
Predicting, Recruiting and Tracking Enrollment of
Young Adults to an Online Intervention to Support
Healthy Eating

www.aurora.org/jpcrr

95

Michelle Groesbeck,1 Michael Sheehan,1 Noel Maddy,1
Viji Ramaswami,2 Margaret Rukstalis,3 Ashley Ryman,3
Gwen L. Alexander1
Henry Ford Health System; 2University of Michigan;
Geisinger Health System
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Background/Aims: Young adults, known as Generation
Y, eat well below the daily recommended servings of
fruits and vegetables and consume high rates of sweetened
beverages. With a busy, ever-evolving lifestyle and lifelong
exposure to the instant and browsable Internet, recruitment
and engagement efforts require accommodating challenges
of preference for quick food, quick read, and low attention
to snail mail. We describe strategies and monitoring utilized
to engage this diverse and understudied population in a twosite, online, randomized intervention trial (MENU GenY)
designed to support healthy food choices.
Methods: Recruitment from two geographically diverse sites,
metropolitan Detroit, MI, and rural Danville, PA, is ongoing.
Automated data were utilized to identify young adult HMO
members ages 21–30. Mailing strategy, envelope and invitation
letter style were evaluated by focus groups across both sites
and consultants in a two-phase process. Team meetings guided
collaboration efforts on enrollment strategies, and technical
meetings were established and run by project management
to allow the programing staff across sites to focus and drive
technology-specific developments on the study. Mailing
volume, based on sample composition by predicted enrollment
rates, was modeled across the 12-month recruitment timeframe.
Tracking software was developed with two online applications,
an internally built program at Henry Ford Health, Flash
Manager V3, and an administrative console at University of
Michigan CHCR, using the Django framework, to provide
immediate feedback on enrollment rates overall and by site.
Results: An invitation letter was developed with a unique and
catchy color study logo along with a color insert and magnet,
sent in a business-style envelope, and followed by a second
notice letter 10 days following. Young adults responded
favorably to the second “reminder” letter, which nearly
doubled enrollment rate, with the study on schedule to meet
its n=1,624 goal. By comparing prediction to tracking, with
consideration of enrollment by site and by gender, we adjusted
mailing volume and rates to reach quarterly enrollment goals.
Discussion: Through rigorous planning, collaborative team
coordination and guidance by young adult advisors, we
addressed challenges and experienced success with enrolling
a hard-to-reach young adult population. We will provide
enrollment updates and further details.
Keywords: recruitment, enrollment

Group Health Cooperative

Background/Aims: Over the last three years, a team of
Group Health researchers and clinical leaders has worked
collaboratively on projects to reduce low-value care.
The team investigates, tests and implements metrics and
interventions to improve care and reduce costs. The team’s
work is informed by the national Choosing Wisely campaign,
which works with specialty medical societies to generate lists
of low-value clinical activities. Group Health participates in
the Washington State Choosing Wisely Task Force, which has
identified and defined 10 high-priority recommendations on
topics such as imaging, screening and antibiotic use.
Methods: Our team is developing methods to assess
variability in clinician ordering behavior with regard to the
Task Force recommendation to avoid high-end imaging for
uncomplicated headache. Claims data, as in the Group Health
virtual data warehouse (VDW), generally do not identify
the ordering provider for radiology procedures, which
typically have different ordering and performing providers.
To understand ordering patterns, we are instead using
clinical data to identify ordering provider, and to detect both
completed and cancelled orders. We examine all electronic
health record (EHR) orders with a CPT code denoting head
computed tomography or magnetic resonance imaging, and
identify orders with an ICD code signifying uncomplicated
headache. All orders, whether completed or not, should be
accompanied by a justifying diagnosis, although the specifics
of radiology ordering add significant challenges to identifying
these diagnoses. For completed orders, we gather additional
diagnosis information from EHR billing data, which (unlike
claims data) still identifies the ordering provider.
Results: We will compare the sensitivity of EHR ordering
data, EHR billing data, and claims-based VDW data in
identifying ordering of high-end imaging for headache.
Achieving high specificity may not be feasible for this
measure, given the resources required for chart review and
programming exclusionary criteria. However, since our main
goal at this point is to document variability between providers,
high specificity for any individual provider is less critical.
Discussion: Once we validate measures for headache imaging,
we will distribute data to clinics and providers for review and
discussion, and develop measures for other imaging-related
Task Force recommendations. We also will investigate the
feasibility of adding ordering provider to Group Health VDW
data for services provided in Group Health clinics.
Keywords: low-value care, Choosing Wisely
PS1-30:
Incidence of Venous Thromboembolism Following
Major Surgery: Opportunities for Care Improvement

PS1-29:
Choosing Wisely: Using the EHR to Identify
Variability in Provider Ordering Behavior for HighEnd Imaging of the Head

Michael K. Gould,1 Yi-Lin Wu,1 Amy Liu,1 Joel Handler,1
Helen Lau,1 Angelika Clarke,1 Kathy J. Lin,1 Tania Tang1

Sharon Fuller, Roy Pardee, Eva Chang, Gabrielle
Gundersen,1 Robert J. Reid,1 Matthew R. Handley,1
Diana S. Buist1

Background/Aims: Venous thromboembolism (VTE) is
an important cause of preventable death and morbidity
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following major surgery. However, few population-based
studies have examined the perioperative incidence of VTE
among surgical patients, and most studies limited followup to hospital discharge or 1 month following discharge.
This study aimed to define the 90-day incidence of VTE in
this population, examine trends in incidence over time and
identify opportunities for improved use of pharmacological
prophylaxis.
Methods: We performed a retrospective cohort study
using data from electronic health records of adult patients
admitted to one of 14 hospitals in an integrated health
system between January 1, 2010, and March 30, 2013, for
major nonorthopedic surgery, using relevant International
Classification of Disease 9 (ICD-9) procedure codes from the
Surgical Care Improvement Project of the Joint Commission.
For this analysis, we defined VTE as the presence of a new
ICD-9 diagnosis code for pulmonary embolism or deep
venous thrombosis, when accompanied by either a pharmacy
code for an anticoagulant medication at a dose appropriate
for VTE treatment or an ICD-9 procedure code for an
objective diagnostic test for VTE. In a prior validation study,
this definition had positive and negative predictive values of
almost 80%. To capture incident VTE that occurred during
hospitalization or within 90 days of discharge, we reviewed
inpatient, outpatient, emergency department and claims files.
Results: The sample included 27,723 surgical patients.
Patients with VTE were substantially older, had more
comorbid conditions and were more likely to be male, nonHispanic white, widowed and former smokers; 48% of all
admissions were related to cancer. The crude risk of VTE was
1.25% over 90 days. The 90-day incidence rate was 15.9 per
100,000 patient-days of follow-up (95% confidence interval:
14.2–17.6). VTE incidence did not vary by calendar year, and
relatively small differences were observed across hospitals.
Discussion: The incidence of VTE observed in this study
compares favorably to that reported in several prior studies.
Next steps include distinguishing preventable VTE from VTE
that occurred despite receipt of prophylaxis, and development
of risk assessment models to guide rationale use of either
pharmacological or mechanical prophylaxis.
Keywords: venous thromboembolism, surgical outcomes
PS1-31:
Perioperative Morbidity in Cirrhotic
Undergoing Orthopedic Surgery

Patients

Eric M. Nyberg,1 Michael Batech,1 T. Craig Cheetham,1
Mary Alice Chocas,1 Anshuman Singh1
Kaiser Permanente Southern California

1

Background/Aims: Previous studies have shown an
increased risk of morbidity and mortality in cirrhotic
patients undergoing surgery. However, there is a paucity of
studies evaluating the perioperative risks of cirrhotics who
undergo orthopedic surgery. The aim of this study was to
examine outcomes in cirrhotic patients who have undergone
orthopedic surgery.
Methods: This is a retrospective matched-cohort study using
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data from Kaiser Permanente Southern California. Study
participants received a diagnosis for cirrhosis from 1/1/2003
through 12/31/2013, and initial case selection criteria
included age > 18 years, ≥ 6 months continuous health plan
membership, and a procedure code for orthopedic surgery. At
least 3 and up to 5 controls were optimally matched based
on age, gender and cirrhosis diagnosis date. Data abstraction
and summary were subsequently performed for demographic,
socioeconomic, comorbid history and decompensation events
data. Decompensation events included new onset ascites,
variceal bleeding and hepatic encephalopathy. Multivariable
conditional logistic regression estimated the risk of
decompensation from surgery.
Results: We matched 4,263 eligible controls with 853
cirrhotic surgical patients. Mean age of the cohort was 60.5
(standard deviation: 11.44) years and 52.2% were female.
Within 90 days after surgery, cases had more decompensation
events compared to matched controls (24.1% vs. 19.1%).
Discussion: In this large database study including patients
from a large managed care organization, cirrhotics experienced
more decompensation within 90 days after orthopedic surgery
compared to matched controls. Decompensation events result
in significant increases in health care costs and utilization.
Further, the increased morbidity seen in cirrhotics is a potential
cause of quality issues for the managed care organization.
Examination and mitigation of the factors, such as surgery,
that can result in decompensation may help improve systems
for better quality of care.
Keywords: cirrhosis, orthopedic postoperative outcomes
PS2-12:
Design and Implementation of a Clinician-Focused
Intervention to Improve Diagnosis and Management
of Symptomatic Vulvovaginal Atrophy in a Large
Health System
Kimberly K. Vesco,1 Amanda Clark,1 Kate Beadle,1
Joanna Bulkley,1 Ashley Borin,1 Michael Leo1
Kaiser Permanente Northwest

1

Background/Aims: Nearly 50% of postmenopausal women
experience symptoms related to vulvovaginal atrophy (VVA).
However, despite the availability of effective treatment
options, studies show that few women seek treatment for, and
few providers ask women about, these symptoms. Our paired
abstract describes clinician-reported barriers to diagnosis
and management. Here we describe the prevalence of VVA
diagnoses among women seen for well care within Kaiser
Permanente Northwest (KPNW). We also describe the design
of a clinician-focused intervention to improve diagnosis and
management of symptomatic VVA.
Methods: Using electronic medical record (EMR) data, we
identified well visits among women 55 years or older occurring
within 17 KPNW primary care and OB/GYN clinics between
June 2013 and May 2014. We computed the proportion of
women who received a VVA-related diagnosis at the index
visit. We then stratified the clinics based on visit volume and
randomized them to an immediate versus delayed clinician-
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focused intervention. The intervention includes online and
in-person education for clinicians regarding: 1) diagnosis and
management of symptomatic VVA, and 2) new EMR-based
clinical support tools (Smartsets and Smarttexts).
Results: We identified 14,274 unique well visits over the
1-year period of time. Of these, 80.5% (11,500/14,274)
occurred in primary care. Only 5.7% (769/13,544) of visits by
women not already using vaginal estrogen contained a VVArelated diagnosis. There are 371 clinicians; education for
those in the intervention clinics is ongoing (Fall 2014). After
the education period, we’ll prospectively collect EMR data
to compare groups on the following outcomes: 1) proportion
of well visits with VVA diagnoses; 2) proportion of women
receiving vaginal estrogen prescriptions; and 3) proportion of
visits that used the clinical support tools. We will also conduct
an online survey of patients to determine if women in the
intervention clinics are more likely than those in the control
clinics to discuss VVA symptoms with their providers and to
receive education and treatment options if symptomatic.
Discussion: The proportion of postmenopausal women with a
VVA-related diagnosis was lower than expected. The purpose
of our ongoing study is to evaluate whether active outreach to
providers with education and clinical support tools leads to
improved diagnosis and management of VVA.
Keywords: patient care improvement, postmenopause
PS2-13:
Ready to Quit: Predictive Analysis on Member
Readiness of Enrolling Smoking Cessation
Programs in Kaiser Permanente Southern California
Di Meng,1 Terhilda Garrido1
Kaiser Permanente Program Office

1

Background/Aims: We describe a predictive analysis to
help regional operations engage smoking members with high
likelihood of enrollment into smoking cessation services.
Methods: A combination of investigation methods was used:
1) data mining and basic free text parsing and recognition;
2) predictive modeling to discover predictors of member
enrollment in smoking cessation services and score the future
population to identify smoking members with high likelihood
of enrollment; and 3) randomized control trial to (a) identify
the best protocols to outreach these members, and (b) refine
the model and establish a learning cycle to guide operations.
Results: We have identified and processed a wide range of
predictors including smoking habit, social/economic factors,
enrollment history, significant medical conditions, family
characteristics, medical utilization history, online interaction
and other health/social behaviors. The model performed very
well in validation process, with c-stat of 0.76, which provides
a good fit and predicts power. The findings of significant
predictors were in agreement with many literatures. These
predictors include past enrollment, sex and disease burden. We
also found that race/ethnicity and online activity, especially
patient/physician secure email communication on smoking
matter, strongly predict likelihood of enrollment.
Discussion: In the Kaiser Permanente Southern California
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region, approximately 200,000 smokers can be identified
through social history and ICD-9 codes in Kaiser Permanente
HealthConnect. The top 20% of the modeled population
represents 50% of potential enrollees in smoking cessation
programs, and this population will be targeted in the outreach
effort in a randomized control trial designed as follows.
A population of 10,000 will be randomly selected to not
participate in phase one, but will be eligible to participate
after the first phase. Of this 10,000, 5,000 will receive no
intervention and 5,000 will receive only existing auto-dialer
outreach, both of which are within the normal standard of
care. The remaining 30,000 members (10,000 per month) will
be randomized by medical center into three treatment groups
of equal size: auto-dialer plus live phone call, auto-dialer plus
letter, and auto-dialer plus email.
Keywords: predictive modeling, smoking cessation
PS2-18:
Improving Engagement in Addiction Treatment:
Translating Addiction Research Into EvidenceBased Practice
Rulin C. Hechter,1 Scott B. Sangsland,1 Grant R.
Grissom,2 Jim R. Carter,3 Catherine F. Jervey,3 Sean E.
Koon,3 Ashley Hooker2
1
Kaiser Permanente Southern California; 2Polaris Health
Directions; 3Southern California Permanente Medical
Group

Background/Aims: Patient engagement is critical for
the success of addiction treatment. We sought to evaluate
the effectiveness of an innovative patient engagement
enhancement system, Enhanced Engagement in Chemical
Dependency (EECD), for improving patient engagement in
addiction treatment.
Methods: The EECD system promotes motivational
interviewing/motivational enhancement therapy (MI/MET)
and service matching approaches, an evidence-based practice
that can improve engagement. It includes two components:
1) staff training in MI/MET, and 2) a standardized webbased engagement assessment with real-time clinical and
personalized patient reports and program-level management
reports. We will roll out a staggered implementation in 12
outpatient addiction treatment programs at Kaiser Permanente
Southern California, where about 8,000 new intakes were
conducted per year. The analysis employs a stepped wedge
design, in which all adults who have completed an intake in
the 6 months prior to implementation will serve as internal
baseline controls, while all adults who have completed an
intake in the sites that have not yet implemented the system
will serve as external controls for the implementation sites.
We will evaluate the effectiveness of the EECD system on: 1)
improving treatment engagement (attendance at two sessions
within 30 days after the initial treatment visit); 2) authentic
participation in outpatient treatment; 3) clinical outcomes
(addiction severity index); 4) reducing treatment reentry within
6 months following the end of a treatment episode; 5) matching
services to patient needs; and 6) sustained effectiveness in
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improving engagement. Generalized estimating equations
will be used to test for significant differences in proportion of
patients with favorable outcomes on binary variables. Linear
mixed models will be used for continuous outcome variables.
Results: Staff training and a staggered implementation of the
EECD system will be rolled out in 12 sites during October
2014–April 2015, with two initial sites in phase I, five sites in
phase II and five sites in Phase III. The results are forthcoming.
Discussion: This systemic intervention project represents
an important example of translating research into improving
patient care in addiction treatment, through a multidisciplinary
collaboration between researchers, providers and operational
leaders. The findings from this project will facilitate adoption
of evidence-based practices and innovative technologies in
addiction treatment.
Keywords: addiction treatment, patient engagement
PS2-20:
Technical and Data Collection Challenges and
Lessons Learned in the Pain Program for Active
Coping and Training (PPACT) Pragmatic Trial
Reesa L. Laws,1 Alee Rowley1
Kaiser Permanente Northwest

collaboration with regional leaders, clinical managers and
PCPs to learn the needs of patients and meet expectations for
a complex trial is crucial, as is sufficient time to set up data
collection processes within the health care setting and test
research tracking systems and processes necessary to make
operations run as smooth as possible. This presentation will
highlight the technical and data collection challenges and
lessons learned for conducting a pragmatic trial in a health
care setting.
Keywords: pragmatic, data collection

CHRONIC CONDITIONS/DIABETES/
OBESITY/MULTIPLE CHRONIC
CONDITIONS
A3-1:
Impact of Comorbidity Dyads on Heart Failure
Treatment in Older Persons
Jerry H. Gurwitz,1 Alan S. Go,2 Sue Hee Sung,2 Grace
Tabada,2 Robert Goldberg,3 David J. Magid,4 David H.
Smith,5 David McManus,3 Jane S. Saczynski,1 Bruce
Barton3
Meyers Primary Care Institute; 2Kaiser Permanente
Northern California; 3University of Massachusetts;
4
Kaiser Permanente Colorado; 5Kaiser Permanente
Northwest
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Background/Aims: Chronic pain affects at least 116 million
adults in the United States and exacts a tremendous cost in
suffering and lost productivity. While health systems offer
specialized pain services, the primary care setting is where
most patients seek and receive care for pain. The Pain
Program for Active Coping and Training (PPACT) project
is testing the effectiveness of integrating an evidence-based,
interdisciplinary pain management intervention within a
primary care environment.
Methods: The Kaiser Permanente Northwest (KPNW),
Georgia (KPGA) and Hawaii (KPHI) regions are working
with their regional health partners to recruit and implement
the PPACT trial. Efforts at each clinical site involve extracting
electronic medical record data via the virtual data warehouse
and Clarity. KPNW built a tracking system to manage all the
recruitment and implementation processes across the three
regions. The tracking system serves to: 1) house records of
study eligible patients; 2) manage touches with the PCPs
prior to recruitment to ensure we recruit patients whom
PCPs specifically believe this program would work best; 3)
keep track of the recruitment efforts; 4) track all intervention
activities; and 5) aide in data collection processes using KP.org
questionnaires and Kaiser Permanente Message Center IVR
surveys.
Results: We have implemented recruitment efforts across all
regions using a staggered cohort approach. KPNW started
cohort 1 as a pilot to firm up all tracking, recruitment and
intervention processes. Both KPGA and KPHI are now in
the field as well. We are continuing to refine our processes to
meet the recruitment challenges we have encountered in the
regions.
Discussion: Running a pragmatic trial embedded within a
health care system is challenging but possible. Adequate

Background/Aims: The vast majority of heart failure (HF)
patients suffer from multiple noncardiac comorbid conditions
that may have important implications for clinical management.
We assessed the clinical effectiveness and safety associated
with the use of beta-blocker therapy for patients in a HFchronic lung disease dyad group, and the clinical effectiveness
and safety associated with the use of angiotensin-converting
enzyme (ACE) inhibitors/angiotensin II receptor blockers
(ARBs) for patients in a HF-chronic kidney disease (CKD)
dyad group.
Methods: We identified over 30,000 HF patients with a
documented ejection fraction (EF) from four members of
the Cardiovascular Research Network –– Kaiser Permanente
Northern California, Colorado and Northwest, and Fallon
Health-Meyers Primary Care Institute –– from January 1,
2005, through December 31, 2008. To be included in the
cohort, patients had to have > 1 inpatient admission with
primary diagnosis of HF and/or > 3 outpatient encounters
with any diagnosis of HF. Outcomes of interest included:
death, hospitalization due to heart failure, and hospitalization
for any cause.
Results: Beta-blocker therapy was associated with a reduced
risk for death among the overall group of HF-lung disease
patients, and specifically for those with borderline or reduced
EF. ACE/ARB therapy was associated with a reduced risk
for death among the overall group of HF-CKD patients, and
specifically for those with preserved and reduced EF. We
did not detect a statistically significant association between
beta-blocker use and hospitalization for HF or hospitalization
for any cause among the overall group of HF-lung disease
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patients; however, there was a reduced risk observed in
hospitalization from any cause for those with reduced EF. We
did not detect a statistically significant association between
ACE/ARB use and hospitalization for HF or hospitalization
for any cause among the overall group of HF-CKD patients;
however, there was a reduced risk observed in hospitalization
for HF among those with borderline EF.
Discussion: The findings of this observational study may have
clinical implications for the management of HF in patients
with common comorbid conditions including chronic lung
disease and chronic kidney disease.
Keywords: aging, multiple chronic conditions

Discussion: MCC patients experienced longer visits, although
the increase in number of LCDs is associated with a reduction
in the time spent on each LCD within the visit. Salaried AMC
physicians not only spent more time with MCC patients, but
also were more patient-centered in communication. Payment
policies that reward value over volume could facilitate patientcentered care for MCC patients.
Keywords: aging, multiple chronic conditions

A3-2:
Do Patients With Multiple Chronic Conditions
Experience the Same Care as Patients With Fewer
Chronic Illnesses? Insights From Videos of Primary
Care Office Visits

Jia Pu,1 Robert Romanelli,1 Beinan Zhao,1 Sukyung
Chung,1 Vani Nimbal,1 Latha Palaniappan1

Ming Tai-Seale, Weimin Zhang
1

2

Palo Alto Medical Foundation Research Institute;
Samueli Institute
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Background/Aims: How do primary care physicians (PCPs)
manage multiple chronic conditions (MCC) patients given the
financial incentives in their practices?
Methods: Qualitative and quantitative analyses of a
convenience sample of 385 video recordings of older patientPCP conversations in three primary care practice settings — an
academic medical center (AMC) with salaried PCPs, a fee-forservice (FFS) managed care group (MCG) and several FFS innercity solo practices (ICS) — in the Midwest and Southwest. We
identified topics –– issues requiring a response from either patient
or physician — that emerged during a visit and categorized them
according to a coding system. We recorded the time spent on
each topic and visit length. To measure the topic’s severity, we
mapped the topics to the five top leading causes of disabilities
(LCD) identified by the National Center for Health Statistics:
pain, cardiovascular diseases, diabetes, lung diseases and mental
illnesses. We assessed patient-centeredness by physician’s
empathy, warmth and engagement in informed decision-making.
Generalized estimation equation (GEE) analyses examined the
pattern of time use and patient-centeredness across patients with
0 LCD, 1 LCD or ≥ 2 LCDs (i.e. MCC).
Results: Over 56% (216/385) of visits contained ≥ 2 LCDs.
Average length of visits with 0 LCD lasted 13.21 minutes,
whereas visits with 1 LCD lasted 16.63 minutes, and averaged
18.93 minutes for ≥ 2 LCDs. MCC visits in the AMC were
longer (23.91 minutes), followed by MCG (14.82 minutes)
and ICS (12.42 minutes). Within visits, GEE findings
suggested if a visit had only 1 LCD, time spent on the LCD
was 2.90 minutes. If a visit had ≥ 2 LCDs, time on each LCD
was reduced to 2.51 minutes. Compared to FFS PCPs, AMC
physicians not only spent more time (2.95 vs. 2.23 minutes/
LCD) with MCC patients, their communication also was more
patient-centered. Qualitative analyses of MCC visits revealed
a sometimes narrow focus on some individual LCDs while
overlooking others.
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A3-3:
Higher Prevalence of Insulin Resistance Among
Asian Americans Despite Lower Body Mass Index

1

Palo Alto Medical Foundation Research Institute

Background/Aims: This study aims to identify racial/
ethnic differences in the relationship between body mass
index (BMI) and insulin resistance across Asian American
subgroups (Asian Indian, Chinese, Filipino, Japanese,
Korean, Vietnamese), Mexicans, non-Hispanic blacks
(NHBs) and non-Hispanic whites (NHWs) in a large, mixedpayer ambulatory care setting in northern California.
Methods: This cross-sectional study examined electronic
health records of patients aged 18 years or older from 2000–
2012. Insulin resistance was indicated by triglyceride/highdensity lipoprotein ratio > 3. Overweight or obesity was
defined as BMI ≥ 25.
Results: Although Asian Americans had the lowest rate of
overweight and obesity, they had the highest prevalence
of insulin resistance in both normal weight (19%, 9,262 of
49,981) and overweight/obese groups (43%, 15,742 of 36,496),
followed by Mexicans (normal: 12%, 197 of 1,590; overweight:
39%, 2,106 of 5,377), NHWs (normal: 9%, 6,271 of 65,921;
overweight: 32%, 33,475 of 103,695) and NHBs (normal: 6%,
46 of 716; overweight: 16%, 459 of 2,855). After controlling
for age, gender and important comorbidities (presence of
high blood pressure, hyperglycemia, dyslipidemia), Asian
Americans were still significantly more likely to have insulin
resistance in both BMI groups (normal: 1.6 odds ratio [OR],
1.5–1.7 confidence interval [CI]; overweight: 1.3 OR, 1.2–1.4
CI) compared to NHWs. Significant racial/ethnic differences
in insulin resistance were also found across Asian American
subgroups. Among normal weight patients, Asian Indians (OR:
2.1, CI: 2.0–2.2), Chinese (OR: 1.4, CI: 1.3–1.5) and Filipinos
(OR: 1.3, CI: 1.1–1.5) were significantly more likely to have
insulin resistance compared to NHWs after controlling for
age, gender and comorbidities. Higher adjusted risk of insulin
resistance was also observed among Asian Indians (OR: 1.5,
CI: 1.4–1.6) and Chinese (OR: 1.3, CI: 1.2–1.4) overweight/
obese patients, while other Asian subgroups had no significant
difference compared to NHWs.
Discussion: Asian Americans are more likely to have insulin
resistance despite lower rates of overweight and obesity. Our
study suggests the use of lower BMI when screening for
insulin resistance among Asian Americans.
Keywords: insulin resistance, racial/ethnic differences
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A3-4:
Bisphosphonate Drug Holiday and Fracture Risk
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Elizabeth A. McGlynn,1 Wendolyn S. Gozansky2
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Background/Aims: Among women with ≥ 3 years exposure
to bisphosphonates (BPs), we compared the incidence of
fragility fractures in those who discontinued BPs for ≥ 12
months (drug holiday) to those who continued to use BPs
(persistent use).
Methods: This retrospective cohort study included
women aged ≥ 45 years who initiated BP use from four
Kaiser Permanente regions between January 1, 1998, and
December 31, 2009. Drug holiday was defined as ≥ 12
months with BP use at 0% adherence. Persistent use status
required ongoing use at ≥ 50% adherence. The primary
outcome of interest was the first occurrence of an incident
clinical osteoporosis-related fragility fracture, identified
from the electronic medical record (EMR) via ICD-9CM codes. All subjects were followed until fracture,
disenrollment from the health plan, death, or December
31, 2012. From the EMR, we collected information on the
following potential confounders and effect modifiers: race/
ethnicity, age, body mass index, comorbidities, history of
previous fragility fracture, lowest T-score prior to cohort
entry, fall risk, 10-year fracture risk, and prior/concomitant
use of bone-active medications. Persistent users and drug
holiday subjects were compared with regard to several
demographic and clinical characteristics. Time-varying
Cox proportional hazards models were used to compare
osteoporosis-related fracture incidence between the two
groups.
Results: The cohort of 28,620 women, observed for 111,997
person-years, included 17,123 (59.8%) persistent BP users
and 11,497 (40.2%) drug holiday subjects. The drug holiday
group had fewer comorbidities, higher baseline T-scores,
and lower fracture and fall risk scores. A total of 3,571
osteoporosis-related fractures were observed. The unadjusted
rate ratio (RR) for any osteoporosis-related fractures for drug
holiday compared to persistent use was 0.87 (95% confidence
interval [CI]: 0.81–0.94), but was 1.0 (95% CI: 0.9–1.2) for
hip fractures only. The time-varying models suggested no
differences in fracture risk (hazard ratio [HR]: 0.90, 95%
CI: 0.80–1.00) after adjustment for baseline fall and fracture
risk, comorbidities and other bone-active medication use.
Similarly, no difference in hip fracture risk was observed
(HR: 0.84, 95% CI: 0.68–1.03).
Discussion: Women who undertake a holiday from BP use are
not at greater risk of osteoporosis-related fragility fractures,
nor hip fractures specifically, than are women who continue
to use BPs persistently.
Keywords: osteoporosis, fracture risk

Supplement

B4-2:
Improving Lifestyle Interventions for People With
Serious Mental Illnesses: Qualitative Results from
the STRIDE Study
Scott Stumbo,1 Bobbi Jo H. Yarborough,1 Micah T.
Yarborough,1 Thomas J. Young,1 Carla A. Green1
Kaiser Permanente Northwest

1

Background/Aims:
Overweight
and
obesity
are
disproportionately prevalent among individuals with serious
mental illnesses, in part due to psychiatric medications, poor
dietary habits and sedentary lifestyles. Behavioral lifestylechange interventions are effective yet require more than
training participants on energy balance. Interventions must
address factors relevant to the context within which people
attempt to lose weight and improve health, such as lack of the
following: nutrition education, access to and affordability of
healthy foods, safe places to exercise and skills.
Methods: As part of a randomized controlled trial (N=200)
that was successful in producing significant weight loss at 12
months, we conducted 101 semistructured interviews with 84
participants to understand barriers and facilitators of weight
loss and lifestyle changes associated with the intervention, or
with efforts at losing weight and remaining physically active
more generally. Interviews were coded by a team (with 79%
agreement among coders) and were analyzed using Atals.ti.
Results: Interviewees averaged 48 years old; 36% were
men, 21% were nonwhite, and 24% were from the control
group. Participants had diagnoses of schizophrenia or
schizoaffective disorder (41%), bipolar disorder (20%),
affective psychosis (37%) or posttraumatic stress disorder
(2%). Thematic analyses revealed a number of key facilitators
and barriers. Facilitators included: 1) current health concerns
that precipitated the decision to engage in a lifestyle
intervention; 2) group camaraderie facilitating participation
and weight loss during the intervention; and 3) social
support for exercise. Barriers included: 1) loss of structured
support and subsequent difficulties continuing with lifestyle
improvements postintervention; 2) bad weather as a deterrent
to exercise; 3) the interaction of mental health symptoms (e.g.
depression, anxiety) with disinhibited eating; and 4) all-ornothing thinking that led to defeatist attitudes about weight
loss.
Discussion: Successful weight loss can be achieved among
individuals with serious mental illnesses with the right
intervention. We found a strong preference for consistent,
group-based support to foster a sense of accountability, which
motivated behavior changes. Lifestyle change interventions
for this population should also help participants develop
flexible cognitive restraint and the ability to iteratively cope
and adapt to changes in mood and subsequent changes in
motivation to eat healthfully and exercise regularly.
Keywords: serious mental illnesses, behavioral change
D3-3:
Do Financial Incentives Encourage Health Plan
Members to Complete Health Risk Assessments?
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Jason P. Block,1 Dennis Ross-Degnan,1 Matthew W.
Gillman,1 Sheryl L. Rifas-Shiman,1 Renata Smith,1 Ken
Kleinman1
1

Harvard Pilgrim Health Care

Background/Aims: Employers increasingly offer financial
incentives to employees for participation in wellness
activities. Whether these incentives are effective is unclear. In
a nonprofit health plan, we examined the impact of monetary
incentives on completion of a health risk assessment (HRA).
Methods: Harvard Pilgrim Health Care, a nonprofit HMO
in New England, began encouraging members to complete a
HRA starting in 2010. Any health plan member was eligible
to complete a HRA, which included questions about health
behaviors, quality of life and medical conditions. Starting
in 2011, some large employers who contract with Harvard
Pilgrim Health Care for employee health insurance began
incentivizing completion of the HRA. Using records on
health plan members, the HRA and employer incentives,
we gathered data on all adult health plan members from
October 2010 to July 2013 (N=991,743). For this analysis, we
compared completion of a HRA among the 66,639 members
who received incentives versus the 925,104 members who did
not, adjusted for demographics. We used survival analysis to
examine the association of receiving a HRA incentive with
HRA completion.
Results: Among members, mean age was 42.6 years, 52% were
female, and 89% were white. During the 2.75-year followup period, 18,884 members completed a HRA, including
11,254 among the 66,639 with incentives (16.9%) and 7,630
among the 925,104 without (0.8%). In multivariable models
controlling for demographics, being offered an incentive was
strongly associated with time until completion of a HRA in
2011, 2012 and 2013 (hazard ratios: 6.0 [95% confidence
interval: 5.6–6.4] for 2011, 29.2 [28.0–30.5] for 2012 and
46.4 [41.1–48.8] for 2013). Other important predictors
of HRA completion included female gender, Hispanic or
“other” race (vs. white race), and older age. Black members
were less likely to complete the HRA than white members.
Larger incentives were more successful in promoting HRA
completion than smaller incentives.
Discussion: Providing financial incentives was strongly
associated with completion of a health risk assessment in a
nonprofit health plan.
Keywords: financial incentives, health risk assessment
PS1-17:
Should Pharmacists Be Included in a Core Team
to Reduce Hospital Admissions and Mortality for
Patients With Chronic Heart Failure?
Indubala Vardhan,1 Yvonne E. Grant,1 Carmela Astrea,1
Joanna Wolmer,1 Paula Hinz1
Kaiser Permanente Southern California

1

Background/Aims: Heart failure (HF) is a common
disease and accounts for multiple hospital admissions,
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readmissions, increasing health care costs and high mortality.
One in five Americans is diagnosed with HF. Symptoms
are mostly managed with medications. Evidence shows that
a multidisciplinary care team is best practice for managing
HF. More research is needed to determine ideal combinations
for services on a core team to optimize use of resources and
intervention effectiveness. We aimed to determine the impact
on outcomes of adding a clinical pharmacist intervention to
a HF multidisciplinary care team. We hypothesized that a
pharmacist would increase efficiency of the team, and thereby
improve outcomes of decreased hospitalization and mortality.
Methods: We conducted a prospective, pretest-posttest
nonrandomized, single-arm, pilot study to determine impact
of adding a pharmacist intervention. In an ambulatory care
setting, 100 patients who were hospitalized with HF in prior
12 months were invited to participate; 81 patients consented,
enrolled and completed the study. Retrospective data on
81 other comparable patients, admitted for HF in prior 12
months, served as controls. Control patients had received
usual care from the multidisciplinary care team, whereas study
patients received usual care plus pharmacist intervention. The
intervention R-E-A-D was comprised of four steps –– Step 1:
Reconciliation of medications; Step 2: Education to patient/
caregiver on indications for medications; Step 3: Adherence
evaluation; and Step 4: Drug monitor for drug adverse effects,
drug/disease interactions and therapy optimizations. The
study was conducted from May 2010 to November 2011.
Results: Demographic variables included average age 75
years, average medications 10 and average comorbidities 5.
At 12 months postintervention, the control group realized a
decrease of 32 hospital readmissions and a reduction of 60
hospital days (P=0.16), while the intervention group realized
a decrease of 97 readmissions and a reduction of 332 hospital
days (P<0.001). Postintervention, 23 of 81 patients (28%) had
expired in the control group, while 13 of 81 patients (16%)
had expired in the treatment group.
Discussion: The study confirms that pharmacists should be
included as members of a core team to reduce readmissions
and mortality for patients with chronic HF.
Keywords: heart failure intervention, chronic disease
management
PS1-27:
Medical Assistants as Health Coaches: Helping
Obese Patients Set Goals
Paula Lozano,1 June BlueSpruce,1 Dori Rosenberg,1
Kim Wicklund,1 Karen Severson1
Group Health Cooperative

1

Background/Aims: Obesity is a common condition seen in
primary care. However, there have been few programs for
obese patients within existing primary care infrastructure.
We sought to develop a program to train medical assistants
to provide brief health coaching on weight management and
help patients set goals.
Methods: Coaching was based on motivational interviewing
and brief action planning. We used a mixed-methods, iterative
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approach to refine the intervention to prepare for broader
dissemination. We summarize key events, themes and data
collected.
Results: We convened a team of researchers, providers
and operational leaders. In the first 2 months, we trained
all 8 medical assistants (MAs) in one primary care clinic
and worked with them to launch the intervention. A senior
interventionist mentored and provided supervision to the
MAs over several improvement cycles during a 4-month
period. We conducted qualitative interviews to obtain
feedback 6 months into the project. Barriers included patient
reluctance to talk about weight management, preference for
more provider involvement, and time constraints. Facilitators
included feeling that the topic is important, support from
the supervision and training team, and positive coaching
experiences. We made changes to the intervention based on
the interviews and meetings with the clinic providers. During
a 1-month period 8 months after launch, there were 1,143
adult primary care encounters to an average of 5 primary care
providers over 21 clinic days. One-third (36%, n=409) were
by patients with a body mass index > 30, and of these, 5.4%
of patients were coached by an MA. The MAs coached a total
of 23 patients, or 5.5 patients per week.
Discussion: Brief health coaching by MAs coaching may be
feasible once key barriers are addressed. We are currently
piloting revised procedures and continuing to mentor MAs
and providers through 2014.
Keywords: health coaching, behavior change
PS2-1:
Defining Care Needs in Older Adults With a Particular
Set of Multiple Chronic Conditions: Coexisting
Visual, Auditory and Cognitive Impairments
Heather E. Whitson,1 Phillip Liu,2 Gerda G. Fillenbaum,3
Bruce M. Burchett,3 Harvey J. Cohen3
Duke University Health System; 2Duke-National
University of Singapore; 3Duke University
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Background/Aims: Patients who have multiple chronic
conditions (MCCs) represent a majority of older adults and
have high health care needs. Considering the heterogeneity
of MCC, one approach to identifying specific need gaps is to
focus on common pairs or clusters of MCCs. Visual, auditory
and cognitive impairments are common in old age, frequently
coexist, and impact function. However, little is known about
their combined association with patient-centered outcomes in
older adults. Our objective was to assess the relationship of
disability and self-reported health with various combinations
of coexisting visual, auditory and/or cognitive impairments.
Methods: We analyzed sample data from the North Carolina
EPESE study (N=3,871; age 65–105 years), a populationbased epidemiological study of community-dwelling seniors.
Cognition was assessed by the Short Portable Mental Status
Questionnaire, and visual and auditory status determined from
self-reported information. Logistic regression characterized
the cross-sectional associations of all combinations of visual,
auditory and cognitive impairment with disability in activities
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of daily living (ADL), instrumental ADL (IADL) and poor
self-reported health (SRH).
Results: The prevalence of ADL disability was 9.9% (384 of
3,871), IADL disability 29.6% (1,146 of 3,871), and fair/poor
SRH 46.6% (1,805 of 3,871). In adjusted analyses, compared
to persons with no impairments, persons with all three
impairments had increased odds of ADL disability (odds ratio
[OR]: 4.99, 95% confidence interval [CI]: 2.95–8.44), IADL
disability (OR: 10.39, 95% CI: 5.67–19.05) and low SRH
(OR: 2.81, 95% CI: 1.64–4.82). The relationship between
impairments and ADL disability exhibited a “step-wise”
pattern (odds of disability increased as number of impairments
increased), but IADL disability was particularly common in
those with vision impairment, cognitive impairment, or the
combination. While sensory impairments were associated
with poor SRH, cognitive impairment was not unless both
sensory impairments were present.
Discussion: Older adults with coexistent sensory and
cognitive impairments have high functional needs. People
with combined vision and hearing loss are likely to perceive
their health as poor, whereas cognitive impairment may confer
some protection against illness perceptions. Persons with
coexisting visual and cognitive impairments are especially
likely to require assistance with IADLs (e.g. medication
management, handling finances) and may benefit from targeted
clinical services that help overcome those impairments.
Keywords: aging, multiple chronic conditions
PS2-2:
Factors Associated With Time to Diagnosis in
Fibromyalgia
Gabriel Chodick,1 Daliah Weitzman,1 Yael Bar-On,2
Varda Shalev,1 Howard Amital3
1
3

Maccabi Healthcare Services; 2Tel Aviv Medical Center;
Sheba Medical Center, Tel HaShomer

Background/Aims: The diagnosis of fibromyalgia, a chronic
debilitating disorder, is complicated and affected by various
factors of the patient and the caregiver. The objectives of
this study were to investigate the time passing from initial
complaints to diagnosis and to delineate the patient and
physician characteristics affecting that time.
Methods: For this retrospective cohort study we used the
datasets of Maccabi Health Services (MHS), the second
largest health maintenance organization in Israel. We
identified all confirmed cases of fibromyalgia that were
diagnosed by specialists in the community or hospital during
1/2008–12/2011. These patients were compared to sex- andage-matched fibromyalgia-free members. Different complaint
patterns were examined to ascertain time of initial complaints.
The pattern with the best validity was applied on nonvalidated
cases that were diagnosed with fibromyalgia by primary
physician, rheumatologist or at release from hospitalization
during the same period. Patient and primary physician
factors associated with time between initial complaints
and fibromyalgia diagnosis were assessed. A multilevel
generalized mixed linear model with a log-linked gamma
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distribution was used to account for clustering of patients
associated with the same primary physician.
Results: Our study included 2,656 confirmed cases of
fibromyalgia (91% women, mean age: 51.1 years, standard
deviation [SD]: 11.3 years). The most valid initial complaints
pattern included 4 or more complaints within 6 months, found
in 73% of the cases. These results indicated that the mean
duration between initial fibromyalgia-related complaints
to final diagnosis was 4.7 years with SD of 3.6 years. In a
multivariable model, shorter time to diagnosis was associated
with patients of young age, male gender and higher socioeconomic status, and with primary physicians of young age,
family/pediatric/internal specialty versus general, and medical
studies in Eastern or Western Europe versus other continents.
Discussion: The mean time to diagnosis of fibromyalgia is very
long and is significantly influenced by patient and physician
characteristics. Better patient and physician education, and
increased awareness to the disease and its early complaints,
can be a key for improving the diagnosis of fibromyalgia.
Keywords: fibromyalgia, health care services
PS2-3:
The Need for New Care Strategies to Prevent A1c
Relapse
JoAnn M. Sperl-Hillen,1 Heidi L. Ekstrom,1 Patrick J.
O’Connor,1 Richard M. Bergenstal,2 Stephen E. Asche,1
Terese A. DeFor,1 Gerald H. Amundson,1 Deepika
Appana1
1

HealthPartners; 2Park Nicollet

Background/Aims: The principle treatment strategy for
glycemic management in most care settings is reactive; monitor
A1c levels and then react with treatment intensification when
the A1c exceeds the recommended optimal care goal. Our goal
was to assess the potential to improve diabetes performance
measures through preventive strategies directed at patients
who are at A1c goal but at high risk for disease progression
and A1c relapse.
Methods: Patients not meeting optimal care goals were
partitioned into one of three different A1c trajectories: (a)
FLAT –– those who are consistently above optimal A1c
goal, (b) Negative slope –– those patients who are on an
improvement trajectory, and (c) Positive slope –– those
who have previously been meeting A1c goals but who
have relapsed (often due to medical issues, comorbidities,
psychosocial stress, behavioral or medication adherence,
or disease progression). We quantified the proportion of
patients with diabetes who contribute to the relapse vector by
identifying patients with diabetes and A1c tests in the last two
years (9/1/2012–8/31/2014) and quantifying the proportion of
patients who relapsed in year 2, stratified by A1c range and
pharmacologic treatment in year 1.
Results: We identified 29,321 patients with at least two
diabetes diagnoses in years 1 and 2, with median A1c of 7.4%.
Of these, 8,889 (30%) had an A1c > 8% in year 2. Of 6,321
patients with A1c of 7–7.9% in year 1, 2,332 (36.9%) relapsed
to > 8% in year 2. Relapse was higher (43.2%) for patients
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medicated with sulfonylurea or insulin. Only 689/10,202
(6.7%) patients with A1c <7% in year 1 relapsed to A1c >8%
in year 2.
Discussion: We estimate that the phenomenon of A1c relapse
accounts for one-third of all adults identified as having
uncontrolled glucose on quality measures. Proactive care
strategies in high-risk patients close to goal (A1c 7–7.9%)
to help them sustain control could reduce the proportion of
patients not meeting optimal A1c goals. More systematic
use of patient-reported self-monitored blood glucose data
could further help to identify patients who are relapsing
or progressing. Further research is needed to test these
hypotheses.
Keywords: diabetes, optimal A1c goals
PS2-4:
Health Coaching for Patients With Diabetes and
Hypertension: Filling a Gap for Patients and
Physicians
Ellis C. Dillon,1 Laura Panattoni,1 Amy Meehan,1 Judith
Chuang,1 Lisa McCormick,1 Ming Tai-Seale1
1

Palo Alto Medical Foundation Research Institute

Background/Aims: Health coaching is a novel primary care
team-based care model using clinically supervised unlicensed
providers to help patients make lifestyle changes and improve
self-management of diabetes and/or hypertension. Previous
health coaching programs have largely targeted indigent
patients. It is unknown how privately insured patients and feefor-service providers in community practices would respond
to and use health coaching services.
Methods: Findings are drawn from a study conducted at a
large multispecialty clinic serving approximately 29,000
patients with diabetes or hypertension. Data were gathered
6 months after implementation of the health coach program
and include observation/audio recordings of 8 health
coach appointments, interviews with 8 patients, 7 referring
physicians, 2 health coaches and 1 nurse practitioner clinical
supervisor, and electronic health record (EHR) visit data.
Results: Out of the 2,342 patients with a diabetes- or
hypertension-related primary care visit during this period,
197 (12%) had health coach referrals in the EHR, and 113
(5%) had at least one health coach visit. Patients averaged
2.5 (standard deviation: 2.6) health coach visits, but the range
included 1 to 19 visits during this time period. Health coaching
involved direct time spent coaching patients and indirect time
spent on care management and navigation. Direct coaching
ranged from biweekly in-person visits to monthly phone calls.
An average in-person visit was 38 minutes (min: 18, max: 74,
standard deviation: 18.9 minutes). Health coaches developed
a distinct relationship with patients; they worked together to
develop plans that addressed not only health concerns such as
diet, exercise and monitoring of blood pressure/sugar, but also
personal concerns regarding finances, family, etc. Physicians
differed in the language they used to describe the health coach
program to patients and in their criteria for health coaching
referrals. Physicians were appreciative of health coaches as
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members of an extended care team and as liaisons between
patients and services or resources.
Discussion: The role of health coaching in this primary care
setting is still evolving and adjusting to meet varying levels
of patient needs and preferences for contact. Health coaching
fills a gap for patients and physicians who both benefit from
an extended but flexible relationship that provides a new type
of support.
Keywords: health coach, chronic conditions
PS2-5:
Dilated Eye Exam Compliance for Persons With
Diabetes Mellitus in a Managed Care Setting
Jaejin An,1 T. Craig Cheetham,2 Fang Niu,2 Yamina
Rajput,3 Adam Turpcu3
Western University of Health Sciences; Kaiser
Permanente Southern California; 3Genentech Inc.
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Background/Aims: National practice guidelines recommend
regular dilated eye examinations for persons with diabetes
mellitus (DM). Regular exams can identify the presence
of diabetic eye diseases leading to early detection and
treatment along with vision preservation. We aimed to: 1)
assess compliance with guideline-recommended dilated eye
exams among persons with DM, and 2) determine the factors
associated with noncompliance.
Methods: Kaiser Permanente Southern California members
aged ≥ 18 years with DM identified from January 2009 to
December 2010 were followed until disenrollment or study
end date (December 2013). Dilated eye exams were identified
from CPT-4, ICD-9 procedure codes and retinal photographs.
Compliance with guidelines over the entire duration of
follow-up was the binary outcome of interest. A patient
was defined as compliant when having at least one exam in
each 12-month period if there was evidence of retinopathy,
or at least one exam in each 24-month period if there was
no evidence of retinopathy. Multivariate logistic regressions
were used to investigate patient demographics and other
baseline characteristics associated with noncompliance.
Results: Among the 204,073 eligible patients, mean age ±
standard deviation was 61 ± 13 years and 48% were female.
The median follow up was 4.8 years, and overall, 71.1% of
patients were compliant with dilated eye exams, including
27.7% who received an eye exam every year and 4.4% who
never received a dilated eye exam. At baseline 13% of patients
had retinopathy, while an additional 20% of patients developed
retinopathy during follow-up time. Noncompliant patients
were more likely to be younger, black, male, smokers, and
have a Medicare plan, a lower income, a lower education and
a higher specialist co-payment plan. In addition, these patients
were less likely to be adherent to antidiabetes medications, on
statin medications, take a diabetes education class and have
other eye diseases; however, they were more likely to use
insulin, have retinopathy, have nephropathy, and have a lower
comorbidity index.
Discussion: During nearly 5 years of follow-up, 28.9%
of person’s with DM were noncompliant with dilated eye
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exam guidelines. Future research should focus on eye
disease outcomes associated with noncompliance and the
development of interventions to address modifiable factors
associated with noncompliance.
Keywords: diabetes mellitus, risk factors
PS2-6:
Home Monitoring: Patient and Provider Perceptions
of and Use of Home Blood Sugar and Blood Pressure
Measurements in Primary Care Practice
Ellis C. Dillon,1 Amy Meehan,1 Judith Chuang,1 Ming TaiSeale1
1
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Background/Aims: Patients with diabetes and hypertension
are increasingly asked to monitor blood glucose and blood
pressure at home. Home monitoring and the resulting logs
and measurements are sometimes used as a basis for adjusting
treatment. Despite the importance of home monitoring, we
lack an understanding of patients’ ability and education about
how to take accurate measurements, their perception of what
to do with these measurements, and how providers use these
measurements in practice.
Methods: Findings are drawn from a mixed-methods study
of a primary care intervention for patients with diabetes and
hypertension. The study was conducted at a large multispecialty
clinic serving approximately 29,000 patients with diabetes or
hypertension. Data include discussion of home monitoring in
observation/audio recording of 26 primary care appointments,
and interviews with 12 patients, 7 medical assistants and 9
physicians.
Results: The intervention standardized procedures for
collecting patients’ home blood sugar and blood pressure
measurements and logging them in the electronic health record.
However, there was no standardization of the procedures or
tools patients used to collect this data. Patients described various
motivations for home monitoring, ranging from physician
requests to adjusting daily insulin dosage. Several patients were
uneducated about how to take measurement, e.g. what “fasting
blood sugar” meant. Some patients were unsure what to do if
measurements were too high or too low. Other patients lacked
training and reported problems using devices. Physicians often
asked patients to call in/email measurements after appointments
or medication changes. Increasingly physicians appear to be
using these home measurements for clinical decision-making,
yet the reliability of these measurements may vary widely.
Discussion: Home monitoring offers an opportunity to further
engage patients in their care and provides an opportunity to
help them better understand how blood pressure and blood
sugar affects their health. However, patients exhibit varying
strategies of when, how and why to check their blood sugar
and blood pressure. Relying on patient-collected data may
result in problematic clinical decisions, and there is a need
for consistent and early patient education to ensure accurate
home monitoring and steps to take if numbers are either too
high or too low.
Keywords: diabetes, hypertension
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Building an Interactive Platform for Physical Activity
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Background/Aims: Patients with chronic obstructive
pulmonary disease (COPD) who are physically inactive
have worse outcomes. The evidence is unequivocal that
intensive supervised exercise training as part of pulmonary
rehabilitation, a guideline-recommended therapy, improves
symptoms, physical functioning and quality of life and reduces
hospitalizations for COPD exacerbations. However, patient
participation in supervised exercise at center-based programs
is very low, which undermines the wide scale adoption of this
approach in real-world clinical settings for large numbers of
patients. Alternative models to center-based rehabilitation that
are more patient-centered, scalable and sustainable are needed
in order to reach patients who otherwise would not have other
options. The aim of this project was to develop an integrated
informatics architecture to support the implementation of
a patient-centered, technology-enabled physical activity
coaching intervention model (Walk On!) for patients with
COPD.
Methods: A multidisciplinary team of researchers, clinicians,
innovation consultants and software developers, as well as
patient end users, embarked on an iterative design process
over the course of 6 months to build out three key components
of the Walk On! platform. An interactive voice response
(IVR) module was developed to collect physical activity and
symptom data from patients who do not have access to the
Internet. An existing vendor supported web-based physical
activity application paired with a wireless sensor was modified
for use by patients with Internet access. Finally, an interactive
web-based dashboard was created to visually summarize the
integrated physical activity and symptom data from the IVR
and web-based systems for the activity coaches to review
patients’ progress and conduct targeted outreach to support
patients’ efforts to be physically active.
Results: We have completed the IVR module build and are
close to completing the enhancements to the physical activity
web-based application. Building the dashboard that integrates
data from these two sources has required significant effort,
especially the user-interface, coding the dynamic functions
and building the data back-end. The platform will be pilot
tested on 30 patients starting in December 2014.
Discussion: We will present data from our pilot at the
HMORN meeting. The Walk On! platform is designed to be
usable, scalable and generalizable.
Keywords: COPD, intervention
PS2-9:
Health Outcome Effects of Common Medications in
Elders With Multiple Conditions
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Background/Aims: Determining medication effects is more
complex in individuals with multiple chronic conditions
(MCC). One approach to addressing these limitations is
to define effectiveness through the use of cross-condition,
universal health outcomes such as self-reported health (SRH).
Appropriate methodology is needed to evaluate medication
effects in the setting of MCC.
Methods: We studied 9 commonly used oral medications
from national disease guidelines (renin-angiotensin system
blockers (RAS), statins, thiazides, calcium channel blockers,
selective serotonin reuptake inhibitors, metformin, warfarin
and clopidogrel) recommended for 8 common chronic
conditions (atrial fibrillation, coronary artery disease,
depression or anxiety, diabetes mellitus, heart failure,
hyperlipidemia, hypertension and pulmonary embolism/
venous thrombosis) and used by at least 20% of 8,517 Medicare
Current Beneficiary Survey enrollees with two or more MCC
from 2005–2009 with follow-up data available through 2011.
We estimated the odds of high SRH (good-excellent) of the
most commonly used medications for 8 common and morbid
chronic conditions, adjusted for 14 covariates and accounting
for within-subject correlation. For absolute population level
estimates, we applied the longitudinal extension of the
average-attributable-fraction with time-varying conditions on
recurrent SRH.
Results: The most common dyads of conditions at baseline
were hypertension and hyperlipidemia, with 71.3% (6,073
of 8,517). On average, 11.3% (96 of 8,517) discontinued
a medication over the 3-year follow-up period, whereas
6.9% (588 of 8,517) started a new medication. All the
conditions except atrial fibrillation were significantly
associated with poorer SRH; pulmonary embolism/venous
thrombosis had borderline significance. Hyperlipidemia
had significantly higher odds of high SRH. There were four
significant condition-medication interaction terms. Regarding
participants with hypertension, the odds of high SRH for
people who take RAS blockers were greater than those who
do not. Conversely, the odds of high SRH for people who take
thiazide for hypertension are lower than those who do not.
The odds of reporting high SRH for people taking statins is
higher than those not taking statins within the hyperlipidemia
subpopulation. The odds of high SRH among people who have
coronary artery disease is lower in those who take clopidogrel
than those who do not.
Discussion: Medication effects on universal health outcomes
provide a way to compare across conditions.
Keywords: aging, multiple chronic conditions
PS2-10:
Identification of Multiple Chronic Conditions That
Yield the Highest Impact of Cognitive Screening
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Background/Aims: Diabetes mellitus (DM), hypertension
(HTN) and hyperlipidemia (HL) are common geriatric
chronic diseases that may increase dementia risk. Screening
for cognitive impairment is not currently recommended
due to lack of studies demonstrating benefit. HealthPartners
piloted using the Mini-Cog to screen patients aged ≥ 65
years, and physicians expressed concern about the feasibility
of screening all patients. In order to identify subgroups of
patients who may potentially benefit most from cognitive
screening, we examined screen fail rates, retrospective health
care utilization and the impact of multiple chronic conditions
in this cohort.
Methods: Data from the 18 months prior to cognitive
screening was collected from the electronic medical record
and included the Mini-Cog score (scored 0–5, fail is less than
4), demographics, presence of diagnosis for three chronic
diseases, and measures of health care utilization. The cohort
was divided into eight subgroups: DM alone, HTN alone, HL
alone, DM+HTN, DM+HL, HTN+HL, DM+HTN+HL, and
no chronic conditions. Utilization outcomes were analyzed
using Poisson regression accounting for age and sex; the DMonly model was not useable due to a small sample size.
Results: The mean age of the cohort (N=1,124) was 77 years
(41% male), and the overall cognitive screen fail rate was
32%. Fail rates were highest in the small DM group (50%
fail), followed by patients lacking the three chronic conditions
(36% fail), and lowest in the DM+HL (21%) and HTN (26%)
cohorts. Overall, patients failing the screen had a significantly
higher incidence rate of hospitalization (23%) and emergency
room visits (42%). This result was driven by two subgroups of
multiple chronic conditions, DM+HTN and DM+HTN+HL,
with those failing having significant increases in rates of
hospitalization (535% and 56%, respectively) and emergency
room visits (252%, 102%).
Discussion: Based on higher retrospective utilization, patients
with DM+HTN and DM+HTN+HL may benefit most from
cognitive screening. Surprisingly, higher screen fail rates were
found in patients without DM, HTN or HL, which may be
partially explained by a lower rate of clinic visits (mean 0.98
visits per month vs. 1.33). Prospective longitudinal studies are
necessary to better support the role of the screening in specific
groups of patients with chronic conditions.
Keywords: aging, multiple chronic conditions
PS2-11:
The Group Health-University of Washington Adult
Changes in Thought Study: A Living, Learning
Laboratory for Aging and Multiple Chronic
Conditions Research
Eric B. Larson,1 Paul K. Crane,2 Erin J. Bowles,1 Rod L.
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Background/Aims: Delivery system-based research
can meet today’s need for practical clinical evidence and
provide opportunities for discovery in everyday populations,
particularly for an increasing number of people with multiple
chronic conditions. The evolution of the Adult Changes in
Thought (ACT) study, a long-standing partnership between
Group Health and University of Washington, demonstrates the
value and lessons learned from a living laboratory on aging.
Methods: We responded to a 1986 National Institute of Aging
request for Alzheimer’s disease patient registries to identify
people with incident Alzheimer’s disease (AD) at Group
Health. Partnering with University of Washington allowed us
to evaluate candidate genetic markers and develop a biobank.
In 1994, we established the ACT study, a cohort of randomly
selected people over age 65 without dementia. We initially
recruited 2,581 participants, followed by an expansion cohort
of 811, and a continuous replacement sampling strategy to
replace participants who die, become demented or are lost to
follow-up. We maintain a constant cohort of approximately
2,000 living persons who are followed every two years.
Results: ACT has enrolled over 5,000 subjects, including
over 1,000 cases of incident dementia (over 70% AD)
and almost 600 autopsy cases, of which about half have
extensive frozen tissues with a rapid autopsy protocol. Our
biobank includes extensive genome-wide single nucleotide
polymorphism, exome sequence and gene expression data.
Our population-based neuropathology biobank is unique
worldwide. Our collaboration started a learning laboratory
for pragmatic trials, and contributed to the development of
the Seattle Protocols for dementia care, descriptive studies
of health services utilization, and widely accepted risk factor
and outcome data for persons with AD. ACT has served as
the parent grant for numerous studies involving genetics,
neuroimaging, pharmacoepidemiology, neuropathology,
traumatic brain injury, treatment trials, methods development
and career development.
Discussion: Studies of important age-related conditions will
provide valid research results if based on a representative
population. The ACT study created a platform for a populationbased living laboratory on aging across a wide range of
disciplines and scientific inquiry. Effective partnerships,
including widespread data and specimen sharing, are
foundational and critical for optimal success.
Keywords: aging, multiple chronic conditions

COMMUNICATION/DISSEMINATION/
IMPLEMENTATION
B1-5:
Cluster Randomized Trial of Enhanced Versus
Standard Implementation Strategy to Improve
Collaborative Care Uptake and Patient-Level
Utilization Outcomes
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Steven B. Zeliadt,1 Jaimee L. Heffner,2 Deborah E.
Klein,3 George Sayre,4 Lynn F. Reinke,4 Shuva Dawadi,5
David H. Au4

Background/Aims:
Implementation
strategies
are
increasingly being used to promote the uptake of evidencebased practices, yet few studies have demonstrated their
impact on the efficiency of patient-level utilization. This
cluster randomized controlled study determined whether an
enhanced versus standard version of the Replicating Effective
Programs (REP) implementation strategy, designed to promote
the uptake of an evidence-based collaborative care program,
impacted emergency department (ED) utilization outcomes
among patients with bipolar disorder. We hypothesized
that the enhanced version would lead to decreased ED use
compared to the standard.
Methods: Seven community-based clinics in Michigan and
Colorado were randomized to receive either standard (REP) or
enhanced REP (E-REP) to improve the uptake of Life Goals
Collaborative Care (LG-CC). Providers at sites randomized
to REP received the LG-CC toolkit (manual, implementation
guide), LG-CC training and, as needed, technical assistance.
Providers at sites receiving E-REP were given support
to customize LG-CC manuals and training and ongoing
facilitation for 6 months, where organizational barriers to
LG-CC uptake were addressed through provider coaching
to support integration of LG-CC into routine care. Providers
were responsible for implementing four weekly LG-CC group
sessions and monthly care management calls over 6 months
with patients with a diagnosis of bipolar disorder seen at their
clinics. Prior to attending LG-CC sessions, patients were
consented and completed baseline and follow-up assessments
at 6 and 12 months. Primary utilization outcomes included
self-reported ED visits.
Results: Within 12 months, patients (N=246) at sites
randomized to E-REP (n=146) compared to REP sites
(n=100) had a smaller self-reported number of ED visits
(0.14 for E-REP sites vs. 0.36 for REP; odds ratio: 0.24,
P=0.004) adjusted for patient-level demographics (sex, race,
age, education, homelessness, employment), clinical factors
(psychiatric symptoms, medical diagnoses), ED utilization
measured in the baseline survey and number of LG-CC
contacts. LG-CC uptake, particularly having at least 4 care
management contacts, appeared to mediate the effect of the
E-REP implementation strategy and decreased ED use.
Discussion: Implementation strategies such as enhanced
REP that provide customization and coaching in the use of
a collaborative care model may reduce ED use, primarily by
improving overall uptake and increasing care management
contacts.
Keywords: implementation strategies, patient-level outcomes
utilization
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B4-3:
Interviews With Patients Offered Lung Cancer
Screening in Primary Care: Lessons in How
Screening May Influence Smoking Cessation
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Background/Aims: We interviewed current smokers offered
lung cancer screening as part of a demonstration project to
explore how the availability of screening and the receipt
of screening results, including both normal and abnormal
findings, potentially influences patients’ beliefs about the
consequences of smoking and motivations around smoking
cessation.
Methods: We conducted semistructured interviews with 37
patients identified from 7 medical centers across the United
States who were identified as eligible for lung cancer screening
and offered screening by their primary care provider as part
of the Veteran Health Administration’s (VHA) Lung Cancer
Screening Clinical Demonstration Project. Data analysis was
conducted concurrently with data collection using inductive
and deductive content analysis.
Results: A total of 37 current smokers participated in
interviews from among 186 invited screenees purposively
sampled from the Demonstration Project between April and
August 2014; 11% were female and 27% non-Caucasian.
Four patients (11%) declined screening, and 9 of 30 (30%)
patients who were screened during the study period were
identified with a nodule finding < 1 cm. We identified four
themes related to smoking cessation behaviors. Screening,
when offered by their primary care provider, was very
appealing to many patients in contrast with “badgering”
by providers about smoking cessation and descriptions of
futility associated with prior quit attempts. Screening was
associated with reflection and personalization about harms of
smoking; however, sometimes contemplation about screening
reinforced misperceptions about risks of smoking or
exaggerated negative effect and worry. Patients with normal
findings often interpreted the result as evidence that smoking
hasn’t harmed them. Multiple patients with abnormal findings
described the belief that detection of nodules meant they were
being helped by technology. These patients described trusting
their doctors and “watching and waiting” as the way to avoid
chemo and unpleasant treatment for lung cancer, believing
they can put off any action, including quitting, until there is
more evidence of growth.
Discussion: We identified several concerning pathways in
which screening, when offered as part of routine care and
described as having proven efficacy, may negatively influence
cessation. Providers should be aware of these pathways
and tailor discussions to ensure screening does not lower
motivations around cessation.
Keywords: lung cancer screening, smoking cessation
D3-4:
The Role of Cost Information in Health System
Decisions to Adopt New Services
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Background/Aims: Health systems are under increasing
pressure to make careful choices about which new services
to adopt or encourage for their populations. At the same
time, explicit use of information on cost-effectiveness of
interventions in the decision process is controversial in the
United States. Yet health system decision-makers routinely
need to make decisions about what types of interventions
to adopt or promote within a limited budget. Economic
evaluations such as cost-effectiveness analyses are one
source of information that could potentially aid health
system decision-makers in evaluating interventions. Yet
little is known about how useful typical published economic
evaluations are to health system decision-makers, or whether
or not they provide the type of information most useful in the
decision process.
Methods: We conducted in-depth qualitative interviews by
telephone with a purposive sample of 38 public and private
health system decision-makers. We discussed decisionmaking in general, type of information used in the process and
the usefulness of cost information. All transcripts were coded
by trained coders and entered into Atlas.ti, which was used
to code and manage data and to generate reports for analysis.
The team reviewed reports and engaged in an iterative process
of discussion and review, resulting in the final themes. We also
looked at results by size of organization and type of service
under evaluation (medical or mental health).
Results: Participants reported a variety of internal and
external factors perceived to influence adoption to their
organizations. The two most highly endorsed factors were
clinical effectiveness and financial feasibility. Other highly
endorsed factors included ease of integration into current
practice and provider/staff acceptability. Most participants
reported wanting information on direct costs of an intervention,
and about half of the participants wanted published costeffectiveness information. Participants reported differences
in decision-making between medical and mental health
interventions, for example, several participants suggested that
mental health interventions were more difficult to evaluate
both in terms of effectiveness and cost compared to medical
interventions.
Discussion: Cost information is important to all the
organizations and decision-makers we interviewed. However,
typical published economic evaluations may not contain some
of the cost information needed by decision-makers.
Keywords: cost-effectiveness, implementation

University of Massachusetts Medical School; 2Meyers
Primary Care Institute; 3Reliant Medical Group; 4Baystate
Medical Center
1

Background/Aims: Influenza and pneumococcal vaccines
are beneficial but underutilized. Using health information
technology and patient self-reported data within our Epic
electronic health record (EHR), we aim to improve rates
of influenza and pneumococcal vaccination in a large
multispecialty group practice in central Massachusetts.
Methods: We have undertaken a multifaceted vaccine
promotion program with patient-, provider- and systemlevel components. We conducted patient, physician, nurse
and medical assistant qualitative interviews to inform
development of provider educational materials and patient
outreach materials. Provider education was delivered via inperson brief presentations at practice sites given by research
team physicians (respected members of the group practice).
Patient outreach will target patients eligible but overdue for
influenza vaccine (some are also overdue for pneumococcal
vaccine). In November 2014, we will randomize 20,000
patients who are active users of electronic patient portals to
(a) receipt of a portal message providing education and access
information on flu and pneumococcal vaccines, (b) receipt
of an interactive voice recognition (IVR) call with similar
content, (c) both, or (d) neither (usual care). Patients without
electronic portals (10,000 patients) will be randomized to (a)
receipt of IVR call, or (b) usual care. Both outreach methods
will invite patients to report receipt of flu vaccines outside
of the medical group and will automatically update the EHR
with self-reported vaccine completion (increasing accuracy
of existing EHR provider alerts). Both methods will (a) use
questionnaires to elicit barriers for unvaccinated patients, and
(b) deliver information targeted to patient concerns.
Results: We are using multilevel interventions and
technological innovation to increase rates of recommended
vaccine completion in our population and to improve the
accuracy of existing provider-directed EHR vaccine alerts.
To date, factors contributing to success include (a) research
team’s inclusion of physician thought-leaders well-known
within the practice; and (b) alignment of study goals with
the mission of the group practice (improving delivery of
preventive care, improving accuracy and efficiency of EHR
without interfering with workflow, and achieving meaningful
use goals by inviting patient communication via e-portals).
Discussion: Aligning our research with the existing goals
and values of the medical group practice has yielded effective
collaborations and facilitated project success.
Keywords: flu vaccine, patient portal
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Implementation of an Evidence-Based Breast Cancer
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Background/Aims: The Comprehensive Health Enhancement
Support System (CHESS) was created to answer the need for
information and support and to improve the quality of life of
breast cancer patients. CHESS has been validated in several
randomized trials. The aim of the current study is to implement
CHESS as part of standard care at two Denver health care
systems. All women who received a breast cancer diagnosis
were offered access to CHESS during or very shortly after
notification of their diagnosis and throughout the treatment
process to provide information and decision-making support.
Methods: From July 2012 to July 2013, all newly diagnosed
breast cancer patients at both institutions were offered CHESS.
Two months postdiagnosis, CHESS users and non-users were
randomized to no contact or to complete a telephone survey
or interview about CHESS. Patient use of CHESS was tracked
on the system server. In-depth interviews also were conducted
with providers of both institutions after CHESS had been in
use for one year. Providers were asked about organizational
changes affecting CHESS implementation and sustainability,
and potential to sustain CHESS after study completion.
Results: All patients were offered CHESS at least once,
most often by nurses responsible for delivering the
diagnosis. Overall, 24% of patients used CHESS by 2
months postdiagnosis. Users who liked CHESS said it was
a safe and structured place to get needed information. For
others, providing a username and password was a barrier to
CHESS use. Providers liked having the CHESS resource to
give patients; however, some felt that resources required for
sustainability might be best used elsewhere. Other providers
felt that CHESS should be sustained and expanded throughout
each organization because of the potential impact for the
women who preferred to use web-based resources. Providers
also felt that no web-based resource could replace individual
interactions with patients.
Discussion: Patients who liked CHESS felt it was helpful
and appreciated the resource. Providers liked having CHESS
to offer patients. Some providers felt CHESS should be
maintained and expanded, while others felt it was no longer
unique. Various resources may be necessary to meet patient
and provider needs.
Keywords: implementation, breast cancer
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Background/Aims: The CONtrolling Disease Using
Inexpensive Technology (CONDUIT) study tests an approach
to monitoring and managing hypertension that could be easily
and widely disseminated and scalable to self-monitoring of
other conditions.
Methods: The CONDUIT randomized control trial tests
whether an intervention consisting of self-monitoring of
blood pressure (BP) and a feedback loop involving nurses
and primary care providers improves control of hypertension
in patients with uncontrolled hypertension. Rather than
embedding the intervention in a proprietary electronic health
record (EHR), we used the free Microsoft HealthVault
platform to receive participants’ BP readings electronically
and developed an interface to transmit HealthVault data
into the EHR. To further maximize dissemination potential,
participants who could not upload BP data from home could
upload data at their clinics.
Results: Substantial effort was required to develop the
HealthVault-EHR interface, including custom programming
to poll HealthVault for BP data and periodically send
messages to nurses summarizing the patient-uploaded
data. We encountered barriers to system implementation
at multiple levels, often because vendors did not consider
use cases similar to ours. For instance, BP monitors lacked
unique device identifiers; neither the devices, HealthVault or
the EHR validated date/time data; software changes by any
of several entities caused data flows to break and required
frequent revision of patient instructions; and protected
health information protection in clinic-based uploads proved
challenging. Patients and staff expressed satisfaction when
the system worked, but had limited tolerance for software
failures. Most clinicians supported the system, but would
have greater enthusiasm if patient-generated BP readings
were considered in HEDIS scoring.
Discussion: When the CONDUIT system worked as designed,
it was well-accepted by patients and providers, but the various
“moving parts” under control of different organizations led to
multiple challenges and frustrations. For similar interventions
to be successful, hardware and software vendors must consider
a wider range of use cases in their design processes.
Keywords: hypertension, electronic health record
PS2-17:
A Real-World Approach to a Value-Based DecisionMaking Framework for Genetic Testing
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Geisinger Health System

1

Background/Aims: Relatively few genetic tests have
been formally evaluated for cost-effectiveness, and many
lack widely accepted evidence of clinical utility. Pragmatic
approaches are needed to support real-world, value-based
decision-making for genomic-based screening and treatment
strategies, including patient selection criteria to identify those
with greater potential to benefit. The lack of evidentiary
standards for clinical implementation as well as evidence
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gaps are barriers to decision-making for implementation and
reimbursement. Value-improving technology impacts clinical
decisions by improving patient care without a disproportionate
increase in overall costs. Available knowledge about genomic
testing and potential concerns can be integrated and applied
using a process to assess value for patient care. The objective
of this research is to develop a decision-making framework
to support implementation of value-improving technology.
Satisfying this objective should avoid premature use of tests
that provide little benefit or pose significant health risks
compared to usual care.
Methods: Multicriteria decision analysis (MCDA)
provides structure and transparency in evaluating options
by considering the relative importance of different criteria
using a weighting scheme and information on each option’s
performance. The results of the review of health care MCDA
methods are synthesized and applied to systematically
identify and structure elements of value. We then integrate
and evaluate clinical, epidemiological and economic evidence
to assess the value of genetic and pharmacogenomic testing to
support real-world decision-making.
Results: A model with relative weighting for all elements
of measured value is developed and applied to facilitate
aggregating measures to support real-world decision-making.
Current knowledge about genetic and pharmacogenomic
testing is integrated and applied to move from the concept of
value to making a decision. This is done by measuring and
gathering evidence on each of the elements and aggregating
the combined elements, with uncertainty of an outcome
treated as an element of value.
Discussion: Assuming a continuing shortage of formal and
direct evidence for genetic testing, transparent consideration
of available, including indirect, evidence can be used to assess
whether outcomes relative to cost are likely to offer sufficient
value in a comprehensible and actionable decision-making
framework. This framework offers the potential to reduce
barriers to widespread implementation.
Keywords: decision-making, personalized genomic medicine
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Community of Evaluation Practice Across HMORN
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Background/Aims: Kaiser Permanente’s Community
Health Initiative (CHI) strives to foster healthy eating and
active living (HEAL) policy and environmental change to
promote obesity prevention across communities it serves. The
CHI evaluation framework uses a logic model that factors
in baseline conditions, existing community assets, Kaiser
Permanente assets, and design principles toward effective
interventions and community capacity building strategies.
Kaiser Permanente and the Center for Community Health
and Evaluation (CCHE) at Group Health use evidence-
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based community health partnership characteristics to guide
the evaluation of CHI initiatives using four primary design
principles: place-based focus, multilevel interventions,
multisectorial collaboration, and community engagement
and ownership. The aims of the study are to (1) assess the
generalizability of the CHI evaluation framework across
HMORN sites, and (2) evaluate the application of the design
principles as they apply to the multilevel evaluation structures
across HMORN sites toward future evaluation collaborations
within HMORN.
Methods: In an effort to understand the variability in
evaluation experience and the generalizability of evaluation
practice across HMORN sites, semistructured interviews
were conducted with HMORN partners to explore the key
design principles, including: (1) place-based focus to examine
geographic variability across HMORN sites and communities,
(2) multilevel interventions to explore evaluation activities
across HMORN sites and communities, (3) multisectorial
collaborations to examine how evaluation strategies are
used differently across HMORN sites, and (4) community
engagement and ownership to understand how evaluation
teams partner within HMORN sites.
Results: Evaluation lessons learned to date are shared
and may be used to inform multilevel HMORN evaluation
collaborations in the future. Findings support the development
of an evaluation inventory to understand common methods,
metrics and measurements as they are used across HMORN
sites.
Discussion: By gaining a better understanding of how
evaluation practices are developed and informed, efforts
can be made to improve partnerships toward more effective
evaluation efforts and collaborations within HMORN.
Keywords: evaluation, organizational practice
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Background/Aims: Kaiser Permanente (KP) is an integrated
health care delivery system spanning seven geographic regions
with 9.3 million members. The KP Biobank is an extension of
existing biobanks in four KP regions –– Northwest, Southern
California, Georgia and Northern California –– which
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together include specimens and phenotypic data for a total
of 210,000 members. This includes the Research Program on
Genes, Environment, and Health (RPGEH) Biobank, and the
Genetic Epidemiology Research on Adult Health and Aging
(GERA) cohort, which has genome-wide genotype data on
110,266 participants. We describe the design and features of a
new initiative to consolidate these efforts into a single entity,
called the KP Biobank, and expand the cohort to a total of
500,000 participants across all seven KP regions.
Methods: The KP Biobank will include a general cohort
(410,000 participants), designed to represent the diversity
of KP members, and two specialized cohorts: a cancer
cohort (30,000 participants) and a pregnancy cohort (60,000
participants). For the cancer cohort, we will develop a rapid
cases ascertainment system to identify and enroll cases close
to the time of diagnosis. For the pregnancy cohort, newly
pregnant members will be asked to provide specimens during
their first and second trimesters of pregnancy. Whole blood
and serum will be collected from participants in every cohort.
Participants consent to broad future uses of specimens and
data. Specimens will be stored centrally at an existing facility
in Northern California and linked to phenotypic information
from the medical record. We also will collect patient reported
information on demographics, behavioral and environmental
exposures via survey. A unique feature of the KP Biobank is the
establishment of a translational research center (TRC), with a
mission to support clinical integration of new discoveries and
research across the translational continuum. The consolidated
governance of the KP Biobank will streamline and facilitate
collaboration and partnerships through a single access review
committee and application procedure. Any researcher,
including external scientists, may apply for use of specimens
or genotyping data.
Results: Not applicable.
Discussion: The KP Biobank will facilitate future genomic
and nongenomic research, particularly questions addressing
diverse populations, longitudinal measures to assess changes
over time and long-term outcomes.
Keywords: biorepository, genetics
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Background/Aims: Asians report low levels of satisfaction
regarding wait time. Expectations about wait time based on
cultural norms may contribute to this low satisfaction. We
examined drivers of racial/ethnic differences in satisfaction
in wait time by comparing subjective satisfaction scores to
patient-reported and objective electronic health record (EHR)-
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recorded wait times.
Methods: We paired patient satisfaction survey data with
EHR-recorded actual wait times, visit characteristics and
patient demographics. The study population is comprised of
patients of a large multispecialty ambulatory care organization
in Northern California from 2011 to 2013. Patient satisfaction
surveys were mailed to patients after randomly selected clinic
visits. We focused on responses from non-Hispanic white
(NHW), Asian and Latino patients (n=213,375; 80.6% of
264,781 total responses). Individual survey responses were
linked to visit information including wait time in the EHR.
Patient demographics (age, sex, English proficiency), visit
characteristics (scheduled appointment time, appointment
length, time of a day, whether own PCP visit, number of
years with the PCP, number of days between visit and survey
return), and physician fixed effects were controlled in the
multivariate analyses.
Results: After controlling for demographic and visit
characteristics, all Asian subgroups reported substantially
lower levels of satisfaction with wait time and longer
perceived wait time compared to NHW. This trend persisted
after further adjusting for EHR-recorded actual wait time.
More Chinese and Asian Indian patients (the majority of
Asian patients) arrived to the clinic closer to or slightly later
than their scheduled appointment time compared to NHW, but
their total wait time at the waiting room was shorter. Japanese
and Filipinos, on the other hand, arrived sooner and waited
longer than NHW. No noticeable difference was observed in
wait time measures between Latino and NHW patients.
Discussion: Wait time in clinic is an objective measure that
is assessed subjectively in patient satisfaction surveys. The
persistent lower satisfaction and longer perceived wait time
among Asians suggests that Asians have different expectations
regarding wait times. Different cultural norms regarding wait
time among Asians should be taken into account to provide
culturally competent patient-centered services to a diverse
population.
Keywords: wait time, patient-centered care
A2-4:
Is “Asian” a Meaningful Category for Studying
and Reporting Health and Health Care Disparities?
A Comparison of Filipino and Chinese Kaiser
Permanente Northern California Members Aged 25–
79 on Health Status, Selected Health Behaviors, and
Use of the Patient Portal
Nancy P. Gordon1
1
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Background/Aims: While the broad category “Asian” is
often used for health disparities studies and monitoring,
results may not meaningfully describe a race/ethnicity, but
rather mask important differences across Asian subgroups.
To exemplify this, Kaiser Permanente Northern California
(KPNC) Filipino and Chinese health plan members were
compared on demographic and health characteristics and
patient portal use.
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Methods: Data from the 2008–2011 KPNC Member Health
Surveys, 2011 KPNC disease registries and 2011 kp.org
utilization were analyzed for Filipinos and Chinese aged
25–64 (non-senior) and 65–79 (senior) years. All differences
listed are significant at P<0.05 by t-test.
Results: Compared to Chinese, non-senior Filipinos were less
likely to be college graduates (57.2% vs. 73.6%), more likely
to have incomes ≤ $25,000 (non-seniors: 7.4% vs. 4.3%;
seniors: 32.8% vs. 17.1%) and less likely to have incomes
over $80,000 (non-seniors: 42.8% vs. 58.6%; seniors: 16.8%
vs. 32.2%). Filipinos were more likely to be diabetic (nonseniors: 14.4% vs. 5.5%; seniors: 38.8% vs. 21.4%) and
hypertensive (non-seniors: 31.4% vs. 14.7%; seniors: 78.2%
vs. 61.6%), and seniors were less likely to report excellent/
very good health (31.3% vs. 42.3%). Filipino non-seniors
were more likely to be smokers (10.3% vs. 5.0%) and more
likely to sleep < 6 hours/day (14.4% vs. 6.2%). Filipinos aged
25–79 were less likely to consume 3+ servings fruit/vegetables
daily (women: 26.1% vs. 50.6%; men: 18.6% vs. 37.8%),
more likely to be obese (15.4% vs. 6.9%) and less likely to
believe health behavior risks can greatly impact health (nonseniors: 68.3% vs. 82.6%; seniors: 59.9% vs. 71.9%). In 2011
Filipinos were less likely to have activated kp.org accounts
and to have used a secure feature if they had a kp.org account
(ages 25–44: women: 80.9% vs. 86.8% and 74.2% vs. 80.0%;
men: 68.2% vs. 77.6% and 60.9% vs. 63.2%; ages 45–64:
women 62.8% vs. 79.1% and 67.6% vs. 78.7%; men: 58.6%
vs. 75.8% and 69.1% vs. 76.5%; ages 65–79: women 42.9%
vs. 66.8% and 63.0% vs. 80.6%; men: 47.5% vs. 71.8% and
68.8% vs. 85.4%).
Discussion: Using the broad category “Asian” to study/
monitor health and health care disparities is problematic,
especially for comparing populations and applying results to
“Asian” populations with different Asian ethnic mixes.
Keywords: health disparities, Asian health
A2-5:
Are Race/Ethnicity and Comorbid Conditions
Associated With Pregnancy Intention Status?
Mary Anne Armstrong,1 Jeanne A. Darbinian,1 Debbie A.
Postlethwaite1
1

Kaiser Permanente Northern California

Background/Aims: The proportion of pregnancies in the
United States self-reported as unintended (49%), among
the insured and uninsured, has not improved for more
than a decade, representing a major public health problem.
Unintended pregnancy has been found to be associated with
poor pregnancy outcomes in numerous studies. The purpose
of this study was to identify risk factors for unintended
pregnancy in a health care system with equal access to all
that could be used to determine groups of women who would
benefit from risk reduction strategies.
Methods: In this retrospective cohort study, women age
15–44 as of the index date of 6/30/2010 who were members
of an integrated health care delivery system were followed
electronically through 12/31/12 for evidence of pregnancy
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(N=45,351). Self-reported pregnancy intention status at
entry to prenatal care (intended, unintended [mistimed or
unwanted]) and potential risk factors, including age, race/
ethnicity, marital status, education/income, parity, long-acting
reversible contraceptive (LARC) use prior to pregnancy, and
comorbidities (diabetes, hypertension, cardiovascular disease,
obesity), were obtained from electronic medical records.
Pregnancy intention groups were compared on all risk factors
using chi-squared tests. Logistic regression models were
developed to determine which factors were associated with
intended pregnancy.
Results: Bivariate analyses showed that significantly
more black women had unintended pregnancies (71.9%
[2,618/3,641] vs. 32.6% [5,908/18,107] white, 45.7%
[4,808/10,520] Hispanic, 32.8% [3,994/12,190] Asian, p 2
[odds ratio: 0.25 vs. 0, P<0.0001]), and those who did not
use LARC (odds ratio: 0.44 vs. LARC, P<0.0001) were
significantly less likely to have an intended pregnancy.
Having comorbidities was not significantly related to intended
pregnancy.
Discussion: Even when there is equal access to health care,
there are racial and other demographic disparities in pregnancy
intention. Age-appropriate, culturally sensitive unintended
pregnancy reduction interventions targeting groups of women
with identified risk factors should be considered.
Keywords: pregnancy intention, racial/ethnic disparities
PS1-33:
Assessment of Cultural Competence in an Ethnic
Health Program: Evidence-Based Study
Miyoung Cho,1 Jane H. Kim,1 Sarah Hyun,1 Chul S.
Hyun,2 Dohyun Cho1
W Medical Strategy Group; 2World Korean Medical
Organization

1

Background/Aims: Language, culture and socioeconomic
determinants lead to disparities in health care. As our society
becomes more ethnically and racially diverse, there is an
urgent need for a health care access model, which can provide
sociocultural and linguistic needs to all ethnic groups. The
purpose of this study was to evaluate key factors of culturally
competent health care access programs designed to address
cultural and linguistic needs of underserved ethnic groups.
This study utilizes a “Korean Medical Program” (KMP), an
ethnic health program of a local medical center in Bergen
County, NJ, as a health care access model to evaluate its
program as determined by members of the community. These
data are further analyzed to determine specific barriers to
health access and to speculate on the elements required for
cultural competence.
Methods: We utilized document analysis, surveys and
interviews to evaluate experiences of a regional Korean
American community on overall services provided by KMP
and the local medical center. Using data from comprehensive
analysis, we found sociodemographic characteristics,
outcomes of health services, barriers to health care access and
factors governing the effectiveness of KMP.
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Results: Data from 375 Korean American participants
indicated that 51.2% were aware of KMP, and 35.7% knew
about KMP health campaigns, but only 7.1% participated in
campaigns. Most effective means of marketing were through
television, radio and newspapers. 71% were satisfied with
KMP’s services. 74% (n=33) of outpatients were satisfied
with the services, while only 39% (n=50) of inpatients felt
the same. The profiles on access barriers depended on the
ages of the participants. While the most significant barrier in
the younger group (age 20–59) was cost, the most significant
barrier in the older group (age 59+) was language followed
by cost.
Discussion: A culturally competent health program requires
numerous factors. Communication between patients and
health professionals is essential, and well-trained health care
interpreters are needed. Certification programs to train staff
to be culturally competent are also recommended. Finally,
any culturally sensitive program should engage with the
community to collaborate with its health professionals to
address health and welfare needs.
Keywords: ethnic health care access, Korean American

remained consisted across all logistic models examined, even
after adjusting for covariate measures (odds ratio: 0.69, 95%
CI: 0.62–0.77; P<0.0001).
Discussion: Our findings suggest that disparities in glycemic
control among Hispanics compared to whites remain even
after adjusting for critical covariate measures. More work
is needed to understand whether lifestyle choices and other
factors explain differences and whether targeted interventions
can reduce these disparities.
Keywords: disparities, glycemic control
PS2-22:
Embedding Patients, Providers, and Community
Stakeholders in Research to Improve Transgender
Health
Virginia P. Quinn,1 Tracy A. Becerra,1 Theresa Gillespie,2
Enid Hunkeler,3 Tisha Baird,1 Nancy M. Baisch,1 Ashli
Owen-Smith,4 Douglas Roblin,4 Robert Stephenson,2 Vin
Tangpricha,2 Cadence Valentine,5 Michael Goodman2
Kaiser Permanente Southern California; 2Emory
University; 3Kaiser Permanente Northern California;
4
Kaiser Permanente Southeast; 5California State
University Northridge
1

PS1-34:
Disparities in Glycemic Control Among Hispanic
Adults With Diabetes
David M. Mosen,1 Adrianne Feldstein,1 Ashley Borin1
Kaiser Permanente Northwest

1

Background/Aims: Poor glycemic control is associated with
increased morbidity and mortality for adults with diabetes
mellitus (DM). Little research has examined disparities
in glycemic control among Hispanics with DM compared
to whites. The objective of this work was to determine: 1)
whether disparities in glycemic control exist among Hispanics
versus whites; and 2) whether demographics, socioeconomic
status, disease characteristics, health care utilization (primary
care, specialty care, care management services) and treatment
characteristics (oral hypoglycemic medications, insulin use)
explain differences in glycemic control.
Methods: Using an observational study design, we studied
29,825 adults on the Kaiser Permanente Northwest DM
registry as of January 1, 2013, with a valid HbA1c test during
calendar year 2013. Good glycemic control was defined as
HbA1c 30 (vs. body mass index < 30), Charlson comorbidity
score (continuous), primary care utilization in 2013 (1+ visits
vs. none), specialty care utilization (1+ visits vs. none), use
of DM care management services (1+ services vs. none),
use of oral hypoglycemic medications (1+ medications fills
vs. none) and insulin use (any insulin use vs. none). Seven
logistic models were constructed: model 1 (race/ethnicity),
model 2 (model 1 + demographics), model 3 (model 2 + SES),
model 4 (model 3 + disease characteristics), model 5 (model
4 + health care utilization) and model 6 (model 5 + treatment
characteristics).
Results: Hispanics were less likely to have good glycemic
control in unadjusted models (odds ratio: 0.56, 95% confidence
interval [CI]: 0.51–0.61; P<0.0001). This point estimate
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Background/Aims: The Institute of Medicine in its 2011
report highlights unique health challenges facing the
transgender community. Evaluations of outcomes for medical
gender reassignment (more appropriately termed “gender
confirmation”) are rare and of low quality. The literature on
treatment-related quality of life is limited and little is known
about the long-term effects of contra-sex hormones on the risk
of age-related chronic conditions. The Study of Transition,
Outcomes & Gender (STRONG) research program will
provide critical information about morbidity and mortality
following gender confirmation treatments. It will also
assess the comparative effectiveness of gender confirmation
therapies for improving quality of life and alleviating gender
dysphoria. The multidisciplinary STRONG research team
includes investigators from five institutions. Members of the
transgender community and health professionals who care for
transgender individuals are an integral part of the team and
are directly involved in all aspects of this research program
including refinement of research questions, development of
methods and content for data collection, and evaluation and
dissemination of results.
Methods: We identified the population of transgender
individuals enrolled in the Veterans Administration and
Kaiser Permanente health plans in Georgia and Northern and
Southern California with a combination of validated ICD
codes and keyword string searches. To evaluate mortality
and morbidity, we will conduct an electronic medical recordbased retrospective cohort study. To assess quality of life and
other patient reported outcomes, we will conduct an online
cross-sectional survey. Online and in-person focus groups
with transgender stakeholders will guide data collection and
interpretation of results.
Results: ICD codes and keywords identified nearly 15,000
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individuals. These preliminary findings indicate the STRONG
program will represent the largest cohort of transgender
individuals to date and the first such research effort in
the United States. Six in-person focus groups have been
completed with six more in progress. The study survey has
been developed, programmed and pretested via online focus
groups.
Discussion: The STRONG research program will help close
the health disparities gap for the transgender community
through increasing scientific knowledge. The research
findings will provide guidance to clinicians and policy makers
in the care they provide to this sizeable, but underserved,
community.
Keywords: transgender, health disparities

HEALTH INFORMATICS/VIRTUAL DATA
WAREHOUSE
C2-1:
Measuring the Rise of Mobile and Online Care:
Promises and Challenges in Big Data
Luesa L. Jordan, Eva Chang, Glen Kriekenbeck,
James D. Ralston1
1

1

1

Group Health Cooperative

1

Background/Aims: Engaging patients and families is a
key aspect of meaningful use of electronic medical records.
Although several populations are less likely to adopt and
use patient websites to engage in shared electronic medical
records, the increasing availability of mobile devices and
applications has potential to extend patient engagement
in its use. No single data source, however, currently tracks
individual patient shared record use across devices and
software applications. Our objective is to describe our
experience aggregating data sources for measuring enrollee
use of the shared electronic medical record across mobile and
desktop devices.
Methods: Between January 2010 and August 2014, we
merged data from 358,415 Group Health enrollees from web
server activity logs (including mobile application activity)
with Epic/Clarity electronic medical record data. Web
server logs were scanned for string combinations to identify
devices used to access shared medical record (SMR) services
(including medication refills, medical test results, secure
messaging encounters, after-visit summaries, appointment
requests, medical problem lists, allergies and immunizations).
Logs were matched to Epic/Clarity SMR page views within a
time window.
Results: In August 2014, approximately 5.5 million of 150
million web server log entries (<4%) were extracted for
device information. After excluding redundancies, 245,425
SMR entries were retained. Of these, 70% (170,705) with
device information was linked with Epic/Clarity patient page
views. Of unmatched SMR activity, 29% (71,578) was on
server logs alone and 1% (3,142) was on Epic/Clarity alone.
Standard web browsers accounted for 88% (187,262) of
overall web activity (76% [187,262] desktop, 12% [29,964]
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mobile device) and mobile applications accounted for 8%
(18,904); 4% (9,295) was unable to be linked. Among 94,303
enrollees accessing the SMR with device information, 92%
(83,081) used standard web browsers (78% [70,484] desktop,
14% [12,597] mobile device) and 21% (18,965) used mobile
applications.
Discussion: Web server logs and Epic/Clarity can be
combined to describe enrollee use of mobile and desktop
services. Development and maintenance of data requires
regular monitoring for consistency and content. Extraction
logic must be dynamic to accommodate device market and
health care system changes. Understanding adoption and
use of online services across devices will be essential to
successfully engaging patients and families in care.
Keywords: web server logs, shared medical record
C2-3:
Categorizing
Patient-Provider
Secure
Email
Communications to Measure Substitutionary Effect
on In-Person Services
Ted E. Palen,1 Di Meng,2 Terhilda Garrido2
Kaiser Permanente Colorado;
Northern California

1

2

Kaiser Permanente

Background/Aims: Previous observational studies have
reported conflicting results when evaluating patients’ use
of secure email and their use of in-person clinical services.
Different studies have found that secure email between patients
and health care providers may substitute for, increase, or have
no impact on the need for in-person clinical services. In this
study we used diagnosis codes and order codes associated
with emails to categorize the type of email communication.
We then evaluated whether particular categories of emails
substituted for the need for in-person clinical services.
Methods: We used retrospective data from Kaiser Permanente
Colorado members over the age of 18 who were continuously
enrolled for at least 30 months in 2010–2013. We identified
which emails contained diagnosis code(s) and or order
code(s). We categorized emails containing diagnosis code(s)
into low acuity conditions based on diagnosis-related group
categories. We then determined if the patient had a subsequent
in-person appointment.
Results: Health care providers added a diagnosis code to 19%
of secure emails, and 85% of these members did not have a
follow-up visit or telephone call in the next 30 days. Health
care providers placed a coded order within a secure email
encounter 21% of the time, and 85% of these members did not
have a follow-up visit or telephone call in the next 30 days.
Only 8% of secure emails for low acuity conditions resulted in
a follow-up visit within the next 30 days. This is comparable
to rate of follow-up office visits for low acuity conditions.
Discussion: Secure email communication between patients
and health care providers may substitute for the need for
in-person clinical services for specific circumstances and
conditions.
Keywords: secure email, patient-provider communication

www.aurora.org/jpcrr

115

D2-1:
ICD-10: A Transition That’s Already Happening
Alan E. Bauck,1 Michael Allison,1 Donald Bachman,1
Catherine Cleveland,1 Phillip Crawford,1 Suzanne
Gillespie,1 Weiming Hu1
Kaiser Permanente Northwest

1

Background/Aims: The United States currently uses ICD
version 9 (ICD-9) for diagnosis and procedure coding. Federal
regulations require that U.S. health care providers adopt
the next version (ICD-10) by 10/1/2015. The new version
expands the number of diagnosis codes from about 13,000
to 68,000, and increases the number of procedure codes from
approximately 4,000 to 90,000. The Centers for Medicare &
Medicaid Services delayed its ICD-10 implementation date
from 10/1/2014 to 10/1/2015 as a result of congressional
action. However, changes to the electronic health records
based on ICD-10 have continued to move forward. These
changes include changing the pick lists that providers choose
from as well as revamping the underlying data structures to
support diagnoses coding.
Methods: The Center for Health Research Kaiser Northwest
ICD-10 remediation team worked with research project staff
to develop a set of diagnosis groupings (e.g. diabetes, renal
disease, dementia, etc.) that can be coded under both ICD-9 and
ICD-10. The team mapped the expanded provider selections
to both ICD-9 and ICD-10. The team then developed a set of
monitoring reports for these diagnosis groupings in order to
look for points of discontinuity between ICD-9 and ICD-10.
Results: We found variation in rates of diagnosis groupings
before and after the change to provider pick lists. Most
diagnoses groupings have not shown a substantial change
from the transition to more granularly defined diagnosis pick
lists. However, when bilateral diagnosis codes are used, there
can be irregularities in diagnosis rates.
Discussion: Preparing for ICD-10 has generated multiple
changes to the electronic health record systems and their
underlying data structures. Research projects should explore
whether these changes are already impacting diagnoses and
procedure-coding rates. In particular, research projects should
look at trends in diagnoses rates when bilateral diagnosis
codes are used.
Keywords: ICD-10, electronic health record
PS1-20:
Sustaining Use of a Clinical Decision Support Tool
for Primary Care Providers
A. L. Crain,1 JoAnn M. Sperl-Hillen,1 Heidi L. Ekstrom,1
Patrick J. O’Connor,1 Karen L. Margolis,1 William A.
Rush,1 Gerald H. Amundson,1 Deepika Appana1
HealthPartners

1

Background/Aims: Achieving and maintaining high rates
of use of clinical decision support in primary care settings
has been challenging. Our goal was to reach and maintain
high use rates throughout the study period through ongoing
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feedback and incentives to clinics and consented providers.
Methods: We conducted a clinic randomized trial of an
electronic health record (EHR)-based point-of-care clinical
decision support (CDS) tool (called CV Wizard) that
provides prioritized treatment recommendations to optimize
management of six reversible cardiovascular (CV) risk
factors: lipids, blood pressure, glucose, tobacco use, aspirin
use and weight. We assessed use (the number of times the
tool was opened and printed) at targeted office visits for two
groups of primary care providers (PCPs) at 11 intervention
clinics: (a) those who provided informed consent to use and
evaluate the tool (n=54), and (b) those who did not provide
consent but still had access to the CDS (n=69). CDS use rate
per provider was calculated in three postintervention months
as the number of eligible visits at which the tool was used
relative to the number of targeted outpatient visits that month.
The use goal was 80% of targeted visits, and we reported
monthly use rates to clinic leaders for all PCPs, with clinic
compensation totaling $2,000 over the intervention period
to achieve and maintain the goal. Generalized linear models
tested whether PCP consent predicted use of the CDS system.
Results: Among consented PCPs, average CDS use rates at 4,
8 and 12 months after full intervention implementation were
57.0%, 73.9% and 75%. Among PCPs at the same intervention
clinics who did not provide consent, average use rates were
57.3%, 70.7%, and 58.9% (significant difference only at 12
months, P<0.05).
Discussion: We observed robust use of the CDS tool by
PCPs and rooming nurses at targeted primary care visits,
in the context of targeted use to high CV risk patients only,
leadership support and PCP design input, implementation
process measurement and feedback, and small financial
incentives to clinics that achieved high use rates. Additional
evaluation to explain why use rates declined at 12 months in
the nonconsented PCPs is of interest.
Keywords: clinical decision support, cardiovascular risk
PS1-35:
Expectation vs. Reality: Drug Coverage
Pharmacy Fill Rates at Group Health

and

Roy Pardee1
1

Group Health Cooperative

Background/Aims: It seems elementary that data capture of
pharmacy fills at a health maintenance organization (HMO)
should be suspect for members without drug coverage.
Coverage of prescriptions is a major incentive for filling
prescriptions at the HMO pharmacy. Even better –– even
if there are scripts filled at outside pharmacies, they should
generally result in the filing of a claim, which also generates
fill data. Imagine our surprise, then, when it was observed that
over a period of some years, Group Health members without
drug coverage had significantly higher rates of pharmacy
fills than did members who had drug coverage. The proposed
presentation describes the investigation into this seeming
anomaly.
Methods: After independently verifying that we do indeed
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observe higher fill rates in uncovered patients over a period
of four years, we proceeded from the theory that the result
was indication of a virtual data warehouse data problem.
Either we incorrectly computed the DRUGCOV field in
enrollment data, or we somehow mishandled the fills data. To
investigate problems with the fills data, we recalculated rates
of 30-day fills using native Group Health pharmacy data from
our enterprise data warehouse. For the drug coverage flag,
we isolated the set of people whose rates were anomalous,
characterized their plans and coverages, and verified their
drug coverage status.
Results: To our great surprise, we could readily reproduce
the finding in native Group Health pharmacy data. Similarly,
we found no defect in the drug coverage information.
Notwithstanding this, the investigation did arrive at a plausible
(if surprising) explanation for the results.
Discussion: As the saying goes, “the map is not the territory.”
While our intuitions and expectations about our data are
necessary and powerful assets for focusing our uses of data to
pursue research, it is always good to investigate and verify that
our assumptions are true, and doubly important to investigate
and document findings that defy conventional wisdom.
Keywords: data capture, coverage
PS1-43:
Moving to a Weekly Refresh for the Virtual Data
Warehouse
Alan E. Bauck,1 Catherine Cleveland,1 Shannon Leitch,1
John Brandes,1 Brenda Ackerson1
Kaiser Permanente Northwest

1

Background/Aims: Increasingly, conducting high-quality
research requires access to current data. Previously, supplying
current data was expensive because it required custom data
extracts from source systems. In addition, these custom
extracts were less robust because of frequent changes in health
systems’ data structures, and they could only be validated
within the context of a single project. Thus, information
gleaned from them was rarely fed back to the wider research
institution and was not informing more general knowledge
of health-system data. To address these missed opportunities,
and to maximize ways the virtual data warehouse (VDW) can
support research, Kaiser Permanente Northwest’s Center for
Health Research (CHR-NW) investigated how to change the
VDW refresh rate from monthly to weekly.
Methods: We used a variety of data-management tools to
change our processes and infrastructure in order to regularly
deliver reliable data weekly, including: 1) We use SmartBatch
to schedule weekly SAS jobs and SQL Server Agent to
schedule SQL Server Integration Services (SSIS) jobs. 2) We
moved to incremental builds of many data files; instead of
executing a complete pull every week, we only extract data
back to the point in time that it stops changing. 3) We no longer
maintain a mirror copy of the VDW on an older operating
system because of the cost/benefit of this task. 4) To help our
transformation programs run more efficiently, we developed
SSIS packages that pull source data to a local server. 5) We
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improved and automated our monitoring processes. 6) We
established tolerance tests for when to accept or postpone data
from source systems.
Results: We have been able to maintain the CHR-NW
VDW on a weekly refresh cycle since June 2014, with no
missed refreshes. The extract, transform and load programs
that refresh our VDW run 4.4 times faster than they did just
months before the transition. Our monitoring programs allow
us to provide information back to our parent health system
about source data.
Discussion: Changing our data systems to achieve a weekly
refresh cycle was less burdensome than we first anticipated in
terms of staff time. The added monitoring allows us to provide
more stable data to our researchers.
Keywords: virtual data warehouse, weekly refresh
PS2-27:
Record Linkage With Washington State Cancer
Registry
Arvind Ramaprasan1
Group Health Cooperative

1

Background/Aims: At Group Health, the virtual data
warehouse’s (VDW) tumor registry table consists of tumor
cases ascertained by Cancer Surveillance System (CSS) at
the Fred Hutchinson Cancer Research Center (FHCRC).
This data is limited to residents of 13 Puget Sound counties
in the SEER region only. On the other hand, Washington
State Cancer Registry (WSCR) consists of tumor cases for
the entire Washington State residents. The poster describes
the data linkage protocol and the results of linkage of Group
Health members with WSCR database in the absence of
unique identifier.
Methods: Group Health data consists of 1,420,334 members
residing in Washington State. We linked Group Health data
with WSCR database consisting of 613,631 cancer cases
diagnosed during January 1, 1993–December 31, 2011. We
used a probabilistic linkage software application such as
CDC’s Registry Plus Link Plus® to link patient information
such social security number, date of birth, gender, and last and
first names with corresponding data elements in WSCR. We
assessed the quality of the linkage results by comparing the
linkage outcome with VDW’s tumor registry. We calculated
the sensitivity and positive predictive value by comparing the
WSCR linkage results with VDW’s tumor registry. We used
Venn diagrams for visualization of results of comparison.
Results: Sensitivity and positive predictive value are 90%
and 96%, respectively. We found 35,166 (59%) additional
tumor cases as a result of WSCR linkage in comparison to
the VDW tumor registry. Of the above, 21,600 (61%) tumor
cases were reported within SEER region and 13,566 (39%)
cases diagnosed in members residing outside of Puget Sound
region. Of 21,600 SEER cases, 17,248 (88%) tumor cases
were diagnosed after disenrollment from Group Health, and
2,090 SEER cases were found missing from VDW’s tumor
registry. Due to lack of interpretable information, we were
unsuccessful in linking 5,752 records in the VDW tumor
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registry with WSCR data.
Discussion: In the absence of unique identifier, the project
demonstrates a successful linkage using Link Plus. We
now have cancer incidence and survival data for all Group
Health members, not limited to Puget Sound region. This will
augment cancer studies involving members from both SEER
region and outside of Puget Sound counties.
Keywords: linkage, cancer
PS2-28:
Evaluation of Provider Experience With an Electronic
Health Record-Based Clinical Decision Support Tool
Heidi L. Ekstrom,1 Patrick J. O’Connor,1 Karen L.
Margolis,1 William A. Rush,1 Gerald H. Amundson,1
Deepika Appana,1 A. L. Crain,1 JoAnn M. Sperl-Hillen1
HealthPartners

1

Background/Aims: Our goal was to evaluate provider
experience with an electronic health record (EHR)-based
clinical decision support (CDS) tool called CV Wizard
implemented as part of a large randomized trial with 80%
use rates for eligible patients. The tool included a quantitative
“provider” form with prioritized treatment suggestions and a
simpler visual companion “patient” form to efficiently elicit
treatment preferences.
Methods: Two focus groups were held outside of clinic
hours with a meal and $250 compensation. Twelve providers
participated and were asked to comment on open-ended
questions including a) what goes into their decision to use the
tool, b) the implementation process, c) how patients reacted to
it, d) how it could be improved, and e) how effective it was.
The discussions were audio-taped and transcribed verbatim
and examined by the study team to identify themes.
Results: Providers were enthusiastic about the tool and found
it valuable. They were happy that the nurse printed it for
them before visits, and commented that it helped set the visit
agenda and organized cardiovascular (CV) risk information.
They were more likely to discuss CV risk with patients, and
indicated that they took additional time to use it with patients.
There was general consensus that it was time well spent. They
said the tool reinforced their treatment suggestions. Variability
was noted with how nurses and providers were using the tools.
For conversations with patients, some providers preferred to
use the provider form over the patient form, and vice versa.
The patient form was intended to be given to the patient while
waiting to be seen by the provider, but this was often not
happening. Providers had several suggestions for improving
the use process, and asked for better documentation tools for
results (smart phrases).
Discussion: A clinical decision support tool designed to help
providers and patients engage in shared decision-making for
CV risk reduction was well received and perceived as time well
spent with patients. Overcoming some problems associated
with workflow and adding easier ways to document use of the
tool for patient discussions would add to the existing value.
Keywords: clinical decision support, cardiovascular risk
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PS2-30:
Identifying Marijuana, Nicotine and Electronic
Cigarette References Within a Free-Text Data Field
in the Electronic Medical Record Using SAS
Bruce F. Folck,1 Stephen C. Waring,2 Christopher D.
Mack,3 Catherine Cleveland4
Kaiser Permanente Northern California; 2Essentia
Health; 3Group Health Cooperative; 4Kaiser Permanente
Northwest
1

Background/Aims: Marijuana is becoming increasingly
decriminalized and legalized across the country, with no sign
of abatement. Electronic cigarettes are rapidly increasing in
popularity. Nicotine is a common substance utilized in the
process to reduce dependency on tobacco products. Data
on these behaviors are most frequently recorded in the form
of free-text comment fields, and are subject to variations in
spelling, abbreviation and slang. There is a growing need to
be able to identify references to these behaviors in the medical
record.
Methods: Using simple SAS text-string functions, variant
references can be identified. A few specific “short-hand” text
strings were used to capture all variations. A “short-hand
string” is a series of characters one would expect to find
in a word, such as “mari” and “juan” in “marijuana.” Ten
such strings were identified and tested for marijuana, six for
electronic cigarettes and three for nicotine. When a string was
identified within a field, an attempt was made to capture the
entire word in which it was embedded. A manual review of
this isolated candidate text was then performed to verify the
integrity of the contribution for each string.
Results: Over 370 variations and misspellings of “marijuana,”
not including slang and cannabinoid references; over 25
variations of “electronic cigarettes;” and over 50 variations
of “nicotine” have been identified. Some oversampling is
expected. For example, “juan” might identify a proper noun
such as San Juan Hospital; “mari” might identify marinol,
an opioid but not marijuana in a conventional sense; and
“huan” identified ma huang, which is a Chinese equivalent to
ephedra. However, isolating the candidate text strings reduced
the volume of distinct strings requiring manual review to a
manageable level.
Discussion: A library of known misspellings can be
employed to identify variants, but utilizing specific short-hand
strings will also identify new candidates for consideration.
Overinclusiveness is expected owing to idiosyncratic text
entry, but isolating the candidate text will offer manageable
lists for manual review when determining inclusion or
exclusion of the results. Utilizing this series of shorthand strings may obviate the need to maintain an ongoing
compendium of misspellings and variation.
Keywords: marijuana, natural language processing
PS2-31:
Natural Language Processing of the Unstructured
Electronic Health Record Data Using Regular
Expressions and SAS Hash Objects
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Paul J. Hitz,1 Mitch Juusola,1 Stephen C. Waring,1 Irina
V. Haller1
1

Essentia Health

Background/Aims: Structured data in the electronic health
record only tell part of the story of a patient’s health. Much of
the information necessary for health assessment and treatment
is located in notes. This information is vital for maintaining
care quality as well as for use in research. Manual abstraction
of this information is costly and time consuming. The goal of
this study was to develop a natural language processing (NLP)
system to extract health information from provider notes.
Methods: We have implemented NLP techniques in SAS
using hash objects. Our workflow utilizes Excel spreadsheets
to manage NLP regular expressions keywords. Keywords
for the disease identification as well as keywords for generic
terms, family relationships and negation are put into separate
spreadsheets and used in the process. The spreadsheets are
imported into SAS and loaded into hash tables. Each note is
parsed into sentences and standard SAS hash processing is
used to find the token and its position in the sentence. If the
disease keyword is found, the family, generic and negation
hash processes are run. We then utilize each of the token types
and the distance from the disease keyword to identify possible
instances of the condition.
Results: In a random sample of 1,000 patients, we found 195
patients with diagnosis of diabetes (23% with ICD-9 diagnosis
code only, 5% with problem listing only, and 72% with both).
NLP identified 11 additional cases without diagnosis code
or problem listing mention. Overall, agreement between
structured and unstructured data was substantial (kappa=0.66).
Discussion: Preliminary analysis indicates that we can
identify additional disease burden in patients even for
well-documented conditions like diabetes. NLP is a costeffective and efficient approach for collecting information
using unstructured data. In a health care delivery setting this
approach offers the potential for better identification of the
patients’ health care needs. It also has promising implications
for health research by minimizing misclassification errors
and improving case ascertainment. Additional analyses
are planned for other conditions that may not be as well
documented using structured data.
Keywords: natural language processing, hash tables
PS2-33:
A Lightweight Text Mining Tool for Multisite Research
David J. Cronkite,1 David S. Carrell1
Group Health Cooperative

1

Background/Aims: The use of electronic medical records
provides researchers and care administrators with access
to increased patient information. Much of the information,
however, is available only as unstructured data in clinical
notes, which limits its accessibility. Various natural language
processing systems seek to extract information from the clinical
notes and present it as structured data, thereby increasing the

Supplement

data’s usability for research, care administration and quality
assurance. Many of the available open-source tools, however,
require nontrivial installation and configuration. In addition,
customizations, debugging and portability can be challenging
for some users.
Methods: We developed a lightweight Python application that
performs basic information extraction tasks, but that is easy
to install, configure, customize and share. The application
relies on a dictionary to extract content from unstructured
data. The dictionary is a mapping of a set of concepts (e.g.
“hypoesthesia”) to words and phrases that characterize how
that concept would appear in clinical text (e.g. “decreased
sensation,” “impaired sensation,” etc.). The application
converts these words and phrases to regular expressions and
searches the text for matching content, attempting to detect
variations in spelling and to recognize when the word or phrase
is qualified by negation, uncertainty, historical reference or a
reference to someone other than the patient.
Results: We tested the application using a dictionary of 792
entries on a set of 205,748 clinical notes. The application
completed the information extraction task in less than two
hours. We used the more comprehensive Apache Clinical
Text Analysis and Knowledge Extraction System (cTAKES)
as a comparison using the same dictionary and same notes.
We stopped cTAKES after 8.5 days with 144,701 (68.9%)
complete.
Discussion: The application provides a quick means to
access unstructured data with minimal configurations and
environmental settings. Multiple sites can use the same
algorithm simply by sharing the dictionary and a configuration
file.
Keywords: natural language processing, information
extraction
PS2-34:
PopMedNet: Collecting and Using Metadata in
Distributed Research Networks
Jessica M. Malenfant,1 Melanie Davies,1 Bruce Swan,2
Jeffrey Brown1
1

Harvard Pilgrim Health Care; 2Lincoln Peak Partners

Background/Aims: In 2007, the PopMedNet™ platform
was developed through support from Agency for Healthcare
Research and Quality to facilitate multisite distributed research.
This open-source software platform has been deployed in
and currently supports five large-scale distributed research
networks, including the Food and Drug Administration
(FDA) Mini-Sentinel, CRNnet and PCORnet, with over
100 participating sites. Continued PopMedNet software
development has been supported by the FDA, National
Institutes of Health, Office of the National Coordinator and
Patient-Centered Outcomes Research Institute, creating a
scalable and extensible informatics platform that meets the
needs of multiple research networks. These PopMedNet
networks identified a need for improved capture and use
of network metadata to enhance network operations and
collaboration.
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Methods: As networks have grown in size and complexity,
it is increasingly important to improve the capture and use of
institutional, data source and query metadata. Organizational
metadata includes information such as the organizational
descriptions (e.g. health plan, hospital) available data
resources (e.g. claims, registries), local expertise, data models
supported and willingness to participate in different types of
research activities (e.g. clinical trials, observational, etc.). Data
source metadata focuses on a specific resource and includes
information such as data model, data elements and periods
of data capture. Query metadata include information such
as query descriptions, requester and dates. New PopMedNet
functionality was implemented in 2014 that allows for the
capturing and reporting of network metadata.
Results: PopMedNet profile “input screens” for organizations,
data sources and DataMarts (queryable data sources) were
expanded to capture standardized information about each of
these domains. When available, existing metadata standards
were adopted. Also, the query input screen was expanded
to capture additional query metadata. The PopMedNet
system was expanded to allow users to search and display
the metadata. Users can now search for organizations, data
resources or specific queries that meet specific criteria (based
on captured metadata). Access control layers managed how
much information specific users can view.
Discussion: As the adoption and use of distributed networks
grow, there is an increasing need to capture network metadata
to improve collaboration and enable network learning. The
value of distributed networks will grow with the ability to
capture and use network and query metadata.
Keywords: metadata, distributed research

HEALTH SERVICES RESEARCH/
HEALTH POLICY/COSTS
A1-2:
Increasing Preventive Care With Expanded Medicare
Coverage Under the Affordable Care Act
Sukyung Chung,1 Lenard Lesser,1 Diane Lauderdale,2
Nicole E. Johns,1 Latha Palaniappan,3 Harold S. Luft1
Palo Alto Medical Foundation Research Institute;
University of Chicago; 3Stanford University School of
Medicine
1
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Background/Aims: Under the Patient Protection and
Affordable Care Act (ACA), Medicare coverage was expanded
in 2011 to fully cover comprehensive annual preventive care
visits. We assessed the impact of this coverage expansion on
the utilization of preventive services.
Methods: We used 2007–2013 electronic health record data
from primary care patients of Medicare-eligible age (65–75) at
a large multispecialty organization in California (N=204,388
patient-years). Using a difference-in-differences approach,
we compared trends in preventive visits and recommended
preventive care services across insurance coverage groups
(Medicare fee-for-service [FFS] and HMO, private FFS and
HMO) pre- and post-ACA. This analytic design allows us to
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assess the effects of the ACA controlling for contemporaneous
changes in practice.
Results: Prior to the ACA, each year 1.4% of Medicare
FFS enrollees had a Medicare-covered preventive visit. This
rose substantially with coverage expansion to 27.5%. With
expanded Medicare coverage, their use of privately covered
or self-paid preventive visits decreased by two-thirds, from
16.0% pre-ACA to 5.5% post-ACA, which suggests that
Medicare is partially substituting for previously privately
covered or self-pay preventive care visits. Even with an
overall increase in preventive visit use, rates of preventive
visits in 2011–2013 among Medicare FFS beneficiaries were
still 10–20% lower than other insurance groups (Medicare
HMO: 52.7%, private HMO: 43.5%, private FFS: 42.6%).
Frequency of nonpreventive office visits has been decreasing,
more rapidly among Medicare FFS enrollees, during the same
time period. Completion of many recommended preventive
services among Medicare FFS enrollees increased, particularly
in those requiring extended physician time.
Discussion: Expanded preventive visit coverage under ACA
led to a marked increase in preventive visits among Medicare
enrollees. Preventive visits have replaced some routine office
visits. The use of preventive visits among Medicare FFS
enrollees may continue to increase, as the rate of utilization is
still lower than seniors with private coverage only.
Keywords: preventive visit, Medicare coverage
A1-3:
Who Is Coming to Kaiser? A Comparison of the
Characteristics of Estimated Eligible to Purchase
Insurance Through Colorado’s Marketplace to
Kaiser Permanente Colorado New Members
Jennifer Barrow,1 David J. Magid,1 Jennifer Ellis,1 Susan
Shetterly1
1

Kaiser Permanente Colorado

Background/Aims: An estimated 254,000 Coloradans were
eligible to purchase private insurance through Colorado’s
health insurance marketplace. Many of those eligible
chose Kaiser Permanente Colorado (KPCO). New member
characteristics could impact both operational decisions and
provision of quality care. This project compares characteristics
of Coloradans estimated to be eligible (estimated eligible)
to purchase insurance through the marketplace, those who
enrolled through the marketplace, and those who chose
KPCO.
Methods: This study included data on the estimated eligible
population from the Colorado Health Institute’s 2013
Colorado Household Access Survey of 10,224 randomly
digit dialed Coloradans. Preliminary data about Coloradans
who enrolled through the marketplace were collected by
the administrator, Connect for Health Colorado. KPCO data
were from KPCO’s administrative systems and a survey of
2,570 randomly selected KPCO new members through the
marketplace.
Results: As of August 2014, 145,994 Coloradans had
enrolled in one of 10 carrier’s health plans available through
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the marketplace. As of August 2014, 59,645 (41%) enrollees
chose KPCO. To date there were 1,017 (40%) respondents
to the survey. When compared to the estimated eligible,
Coloradans who enrolled through the marketplace were
older. KPCO new members were more educated (54% vs.
27% graduated college), less likely to be Hispanic (9% vs.
24%), and appeared to have a higher household income
than the estimated eligible. The KPCO new members and
estimated eligible were similar in the percentage reporting
having usual source of health care (51% in both groups) and
seeing a provider in the previous 12 months (39% vs. 38%),
but fewer KPCO members reported delaying seeking care
in the previous 12 months because of costs (34% vs. 42%).
KPCO enrollees had similar age distributions to all Coloradan
enrollees (35% Coloradans vs. 36% KPCO 35–54 years old;
25% vs. 27% 55 years old or older).
Discussion: New members to KPCO who enrolled through
Colorado’s marketplace differ from the estimated eligible, but
appear to be similar to all Coloradan enrollees. New enrollee
characteristics inform KPCO’s operational teams how to
position themselves in the marketplace and provide quality
health care. Knowing who enrolled is important for future
plans of all carriers and concerned state health officials.
Keywords: health reform, new members
A1-4:
Medicaid Expansion and the Affordable Care Act:
Data From the First Year of Enrollment at Kaiser
Permanente Northern California
Mark W. Lin,1 Zheng Zhu,1 Wendy Dyer,1 Julie A.
Schmittdiel,1 Alyce S. Adams 1
1

Kaiser Permanente Northern California

Background/Aims: The Affordable Care and Patient
Protection Act (ACA) aims to reduce rates of un-insurance
partly through expansion of Medicaid eligibility and the
establishment of insurance exchanges with income-based
subsidies. While prior studies used historical enrollment
data to predict the characteristics and utilization patterns of
newly eligible Medicaid recipients, few studies to date have
actively analyzed these new enrollees. By providing MediCal coverage and commercial insurance, Kaiser Permanente
provides a unique perspective when analyzing these programs.
As part of a larger ongoing study, we aim to provide early
data on the characteristics and preliminary utilization patterns
of new Medi-Cal enrollees after the roll-out of insurance
expansion under the ACA.
Methods: This is a descriptive study including two distinct
cohorts of adult (18–64) Kaiser Permanente Northern
California (KPNC) members who were newly enrolled in
KPNC Medicaid in 2013 and 2014, defined as no KPNC
enrollment in the prior 12 months.
Results: Between 1/2014 and 6/2014, 9,795 adults enrolled
in Medi-Cal while 5,322 enrolled in 2013. Compared to
enrollees in 2013, Medi-Cal enrollees in 2014 were older (44%
aged 41–64 vs. 29.2%). New enrollees were predominantly
female (58.7% female vs. 41.3% male), but less so than in
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2013 (62.2% female vs. 37.8% male). 2014 enrollees were
proportionally less likely to be white (29.0% vs. 30.0%),
black (15.3% vs. 24.5%) or Hispanic (17.0% vs. 27.8%),
and proportionally more likely to be Asian (10.2% vs 9.7%).
However, a larger percentage was classified as “unknown”
(26.8% vs 6.2%). Preliminary rates of utilization (per member
per month) were similar, except for outpatient visits where the
mean for the post-ACA cohort was 0.98 (1.59) relative to 0.74
(0.94) for the pre-ACA cohort.
Discussion: Consistent with expectations, newly enrolled
Medi-Cal beneficiaries post-ACA were older and less
predominantly female. However, there also was a decrease
in race/ethnicity ascertainment in the post-ACA cohort.
Additional analysis will explore differences in utilization
once a full year of data for the 2014 cohort has been collected.
When combined with data on medical comorbidities of this
population, this study will help further understand the needs
of the newly insured post-Medicaid expansion.
Keywords: Medicaid expansion, Affordable Care Act
A2-2:
Race-Ethnic Differences in Kaiser Permanente
Northern California Seniors’ Access and Preferences
for Using the Web for Health Information and HealthRelated Transactions, 2013
Nancy P. Gordon,1 Mark C. Hornbrook,2 Teresa Y. Lin1
Kaiser Permanente Northern
Permanente Northwest
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2
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Background/Aims: Patients are being encouraged to use the
Internet to obtain health information and interact with the
health care system. However, surveys suggest lower use of the
Internet by seniors, especially blacks, Latinos, and those aged
75+. We examined whether race-ethnic and age disparities
exist in a Medicare-age population regarding readiness and
preferences for using the Internet for health-related purposes.
Methods: In 2013 we surveyed an age-gender stratified
random sample of non-Limited English Proficient white (W),
black (B), Latino (L), Filipino (F) and Chinese (C) seniors
aged 65–79 who were Kaiser Permanente Northern California
members for 2+ years. The study sample was linked to 2013
kp.org utilization data (activated account, use of email, online
lab views, online Rx refills). SAS Proc Surveymeans and
Surveylogistic were used to analyze respondent data weighted
to the study population. The final sample included 849 whites,
567 blacks, 653 Latinos, 219 Filipinos and 314 Chinese.
Results: Significant (P<0.05) race-ethnic differences were
found in easy access to a computer (70.7% B, 63.0% L,
57.5% F vs. 85.3% W, 82.8% C), tablet (16.0% B, 12.6% L v.
27.1% W, 28.3% C) and smartphone (22.0% L, 19.6% F vs.
31.2% W, 32.8% B, 26.6% C). Blacks, Latinos and Filipinos
were less likely to be able to send secure messages (50.2%
B, 51.7% L, 52.0% F vs. 74.8% W, 73.5% C) and to prefer
to use secure messaging (22.8% B, 25.5% L, 22.0% F vs.
51.4% W, 55.2% C), view lab results online (16.5% B, 17.7%
L, 12.9% F vs. 35.3% W, 37.8% C), order Rx refills online
(13.9% B, 16.5% L, 10.8% F vs. 34.0% W, 36.3% C), conduct
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video visits (12.3% B, 9.5% L, 10.6% F vs. 19.2% W), and
view online videos (17.5% B, 15.2% L, 11.6% F vs. 26.7%
W, 24.3% C). Whites were more likely to prefer to complete
health risk appraisals online (34.7% W vs. 15.6% B, 16.8%
L, 11.6% F, 24.3% C), with very low preference for in-clinic
tablet or interactive voice response completion across all
groups. Non-Internet users were more likely to indicate the
shift to web has made it harder to communicate with doctors
and obtain information.
Discussion: Race-ethnic and age-related differences in access
to and preference for using the Internet for health-related
purposes should be considered when planning and evaluating
use of patient portals and providing health information to
ensure that health care access is not decreased for seniors who
cannot or prefer not to use the Internet.
Keywords: patient portal use, racial-ethnic disparities
B1-1:
Comparison of Organizational Context Across
HMORN Members
Wayne Psek,1 Jing Hao,1 James M. Pitcavage1
Geisinger Health System

Results: Preliminary results indicate a wide variation across
HMORN members in adoption of new models of care and
market consolidation. Four members belonged to Beacon
communities (health information exchanges). While most
systems participated in an ACO, the funding mechanisms
varied (Medicare-shared savings or Pioneer program).
Systems underwent considerable consolidation, with the
largest merger increasing a HMORN member size from 12 to
43 hospitals. Further results are pending.
Discussion: System-level contextual factors differ across
HMORN members. Our findings draw attention to the
relevance of contextual factors and may inform interpretation
of results and implementation.
Keywords: delivery system, organizational context
B1-2:
Acceptance and Adoption of Lean Redesigns
Among Frontline Providers in Primary Care
Dorothy Y. Hung,1 Caroline Gray,1 Meghan C. Martinez,1
Michael I. Harrison,2 Julie A. Schmittdiel3
Palo Alto Medical Foundation Research Institute;
Agency for Healthcare Research and Quality; 3Kaiser
Permanente Northern California
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Background/Aims: Organizational context is an important
element in implementation science and comparative
effectiveness research (CER). Contextual factors include
practice, hospital, system and environmental factors that may
influence care delivery. For multisystem research networks
such as the HMORN, awareness and inclusion of contextual
factors can strengthen research design and interpretation
of findings. Similarly, consideration of local contextual
factors can enhance dissemination and implementation of
interventions across systems. To our knowledge a comparative
analysis of system-level contextual factors reflecting recent
market and policy changes has not been performed for
HMORN members. The aim of this study is to describe
differences and similarities in seven system-level contextual
factors across HMORN delivery systems and discuss their
implications for CER and implementation research.
Methods: We performed a review of system-level contextual
factors representing major policy, market or operational
changes from 2004 to 2014. Contextual factors were: 1)
accountable care organization (ACO) participation; 2)
patient-centered medical home (PCMH) implementation; 3)
CMS-CMMI program participation; 4) market consolidation
(Mergers & Acquisitions); 5) systemwide adoption of Lean
or continuous quality improvement (CQI) programs; 6)
Beacon Community Grants; and 7) systemwide population
health management program. A manual review of several
data sources including HMORN member websites, CMS
website, National Committee for Quality Assurance website
and Office of the National Coordinator for Health Information
technology website. Additional data was attained using a
keyword search in industry journals. For each contextual
factor we determined a system’s level of participation, start
and end dates, and program or consolidation characteristics
as applicable.

Background/Aims: This study examines the implementation
and scale-up of Lean methodology for enhancing value in
a large ambulatory care delivery system. While evidence
suggests that Lean techniques can lead to higher quality care
at lower cost, its success or failure is inextricably tied to the
views and activities of frontline care providers who are the
daily implementers of new workflows. This study explores
how frontline views and activities impacted systemwide
efforts to redesign primary care.
Methods: This work stems from a collaborative, mixedmethods evaluation of a major operational initiative
to implement Lean as a common platform across the
organization. The current analysis was guided by a modified
version of the Consolidated Framework for Implementation
Research, which defines various “measures” of success when
implementing process redesigns. Drawing on over 100 indepth interviews with physicians and staff conducted between
January 2012 and March 2014, we sought to understand the
extent to which new Lean workflows were accepted and
adopted into practice, and the contextual factors that impact
successful implementation.
Results: Frontline views on Lean’s potential to enhance value
were impacted in part by: local dynamics of each care team;
perceived skill or competency of team members (namely,
medical assistants and licensed vocational nurses) in taking on
new roles or scopes of work; and physicians’ own perceived
efficiency prior to the introduction of Lean redesigns. The
implementation strategy used by the organization was also
critical. Physicians and staff who viewed the effort as “topdown” or “inflexible” were less likely to comply with changes.
Even those who expressed positive views about Lean as
an overall strategy for redesigning care, but who found the
implementation process excessively top-down, were less
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likely to accept and adopt new modes of operation.
Discussion: Gaining “buy-in” from frontline providers is
critical to implementing workflows that are designed to
improve the delivery of health care. Understanding how
clinical insiders’ views inform their decision to embrace or
reject changes is important for managing change, and may
also be instructive for organizations attempting to implement
similar, operational initiatives.
Keywords: Lean process redesign, implementation measures/
success
B1-3:
Implementing a Transitional Care Program for Older
Adults at High Risk for Readmission
Dorothy Y. Hung,1 Francesca Nicosia1
1

Palo Alto Medical Foundation Research Institute

Background/Aims: This study describes the implementation
of a transitional care program for older adults at high risk
for hospital readmission. Despite increasing efforts to
reduce preventable readmissions through postdischarge
care coordination, little research has been done on how
to operationalize transitional care in community settings.
We sought to understand how implementation efforts were
impacted by factors including intervention complexity,
patient beliefs about transitional care, and program fidelity
with ramifications on staff roles and scope of work.
Methods: Our analysis is guided by the Agency for Healthcare
Research and Quality “Care Transitions Framework” (CTF),
a novel adaptation of the Consolidated Framework for
Implementation Research. Seventeen in-depth interviews
with program staff and leadership were conducted in January
and February 2014. Interviews were recorded, transcribed
verbatim and analyzed by two qualitative researchers for
intercoder reliability based on emergent themes and relevant
constructs from the CTF.
Results: The intervention was a complex collaboration
between organizations, which served to bridge multiple
settings ranging from the hospital and outpatient clinic to the
patient’s home and community. While this partnership allowed
for comprehensive services across the care continuum, it posed
unique operational challenges for program coordination and
communication. Challenges included engaging hospital staff
to fully understand the program’s goals and scope of services,
particularly when making referrals. Patients’ knowledge
and beliefs about transitional care services also directly
impacted their choice to enroll, as many older patients have
preconceived notions about receiving home-based assistance
and what that signifies, despite the potential benefits of such
services. Finally, fidelity to the program’s original coaching
model was affected by midstream modifications to patient
eligibility criteria. As the program was spread to other
hospital units, patients with more complex medical and social
needs were enrolled, resulting in increasing shifts from health
coaching to clinical case management. This, in turn, created
greater need for clarity around the referral process as well as
staff roles and scope of work.
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Discussion: This study describes contextual factors that
impacted the implementation and hospitalwide spread of a
transitional care program for older adults. Lessons learned
can inform future efforts to implement similar transitional
care interventions that are based in the community.
Keywords: transitional care, qualitative research
C1-4:
Pragmatic and Adaptive Approaches Accelerate
Recruitment of Adolescents in Asthma Intervention
Trial (Puff City in the Clinic)
Christine L. Joseph,1 Dennis R. Ownby,2 Edward M.
Zoratti,1 Talan Zhang,1 Christine Cole Johnson,1 Mei Lu 1
Henry Ford Health System; 2Georgia Regents University

1

Background/Aims: Recruitment of patients for randomized
clinical trials (RCT) remains a challenge for investigators.
“Puff City in the Clinic” is multisite, open-label, randomized
Phase II/III trial designed to evaluate a clinic-based asthma
management intervention targeting urban youth. Pragmatic
and adaptive approaches were used to accelerate recruitment
for this RCT.
Methods: Using our electronic medical record (EMR), study
eligibility criteria were applied to our patient population in
order to establish a pool of potentially eligible patients and
the clinics in which they were being seen. Clinical sites seeing
the bulk of patients were identified, recruited, initiated and
trained. Potentially eligible patients are identified through our
automated appointment scheduling process and approached
for enrollment at a scheduled visit. Enrollment goals were 250
patients in Phase II and 500 for total Phase II/III enrollment.
Enrollment began in the second quarter of 2013. Using only
onsite clinic staff to conduct recruitment, study enrollment
was below target after 12 months of recruitment (57%; 63
patients). To improve recruitment, several strategies were
implemented. Recruitment reports by clinic were generated
weekly to note successes as well as missed opportunities.
We made use of the automated scheduling system to better
identify patients with same-day appointments. We deployed
research staff to compensate for staff shortages at the clinical
site. Per-patient payment and responding to feedback from the
clinical site helped to maintain site engagement.
Results: Enrollment rates have increased after implementation
of these strategies, with 110 patients recruited in just 9 months
(total to date: 106%; 173). Real-time monitoring of patient
recruitment allowed us to optimize recruitment strategies as
needed, including use of the scheduling system and EMR.
Key in improving recruitment is clinical site engagement,
resource provision and flexible staff support.
Discussion: Onsite recruitment of patients during routine
clinical care has been feasible for the RCT of an asthma
intervention. Integration of the automated scheduling system
allowed the identification of missed opportunities and the need
for more resources. Together, these strategies have increased
patient recruitment rates.
Keywords: recruitment, randomized control trial
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C3-4:
Low Reach of Four Different Alcohol Screening
Approaches in the Absence of Population-Based
Screening: Results From One Large Integrated
Health Care System
Gwen T. Lapham,1 Emily C. Williams,1 Julie E. Richards,1
Evette J. Ludman,1 Paula Lozano,1 Ryan Caldeiro,1 Amy
Lee,1 Katharine A. Bradley1
1

Group Health Cooperative

Background/Aims: Population-based alcohol screening is
recommended for identifying patients who may benefit from
brief alcohol interventions. Although few health systems
universally screen primary care patients for unhealthy alcohol
use, some may offer screening at specific appointments or
through online health risk assessments. However, little is
known about the reach of various alcohol screening approaches
in the absence of universal alcohol screening. The objective
was to evaluate the proportion of primary care patients who
were: 1) screened for unhealthy alcohol use, and 2) screened
positive as a result of four different screening approaches.
Methods: This project included 262,616 adults enrolled
in Group Health in 2012 who had at least one primary care
visit. Electronic medical record documentation of Alcohol
Use Disorders Identification Test – Consumption (AUDIT-C)
screening results were obtained from four screening
approaches: online health risk assessment; progress note
documentation through a template completed at preventive
visits; paper-based questionnaire completed at mental health
visits; and ad-hoc screening when providers had concerns.
AUDIT-C results, ranging from 0–12 points, were positive
for unhealthy alcohol use at scores of ≥ 3 and ≥ 4 points for
women and men, respectively. The percentage of patients
screened and the percentage of screened patients who were
positive for unhealthy alcohol use were estimated overall and
across the four screening approaches.
Results: Overall, 14% (36,435) were screened with the
AUDIT-C. The approach-specific percentages of patients
screened were 8% online, 3% at preventive visits, 1% at
mental health visits and 3% by ad-hoc screening. Of those
screened, 33% were positive for unhealthy alcohol use and
the approach-specific percentages of patients who screened
positive were 35% online, 28% at preventive visits, 40% at
mental health visits and 45% by ad-hoc screening.
Discussion: Despite four approaches to alcohol screening,
86% of primary care patients were not screened for unhealthy
alcohol use. Formal implementation of universal screening is
likely necessary to achieve high rates of alcohol screening.
Keywords: unhealthy alcohol use, preventive screening
D1-1:
Primary Care Provider Perspectives on Reducing
Low-Value Care
Diana S. Buist,1 Matthew R. Handley,1 Eva Chang,1 Roy
Pardee,1 Gabrielle Gundersen,1 Allen Cheadle,1 Robert
J. Reid1
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Background/Aims: Constraining costs and enhancing value
in health care delivery is a national priority. Understanding
the clinician perspective is particularly important because
health care professionals play key roles in choosing what
health care services are used. This study explores clinicians’
perceived use of and professional responsibility for reducing
low-value care, barriers to decreasing its use, and knowledge
and perceived legitimacy of the Choosing Wisely campaign.
Methods: We conducted an online survey of 304 primary care
clinicians at Group Health in Fall 2013. The overall response
rate was 62% (n=189).
Results: Nearly all (93%) responded that the cost of care
they personally deliver is important to different stakeholders
and believe it is fair to ask providers to be cost-conscious.
Over half (62%) said patients request unnecessary tests or
procedures at least several times per week. The majority
indicated they were somewhat or completely comfortable
discussing low-value care with colleagues (70%) and patients
(88%); conversations with patients were reported much more
frequently than with providers (10% and 56% five or more
discussions in the past 30 days, respectively). Providers
indicated patients follow their advice the majority of the time
about unnecessary tests or procedures when conversations
happen. Notable perceived barriers to decreasing low-value
care included: time (45%), community standards (43%),
challenges overcoming patient preferences and values (43%),
fear of patients’ dissatisfaction (40%), patients’ knowledge
about harms of having low-value care (37%), availability of
tools to support relevant shared decision-making (36%) and
fear of litigation (31%). Almost two-thirds of providers were
aware of the national Choosing Wisely campaign, nearly all
of which considered it a legitimate source of information on
unnecessary tests and procedures.
Discussion: There were few differences in national physician
surveys and our survey of integrated delivery system
clinicians — patients listen to their providers and the majority
of providers report talking with patients about reasons to avoid
unnecessary tests. Awareness and perceived legitimacy of the
Choosing Wisely campaign suggests the campaign and others
like it may be used to activate providers to be conscientious
stewards of limited health care resources. Additional focus on
training providers to have discussions with colleagues about
low-value care could be beneficial.
Keywords: low-value care, Choosing Wisely
D1-2:
Risk Stratification and Population Management:
Validation of the Patient Stratification Model Based
on Electronic Health Record
Irina V. Haller,1 Brian P. Johnson,1 Michael Van Scoy,1
Catherine VonRueden,1 Paul J. Hitz,1 Joseph Bianco1
1

Essentia Health

Background/Aims: Population health management and
patient risk stratification are essential components of health
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care delivery in order to achieve the Triple Aim of better
health outcomes, better care and lower health care costs.
Many current risk adjustment/risk stratification models are
based on claims data, which often are unavailable in health
care setting. This study evaluated an electronic health recordbased patient stratification model (PSM) and its accuracy in
predicting future utilization of high-cost health care services.
Methods: A 24-item scoring system, PSM includes markers
for chronic conditions, disease states, lab values, health
behaviors and health care utilization. In this retrospective
cohort study, we focused on adult (18+ years old) primary
care patients from a regional health care system (N=250,903).
Patients were classified based on demographics, place of
residence (isolated rural or small rural, large rural, urban) and
prevalence of PSM markers at baseline (9/1/11–8/31/12). The
outcome measure in this analysis was defined as 3 or more
emergency department (ED) visits at follow-up (9/1/12–
8/31/13). We used a logistic regression model to estimate the
odds ratio (OR) of the baseline factors on the outcome using
both unweighted and weighted PSM scoring. Weights for the
PSM markers were calculated as ratios of deviations of the
OR from one and the sum of the deviations. The unweighted
and weighted composite scoring systems were assessed on the
basis of predictive characteristics of the models (c-statistic).
In addition, we will examine interactions between age groups
and PSM markers and use bootstrap methods of resampling to
assess the variation in predictions.
Results: The average age in the cohort was 49.0 (standard
deviation: 19.2) years at baseline, with 37.0% being 40 or
younger and 23.0% being 65 or older; 54.3% were female
and 57.9% resided in rural areas. Frequent ED use at followup was observed in 2.7% of the study cohort. The c-statistics
for the models using unweighted and weighted baseline PSM
markers were 0.834 and 0.868, respectively, with a difference
of 0.034 (95% confidence interval: 0.032–0.037).
Discussion: A model that includes weighted PSM markers,
demographics and place of residence had better accuracy in
predicting future frequent ED use. Additional analyses will
help with further refinement and calibration of the model.
Keywords: risk stratification, electronic health record
D1-3:
Linking Medication Orders to Prescription Fills:
Lessons From HMO Enrollees Applicable to PPO
Patients
Su-Ying Liang,1 Laura J. Eaton,1 Jia Pu,1 Tony Chen,1
Harold S. Luft1
1

Palo Alto Medical Foundation Research Institute

Background/Aims: This study develops an approach to
estimate the prescription fill rate when detailed medication
orders from electronic health records are available but
pharmacy dispensing data are limited.
Methods: Data included medication orders from the electronic
health records and pharmacy claims from a large ambulatory
group practice with mixed payment sources. Pharmacy claims
were available only for HMO patients, but no direct link was
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available to track whether a pharmacy claim was tied to a
particular medication order. We analyzed 608,871 medication
orders from 2007 to 2013 for 26,875 HMO patients who were
enrolled in an HMO plan in the calendar year preceding,
during and after the medication ordering date. We developed
an algorithm matching the pharmacy claims to medication
orders by the patient identifier, the generic product identifier
and the prescription fill date within the eligible timeframe
(i.e. within 365 days of the ordering date or between the
ordering date and a specified termination date). Fill rates were
computed separately for the index (i.e. newly initiated therapy)
and renewal orders for each drug. Sensitivity analyses were
conducted using different matching algorithms, e.g. using
simple generic name and medication strength.
Results: Overall, 75% of the 608,871 medication orders had
matched pharmacy claims using the proposed algorithm. Fill
rates were higher among renewal orders than index orders
(76% vs. 74%, P<0.01). Preliminary findings suggested a
higher fill rate for chronic conditions compared to acute
conditions (78% vs. 74%, P<0.01). In addition, there were
variations across therapeutic classes, ranging from 83% fill
rate of anti-infective agents to 40% of nutritional products.
Sensitivity analyses using different matching criteria yielded
a similar overall fill rate (73.6%).
Discussion: We developed a generic approach to estimate
the prescription fill rates based on medication orders and
pharmacy claims from HMO patients. This is an important first
step, as the estimated fill rates can serve as a benchmark and
be applied to patients who did not have pharmacy dispensing
data in the same delivery system. Applications of estimated
fill rates can be further extended to estimate pharmacy costs
associated with medication orders or examine patterns of
medication adherence over a range of conditions.
Keywords: prescription fill, medication orders
D1-4:
Severe Obesity on Labor and Delivery: Variation in
Hospital Resources Among California Hospitals
Daniele S. Feldman,1 Moshe Fridman,2 Lisa Bollman,3
Lisa Korst,4 Samia El Haj Ibrahim,1 Arlene Fink,5
Kimberly D. Gregory1
Cedars-Sinai Medical Center; 2AMF Consulting;
Community Perinatal Network; 4Childbirth Research
Associates; 5University of California Los Angeles
1

3

Background/Aims: More than half of pregnant women are
overweight and 8% of reproductive aged women are extremely
obese. Rates of maternal obesity and obstetrical complications
associated with obesity are increasing. How hospitals are
responding to this trend in terms of both clinical practices
and resources is unknown. The objective of this study is to
describe how labor and delivery (L&D) units in California are
equipped to care for women with extreme obesity.
Methods: A cross-sectional study based on a survey
instrument designed and validated to collect information on
childbirth practices and resources from nurse managers on
L&D units in all California hospitals. Based on responses
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to specific survey items, hospitals were stratified by type
(Community, Teaching, and Integrated Delivery System
[IDS] hospitals) and obesity resources (low level [LL] — at
least one key piece of equipment not available in hospital;
intermediate level [IL] — all equipment available in hospital
but not kept on L&D; and high level [HL] — all equipment
available in hospital and kept on L&D). Survey questions
identified hospitals that transfer out women and ascertained
the availability of the following resources to accommodate
women with severe obesity: operating table, special gurney,
surgical instruments and retractor equipment.
Results: Nearly all hospitals responded to the survey (239/248
[96%]). There were 187 community hospitals, 27 teaching
hospitals and 25 IDS hospitals. Of these, there were 77 HL
(32.2%), 143 IL (51.5%) and 39 LL (16.3%) hospitals. Of the
25 IDS hospitals, there were 15 HL (60%), 8 IL (32%) and 2
LL (8%). Only one IDS hospital reported that they had ever
transferred a patient out for extreme obesity and this was a
LL hospital.
Discussion: Hospitals vary by resources available to manage
obese patients. IDS hospitals are better equipped to care for
obese patients with nearly twice as many HL IDS hospitals
than the total hospital sample. The extent to which this is
associated with patient outcomes remains to be determined
and is the focus of ongoing research. Primary outcomes
should include cesarean delivery rates and composite maternal
morbidity among obese patients who delivered at hospitals
with LL, IL and HL obesity resources
Keywords: hospital resources, severe obesity

Results: Preliminary results (N=1,002) of KPNC youth age
10–17 in 2009–2010 showed concussion diagnoses were
highest among boys playing football (31.6% [223/706]) soccer
(8.8% [62/706] and baseball (8.64% [61/706]). Concussion
diagnoses were highest among girls playing soccer (27.7%
[82/296]), softball (10.47% [31/296]) and basketball (10.14%
[30/296]). Reconcussions occurred in 7.4% within 18 months.
Reconcussions among those with concussions prior to index
compared with those without were higher (11.6% [22/189]
vs. 6.5% [52/795], P=0.02). Those playing contact/collision
sports were more likely to have reconcussions compared
with limited/noncontact sports (9.4% [53/561] vs. 5.0%
[21/417], P=0.01). Of reconcussed subjects, those who played
contact/collision sports were more likely to be reconcussed
due to sports participation compared with those who played
limited/noncontact sports (81.1% [43/53] vs. 52.74% [11/21],
P=0.02). In multivariable analyses, age 14–17 compared to
age 10–13 (odds ratio [OR]: 2.59, 95% confidence interval
[CI]: 1.36–4.97), and blurred vision/light sensitivity (OR:
2.10, 95% CI: 1.16–3.78) and dizziness or lightheadedness
(OR: 1.75, 95% CI: 1.02–2.98) vs. absence of these symptoms
were significantly associated with reconcussion.
Discussion: Preliminary findings show risk of reconcussion in
athletic youth is a serious public health problem. Final results
on 2,065 subjects will show comparisons in reconcussion
rates and risk factors associated with reconcussions before
and after enactment of CA-AB 25.
Keywords: sports-related concussion, reconcussion

D1-5:
The Risk of Subsequent Concussion or
Reconcussion Among Youth Participating in Sports

D3-2:
Estimating the Human Resource Costs of Developing
and Implementing Shared Medical Appointments in
Primary Care
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Mary Carol Mazza,1 Ming Tai-Seale1

Kaiser Permanente Northern California

Palo Alto Medical Foundation Research Institute

1

1

Background/Aims: In 2012, an amendment to the California
Education Code (CA-AB 25) was enacted requiring schoolbased athletic programs to remove youth from the sport
played when a concussion occurred, and to provide more
rigorous evaluation and treatment. Youth were required to
obtain written clearance from their health care provider before
returning to play.
Methods: A retrospective cohort study was conducted of
Kaiser Permanente Northern California (KPNC) members
age 10–17 years with sports-related concussions from
2009–2010 and 2012–2013. Our aims were to calculate
subsequent concussion (reconcussion) rates and compare
risks for reconcussion before and after enactment of CA-AB
25. Data obtained determined type of sport, level of contact
(noncontact, limited contact, contact and collision), presenting
symptoms, and evidence of prior and reconcussion to the
index concussion. Chi-square tests and logistic regression
analysis were performed to assess the association of index
concussion demographic (age, gender, race/ethnicity, median
family income) and clinical characteristics with reconcussion.

Background/Aims: Shared medical appointments (SMAs)
or group visits have been shown to improve access, but
there is no research to date on the costs of developing and
implementing SMAs. We estimate the human resource costs
of developing and implementing an administrative program to
support SMAs and an additional SMA on cancer survivorship.
Methods: Activity-based costing was used to analyze the
human resource costs for completed tasks, personnel involved
and time to complete tasks. The study occurred in one division
of a nonprofit, multispecialty group practice in northern
California that serves 126,000 patients. We conducted indepth, key-informant interviews with stakeholders involved
in SMAs –– clinicians, coordinator, and operations manager
–– from different levels of the organization. National median
wages were calculated from the 2013 Bureau of Labor
Statistics.
Results: We estimate that the human resource cost to develop
and implement a program to support SMAs was $62,874. The
employee who spent the most time (1,255 hours) was the SMA
coordinator and the activity that required the most time (1,211
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hours, $52,945) was for research tasks including establishing
workflow and logistics of a SMA program. Once the SMA
program was established, the cancer survivorship SMA cost
$7,271 to develop and implement. The physician who ran the
cancer survivorship SMA spent the most time and provided
the most expensive labor (72.5 hours, $6,513) and the most
time-consuming and costly activity was the development of
materials (44 hours, $3,768).
Discussion: Developing and implementing a program to
support SMAs took the SMA coordinator about 8 months.
Introducing new providers or a new type of SMA may require
a relatively modest incremental commitment of organizational
resources and provider time (less than 6% of the time and less
than 14% of the finances required to start the initial SMA). It is
possible that the total time and cost could be further decreased
by leveraging relevant materials from existing SMAs.
Keywords: primary care, activity-based costing
ECI-2:
Reductions in Medical Resource Use Among
Primary Care Physicians Following the Adoption of
Personalized, Transparent Reporting
Eva Chang,1 Diana S. Buist,1 Matthew R. Handley,1 Roy
Pardee,1 Gabrielle Gundersen,1 Robert J. Reid1
1
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Background/Aims: With Group Health’s commitment to
Affordable Excellence, Group Health has implemented
multifaceted interventions since 2011 around helping
clinicians become aware of their health services use relative
to their colleagues, with the goal of increasing quality and
reducing waste. This quality improvement initiative aims
to measure changes in physician medical resource use and
identify physician practice characteristics associated with
decreasing use of low-value services.
Methods: We calculated physician ordering rates for specialty
referrals, prescriptions, high-end imaging, and lab tests for
197 practicing primary care physicians with panels greater
than 500 in 2012 and 2013. Our primary outcomes were the
differences between 2013 and 2012 ordering rates per 1,000
patients adjusted for age, sex and clinical complexity. Multiple
regression models were used to examine associations between
outcomes and physician years in practice and FTE-adjusted
panel size. Models also were adjusted for gender and ethnicity.
Results: In 2012, mean (with standard deviation) primary
care physician ordering rates for referrals, prescriptions,
imaging and labs were 336.1 (142.7), 7,838.2 (1,601.3), 19.8
(10.6) and 1,805.7 (647.5), respectively. Between 2013 and
2012, ordering decreased across all services; mean change in
referrals, prescriptions, imaging and labs was -89.6 (125.7),
-1,255.5 (1,509.5), -5.3 (8.9) and -435.9 (562.1), respectively.
For referral, imaging and lab test orders, reduction was
greatest in physicians newer to practice. Also for lab test
orders, physicians with smaller panels had greater reductions.
We did not observe any significant practice characteristics
associated with change in prescriptions.
Discussion: Group Health physicians with fewer years
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practicing and smaller panel sizes were associated with larger
decreases in resource use from 2013 to 2012. The larger
decrease in resource use in newer physicians may be associated
with a learning curve early in practice and may represent an
important time for early feedback and intervention. Since the
multifaceted intervention also may have influenced physician
resource use, more understanding of what accounts for
reductions in resource use is useful for future development of
interventions.
Keywords: resource utilization, primary care practice
PD2-5:
Adverse Effects of Fecal-Based Colorectal Cancer
Screening
Grace Clarke Hillyer,1 Christopher D. Jensen,2 Wei K.
Zhao,2 Alfred I. Neugut,1 Benjamin Lebwohl,1 Douglas
A. Corley2
1
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Background/Aims: Individuals report that the colorectal
cancer (CRC) screening process is stressful and, for some,
studies indicate that this stress has a downstream impact on
motivation to engage in health behaviors and use of health
care services. We examined ambulatory primary care (APC)
utilization following a false-positive fecal immunochemical
test (FIT) to screen for CRC among patients enrolled at the
Kaiser Permanente Northern California PROSPR site between
2007 and 2011.
Methods: Included were adults aged 50–89 years who
were enrolled in Kaiser Permanente Northern California
continuously for 36 months. The first FIT completed during
this period for those with a true-negative FIT (negative FIT
and not diagnosed with CRC in the subsequent 12 months)
and a false-positive FIT (no CRC or adenoma detected
with diagnostic colonoscopy following a positive FIT) was
identified. The mean number of APC visits in the 12 months
following the FIT screening result was compared to the
prior 12-month period. Associations between differences in
APC utilization pre- to post-FIT by test result and patient
demographic characteristics and Charlson comorbidity score
were assessed.
Results: We examined 582,997 electronic medical records.
For true-negative FIT, we did not detect a change in the number
of APC visits pre- vs. post-FIT, whereas there was an increase
among patients with a false-positive FIT. Comparison of mean
APC visits pre- to post-FIT screening for true-negative FIT
was -0.02 (standard deviation [SD]: 2.4] vs. 0.57 [SD: 2.6]
for false-positive FIT (P<0.001). In multivariable analysis,
those with a false-positive FIT were 64% more likely to have
increased APC utilization post-FIT compared to those with a
true-negative FIT and that utilization tended to increase with
age. Those with no comorbidities were 45% more likely to
increase their APC utilization post-false-positive FIT, and this
association decreased as comorbidities increased. Men were
less likely than females to engage in increased APC utilization
post-false-positive FIT.
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Discussion: This study demonstrates that primary care
utilization varies significantly by fecal-based colorectal
cancer screening test result. Further evaluation of the nature
of these visits, as well as underlying behavioral determinants
of the utilization is warranted.
Keywords: fecal-based colorectal cancer screening, harms of
cancer screening
PS1-2:
Using Systematic Review and Decision Modeling
to Fill Gaps in Evidence: Application to Positron
Emission Tomography Scan Use in Posttreatment
Squamous Cell Carcinoma of the Oropharynx

Results: The results presented are a decision-analysis model
with assumptions, parameters and input values documented
from the systematic review, CRN VDW data and input
provided by the CRN Head and Neck Cancer Scientific
Interest Group.
Discussion: The finalized decision-analysis model will
support simulations to estimate comparative effectiveness
outcomes and cost-effectiveness of the HPV-positive SCOOP
post-nonsurgical treatment imaging alternatives to provide
much needed evidence to evaluate and improve clinical
decision-making and patient outcomes and to identify future
research needs.
Keywords: systematic review, cancer
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Background/Aims: There is a general lack of costeffectiveness evidence for positron emission tomography
(PET) scan use in cancer suitable to support decision-making,
and specifically for post-nonsurgical treatment of squamous
cell carcinoma of the oropharynx (SCOOP). The value of
effectiveness research is greatest when there are considerable
data challenges and uncertainty due to early adoption of new
technology and/or emerging serious high-growth disease.
New expensive technology commonly becomes the standard
of care without adequate evidence to support its value,
including whether its performance does more good than harm
to patients compared to the previous standard or alternatives.
An example is the lack of evidence-informed standards
for postchemoradiation imaging of SCOOP for patient
management. The standard of care is posttreatment physical
examination with imaging at 8–12 weeks using PET scan,
computed tomography scan or ultrasound. Due to limits in the
sensitivity and negative predictive value of these alternatives,
patients may be over- or undertreated. A particular concern is
PET scans are routinely used in practice although they have
a high false-positive rate, which often result in unnecessary
procedures.
Methods: A recommended efficient and evidence-based
approach to providing needed information addressing health
care cost and quality research gaps is decision and simulation
modeling informed by a systematic review of the literature
to obtain relevant information for model assumptions and
parameter values augmented by expert input and consensus
review. This approach will be applied to three posttreatment
imaging alternatives for human papillomavirus (HPV)positive SCOOP patients, and supplemented by Cancer
Research Network (CRN) virtual data warehouse (VDW)
patient data from HMORN participants and a technical expert
panel from the newly formed CRN Head and Neck Cancer
Scientific Interest Group.
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Background/Aims: Extended core prostate biopsy (ECPB)
removing 10–12 tissue cores is the standard of care in men
investigated for prostate cancer; however, the manner of
pathologic examination varies. Urologists may process cores
by laterality into two specimen jars, or separate each core into
12 specimens for pathologic review. Considering the high
volume of ECPBs performed annually, varying strategies of
submitting specimens for review could lead to variations of
over $1 billion in health care expenditures. We will examine
the association between number of jars submitted for
pathologic review and rates of prostate cancer detection and
equivocal diagnoses.
Methods: We are conducting a pilot project at two Cancer
Research Network (CRN) sites –– Meyers Primary Care
Institute (MPCI) in Worcester, MA, and Marshfield Clinic
(MCRF) in Marshfield, WI –– to determine patterns of
processing ECPB tissue cores for pathologic review in men
aged 30–95 years who underwent ECPB between 2008–2011.
ECPBs and subsequent pathology services were identified
in the CRN virtual data warehouse (VDW). Prostate cancer
diagnoses were identified in VDW tumor files and equivocal
diagnoses as repeat ECPBs within 7–180 days of the initial
biopsy. Site-specific methods for identifying and validating
jar number have been developed.
Results: To establish this pilot study, we constructed datasets
using the CRN VDW, discovered new variables in raw claims
data, and performed medical record abstraction to validate
new variables. At MPCI, 731 ECPBs were conducted 2008–
2011, with a median of 2 jars per ECPB (range: 1–36). Jar
number was extracted from raw claims data and validated
through selected medical chart review. At MCRF, 902 ECPBs
were conducted 2008–2011, with a median of 3 jars per ECPB
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(range: 1–12). A jar number algorithm that partly includes
manual abstraction for some patients was developed and
validated through a systematic review of all identified biopsy
patients. Additional analyses linking jar number to patient
outcomes are ongoing.
Discussion: A two-site CRN pilot project was successfully
developed to investigate the association between jar number
for ECPB pathologic review and patient prostate cancer
outcomes. Combining VDW and raw claims data, we have
established a strong foundation for future research in this area.
Keywords: prostate biopsy, pathology
PS1-14:
Cost-Effectiveness of Taxanes in the Treatment of
Metastatic Breast Cancer: A Review of the Literature
Erika L. Estrada,1 Albert J. Farias,1 Janet Mora Marquez,1
Cecilia Portugal,1 Aniket A. Kawatkar1
1
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Background/Aims: Metastatic breast cancer (MBC) is
an incurable disease in which regardless of treatment, total
survival time is often less than a year. In these patients
suffering from MBC, mitigation of symptoms, reducing side
effects of therapy and enhancing quality of life are the major
issues in selecting a treatment. Taxanes have been shown to be
efficacious as single agents or in combination with other agents
as compared to other chemotherapy regimens. Docetaxel has
received more support over paclitaxel in many analyses that
have compared the two drugs indirectly. A direct comparison
of both docetaxel and paclitaxel has not been possible until
recently due to a lack of randomized trials. Little is known in
reference to cost-effectiveness of taxanes in the treatment of
MBC when compared directly. The objective of this literature
review was to assess cost-effectiveness literature comparing
docetaxel and paclitaxel in MBC.
Methods: PubMed was used to conduct a search for
manuscripts published 2005–2014. Search terms included
“metastatic breast cancer” in addition to “cost-effectiveness”
(n=96), “cost-utility” (n=9), “docetaxel” (n=332) and
“paclitaxel” (n=336). Only articles that included costeffectiveness analyses and a direct comparison among the
taxanes were included.
Results: A total of three cost-effectiveness studies were
identified and included in the final review. Two of the
three studies utilized data from a randomized controlled
trial. The cost-effectiveness analyses reported incremental
cost-effectiveness ratios (ICER) and quality adjusted lifeyears (QALY) and concluded that docetaxel, compared to
paclitaxel, was superior and improved QALYs by 0.33–0.75.
It is important to note that all three analyses were conducted
outside of the United States.
Discussion: In North America, breast cancer remains the
most frequently diagnosed cancer in women. Yet, there are
no new comprehensive economic analyses comparing the two
taxanes published recently in the United States. Literature
reflecting such comparisons has been published within the
United Kingdom, Spain and Canada (reflected in this review).
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However, with the prevalence for the disease growing, it is
important to continuously develop models assessing costeffectiveness among patients with MBC.
Keywords: cost-effectiveness, metastatic breast cancer
PS1-22:
Inability of Primary Care Providers to Predict
Medication Fulfillment of New Prescriptions
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Background/Aims: Physician prediction of patient
medication adherence to chronic therapy is unreliable, but the
accuracy of physician predictions is largely unstudied for new
prescriptions. Our aim was to determine if provider perception
of the likelihood a patient will pick up a medication is an
accurate predictor of primary medication nonadherence.
Methods: We conducted a prospective cohort study as part of
a randomized clinical trial. Providers at 24 primary care and
family medicine Geisinger clinics were asked to complete a
“best practice alert” (BPA) within the electronic health record
when placing an order for a new antihypertensive, antidiabetic,
antihyperlipidemic or antiasthmatic medication. The BPA
asked: “In your opinion, how likely is it that this patient will
pick up this medication?” The provider could select from
a 5-level Likert item with responses ranging from “very
unlikely” to “very likely.” Provider response was correlated
to the principle outcome variable, medication first fill after 14
days as identified from the records of the pharmacy to which
the prescription was transmitted.
Results: A total of 4,822 patients over 11 months were
included, and 4,532 (94%) patients filled their prescription
within 14 days. Providers answered the BPA 89% of the time.
Among respondents, most felt their patients would be likely
or very likely to pick up their new medication (90.6% vs.
86.8% of providers chose likely or very likely among adherent
and nonadherent groups, respectively). Only 10 (3.9%) of
new medication orders not filled (nonadherent) versus 110
(2.7%) filled (adherent) were suspected by providers to be
unlikely or very unlikely to be picked up, resulting in only
an 8.3% positive predictive value for primary medication
nonadherence.
Discussion: Our study suggests that physicians
overwhelmingly believe their patients are likely/very likely to
pick up their first prescription. A physician’s intuition about
a patient’s likelihood of filling a new medication does not
reliably identify patients who do not fill new prescriptions for
chronic medications. Our study’s ability to assess prediction
accurately is limited by the unusually high first-fill rate of
patients in this trial. Our findings are congruent with other
reports assessing physician perceptions of patient adherence
to chronic medications.
Keywords: primary adherence, prediction
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Consultation and Referral Patterns of Primary Care
Nurse Practitioners
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is supported by appropriate tools and technologies to facilitate
proactive population-based management. Operationalizing
these core principles into sustainable practice beyond mere
attainment of national recognition is still the subject of
intensive experimentation across many health systems,
including Kaiser Permanente Southern California (KPSC).
The aim of this study is to evaluate the effects of an enhanced
PCMH care model at one medical center in KPSC.
Methods: We will use a retrospective propensity-score
matched control design to compare changes in the primary
composite outcome of hospitalizations and emergency
department visits in the 12 months before and after AdvancedPCMH implementation. The care transformation included
changes to the structures, functions, roles/responsibilities of
the care team, workflows and processes of care; chief among
these changes was formalizing the role of a care navigator and
embedding social medicine resources and behavioral health
within primary care. Advanced-PCMH was implemented in
two primary care modules with 14 providers. A total of 300
patients who were high utilizers of hospital-based services in
the previous six months or at increased risk for use of hospitalbased services due to their utilization patterns in the previous
six months and patients who were 90 years of age or older were
enrolled. Approximately 600 patients will be selected from
five comparable primary care modules to serve as controls.
We also will measure level of exposure to Advanced-PCMH
care elements, standard quality-of-care processes, behavioral
and clinical outcomes, patient satisfaction, quality of end-oflife care, and perceptions of team functioning, satisfaction and
level of burnout by providers.
Results: We are in the process of extracting the data and will
have results available at the meeting in March 2015.
Discussion: Findings from this evaluation will inform future
efforts in our system to achieve the triple aim of better care
and outcomes at potentially lower cost.
Keywords: patient-centered medical home, evaluation

Background/Aims: The aims of the Primary Care Nurse
Practitioner Consultation & Referral Patterns study included:
a) determining the percentage of patients for which primary
care nurse practitioners (NPs) request referrals or formal
consultations; and b) exploring the patient, provider
and system characteristics associated with variation in
consultation/referral. Specifically, the project will contribute
to understanding the decision-making models for when and
how patients are referred by NPs to physicians and other
health care providers.
Methods: Primary care NPs who were individual members
of the American Association of Nurse Practitioners were
invited to participate in the study. During a 3-week period,
participants recorded summary data identifying: a) all the
patients seen on a particular day, b) the number of patients
seen by age category, and c) the type of patient visit. When any
visit occurs in which they initiate an informal consult, formal
consult or referral, the NPs recorded de-identified data to
describe the encounter, preferably at the time they completed
their routine charting after each of these encounters.
Results: Results are forthcoming. Data collection is ongoing
through September 30, 2014, and the analysis will be
completed by February 2015. Descriptive statistics will be
used to examine the distribution of key outcome and predictor
variables. Means and standard deviations will be computed
for continuous variables and percentages for categorical
variables. These data will be used to describe the study
participants, address the research questions and inform the
statistical analysis.
Discussion: Conclusions will contribute to understanding the
decision-making models for when and how primary care NPs
are consulting and referring.
Keywords: nurse practitioners, consultations, referrals

MENTAL HEALTH/CHEMICAL
DEPENDENCY

PS1-37:
Evaluation of an Advanced Patient-Centered Medical
Home Model at Kaiser Permanente Los Angeles
Medical Center

C3-1:
Smoking Prevalence and Use of Cessation
Medications Among Patients With Psychiatric
Disorders in an Integrated Health Care Delivery
System: A Case-Control Study

William N. Grice,1 Anthony L. Morena,1 Richard A.
Mehlman,1 Zakiya N. Devine,1 Huong Q. Nguyen,1
Ernest Shen,1 Angelika Clarke1
Kaiser Permanente Southern California

1

Background/Aims: Organizing cost-effective patientcentered care for individuals with complex medical and
social needs continues to be challenging for many health
care systems. The patient-centered medical home (PCMH) is
a popular model that emphasizes enhanced access to teambased comprehensive and coordinated care that actively
engages patients and their families in self-care and that which
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Kelly C. Young-Wolff,1 Andrea
Constance Weisner1
1

H.

Kline-Simon,1

Kaiser Permanente Northern California

Background/Aims: Although impressive gains have been
made in recent decades in reducing overall rates of smoking
in the United States, individuals with behavioral health
conditions continue to smoke at high rates and have limited
success with quitting. The current study tested whether
longitudinal disparities in smoking prevalence would also be
found among individuals with behavioral health conditions
in an integrated health care delivery system with convenient
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access to tobacco treatments.
Methods: This secondary analysis examined smoking
prevalence over four years in a subsample of Kaiser
Permanente Northern California patients diagnosed with
the five most prevalent behavioral health conditions (cases)
in 2010 (n=155,733): depression, anxiety, substance use
disorders, bipolar spectrum disorders, and attention deficit
hyperactivity disorders (ADHD). Nonbehavioral health
condition-matched controls were created for all unique cases
(n=155,733). Smoking status for each of the behavioral health
cases and matched controls was compared over a 4-year
period (2010–2013) using a logistic regression generalized
estimating equation model. Logistic regression analyses also
were used to compare tobacco cessation medication use in
2010 among smokers with behavioral health conditions and
smoking-matched controls.
Results: Participants with behavioral health conditions had
significantly higher odds of smoking over the 4-year period
compared to matched controls (P<0.001 for all). Patients with
substance use disorders and bipolar spectrum disorders had
the largest differences in odds of smoking relative to their
matched controls. Smoking prevalence decreased over 4 years
overall, but to a lesser extent among cases with depression,
anxiety, substance use disorders and bipolar disorder
compared to controls (P<0.001 for all). With the exception
of ADHD, smokers with behavioral health conditions were
significantly more likely than matched controls who smoked
to utilize tobacco cessation medications in 2010 (P<0.001 for
all).
Discussion: Similar to findings in the general U.S. population,
results from an integrated health care delivery system indicate
that smoking prevalence is decreasing at slower rates among
individuals with versus without behavioral health conditions.
Findings highlight the potential to address smoking among
disproportionately impacted groups within a health care
setting.
Keywords: behavioral health conditions, smoking prevalence
C3-2:
Removing Barriers to Preventive Care for People
With Serious Mental Illnesses: Preliminary Results
From the PRIME Study
Bobbi Jo H. Yarborough,1 Scott Stumbo,1 Micah T.
Yarborough,1 Carla A. Green1
Kaiser Permanente Northwest

1

Background/Aims: People with serious mental illnesses
(SMI) experience premature morbidity and mortality, largely
due to preventable conditions, and may not receive guidelineconcordant preventive care. Understanding modifiable factors
that produce health disparities among this population will
inform efforts to improve care delivery and reduce excess
mortality.
Methods: Interview and survey data was obtained from
primary care providers (PCPs) practicing in a not-for-profit
integrated health plan, Federally Qualified Health Centers and
safety-net clinics, and patients with SMI. Formative interviews
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with both groups explored approaches, experiences, barriers
and perceived effectiveness of preventive services for people
with SMI. Web-based surveys with PCPs (n=249; response
rate=51%) and interviews with patients diagnosed with
schizophrenia-spectrum disorders, affective psychosis or
mood disorders, followed formative interviews. Patient data
collection is ongoing (projected n=150).
Results: PCPs felt patients with SMI lacked future orientation
and interest in prevention and perceived that these patients
have too many needs and are seen too infrequently to affect
their health. For providers, lack of time was the most common
barrier to providing preventive care (89%). Providers felt
office visits were too short, particularly when patients were
experiencing psychiatric symptoms; 59% said psychiatric
stability greatly/moderately affected ability to provide
preventive services. Patients agreed visits were short but saw
symptoms as a barrier only when they interfered with making/
attending appointments or made providers uncomfortable.
Provider-patient relationships were a barrier if providers were
dismissive/rude. Patients mentioned appointment logistics
(e.g. scheduling, transportation), costs, avoidance and
forgetfulness as barriers. A lack of interest in prevention was
not supported among patients. Both groups mentioned lack of
time, lack of coordination with mental health providers, lack
of insurance coverage and lack of understanding insurance as
barriers.
Discussion: To increase preventive service use among
patients with SMI, patients need assistance overcoming
logistical barriers that prevent them from getting into the
office. Psychiatric symptoms can make it difficult to get in,
but once patients are in front of the PCP they are amenable
to prevention, particularly when recommendations come
from a provider who engages them. Providers need more
time, resources that support collaboration with mental health
providers, and some may need additional training to increase
their comfort with these patients and their confidence that
their recommendations can be effective.
Keywords: preventive services, serious mental illness
C3-3:
Diabetes Mellitus and Rheumatoid Arthritis Predict
Depression Disorder Diagnosis in Nonelderly Adults
in Primary Care Settings
Euijung Ryu,1 Alanna M. Chamberlain,1 Richard S.
Pendegraft,1 William V. Bobo,1 Jyotishman Pathak1
1

Mayo Clinic

Background/Aims: Depressive disorders (DEP) are often
comorbid with other chronic conditions. Bidirectional
associations between DEP and these conditions are poorly
understood. In this study, we aimed to identify chronic
conditions with the greatest influence on the DEP diagnosis.
Methods: A validated electronic health record-based
algorithm was applied to identify DEP patients receiving
primary care at Mayo Clinic between 2000 and 2013. Cases
were identified on the basis of having > 2 DEP-related ICD9 diagnosis codes, > 1 antidepressant prescription, and > 3
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mentions of in- or outpatient clinical notes for DEP. Controls
were matched on birth year (± 2 years), sex and outpatient
clinic visits at the same year. We ascertained 26 chronic
condition categories, as defined by Chronic Conditions Data
Warehouse, using the 5 years of medical records prior to the
DEP diagnosis. For each age group at diagnosis (60 years),
gradient boosting machine models were applied to estimate
relative influence (RI) of the chronic conditions on the DEP
diagnosis.
Results: A total of 11,219 DEP cases were identified (median
age at DEP diagnosis 44 years, 34% male and 89% white). The
proportion of subjects with at least one co-occurring condition
increased with older age and was higher in DEP cases
compared to controls (9.5% vs. 6.9% for subjects 60 years).
For subjects aged ≤ 45 years, diabetes mellitus (RI=19.6%)
was identified as the most influential condition contributing
to the risk of DEP, followed by asthma (RI=11.6%) and
rheumatoid arthritis (RI=11.0%). For subjects aged 46–60
years, the most influential condition was rheumatoid arthritis
(RI=13.2%) followed by diabetes mellitus (RI=12.9%).
For subjects older than 60 years, dementia (RI=10.7%) and
rheumatoid arthritis (RI=10.2%) showed similar relative
contribution to the risk of DEP.
Discussion: Among nonelderly adults who received primary
care at Mayo Clinic (2000–2013), diabetes mellitus and
rheumatoid arthritis were the strongest risk predictors for
a diagnosis of depression among 26 chronic conditions
considered. Our results suggest that certain chronic conditions
may play a role in exacerbating, precipitating or increasing
longitudinal risk of medically significant depression.
Keywords: depression, electronic health record
C3-5:
Single-Item Screens for Prescription and Illicit Drug
Misuse Largely Identifies Primary Care Patients
With Unrecognized Drug Use
Katharine A. Bradley,1 Gwen T. Lapham,1 Ryan Caldeiro,1
Larry Marx1
Group Health Cooperative

1

Background/Aims: The U.S. Preventive Services Task Force
recommends depression and alcohol screening as part of
routine primary care, but not drug screening because brief
primary care counseling about drug use does not improved
outcomes. However, drug screening might be helpful if it led
to identification and treatment of patients with unrecognized
substance use disorders. The objective was to describe
the prevalence of positive drug and marijuana screens in a
primary care population and whether patients who screened
positive had previously recognized substance use disorders.
Methods: We conducted a 3-week feasibility test of universal
depression and alcohol misuse screening in one primary care
clinic as a prelude to behavioral health integration. Providers
asked that we also screen for illicit drug and marijuana use
(the latter was legal in Washington state). A total of 409
(61%) of 667 patients who were seen in the primary care
clinic for a 3-week period completed a one-page behavioral
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health questionnaire that included brief depression (PHQ-2),
alcohol misuse (AUDIT-C), drug (validated single-item) and
marijuana screens. The latter was adapted from the singleitem drug screen.
Results: Of 409 patients who completed screening (68%
women; 10%, 17%, 43% and 31% age <30, 30–44, 45–64 and
≥65 years, respectively), 4% screened positive for past-year
prescription or illicit drug use, 13% reported marijuana pastyear use (3% daily or almost) and 16% screened positive for
alcohol misuse. Among the 16 patients who screened positive
for drug misuse, 4 (25%) reported daily drug misuse, and 7
(44%) screened positive for alcohol misuse. Only 1 (6%) of
the 16 patients who screened positive for drug misuse had a
prior diagnosis of a substance use disorders (but not in the
past year). However, 38% had been prescribed opioids and
13% benzodiazepines in the past year (38% either). Providers
found drug screening valuable as they had been previously
unaware of most patients’ drug use.
Discussion: Most patients who screened positive for illicit or
prescription drug misuse did not have recognized substance
use disorders. Findings suggest that routine screening with
single-item drug and marijuana screens provide important
clinical information for primary care teams.
Keywords: drug misuse, preventive screening
PS1-32:
The Utilization of the Search Function of the Scoring
Website for the Handbook of Normative Data for
Neuropsychological Assessment for Research of
Underserved Populations
Katherine W. Smith,1 Ariella Benji,1 Nardos Bellete,1
Payam Kharazi,1 Hussah Al-Kharafi,1 Rodger Questin,1
Marcia Nimmer,1 Paula Cedillo,1 Enrique Lopez1
Cedars-Sinai Medical Center

1

Background/Aims: Clinicians and neuroscience researchers
are still faced with the cumbersome task of searching through
handbooks, journals and online databases to search for
neuropsychological norms when assessing individuals on
neuropsychological measures, specifically those from diverse
populations.
Methods: In order to make the acquisition of
neuropsychological normative data more simple and efficient,
and to increase the validity of appropriate neuropsychological
measures for specific populations, the Handbook of Normative
Data for Neuropsychological Assessment (Mitrushina et al.,
2005) has now been computerized and is easily accessible
online. A specific search function (http://npnorms.com/
search) in the computerized database allows a clinician to
input demographic information (e.g. age, education, gender
identity, country of origin and language) to determine
what norms are available for some of the most common
neuropsychological measures used (e.g. Trail Making Test,
Color Trails Test, Stroop, Grooved Pegboard and Wisconsin
Card Sorting Test).
Results: This newly developed, Internet-based program
allows the examiner to fill in demographic information to find
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the appropriate measures to administer to a specific client.
Additionally, this Internet tool can be utilized for research
purposes in determining where important normative data is
lacking for at-risk individuals.
Discussion: Since all information is consolidated in one
location and consistently updated to reflect available research
on culturally appropriate measures and normative data, this
is particularly useful and efficient for neuroscientists who
are both conducting research and are providing clinical care,
particularly those who see underserved minority groups.
Keywords: neuroscience, cognition

PATIENT-CENTERED OUTCOMES
RESEARCH/PATIENT AND
STAKEHOLDER ENGAGEMENT
D4-1:
Best Practices in Patient Engagement in Research:
Creating an Engagement Checklist
Sarah D. Madrid,1 Leslie A. Wright1
Kaiser Permanente Colorado

1

Background/Aims: With the establishment of the PatientCentered Outcomes Research Institute in 2010 and
subsequent explosion in recognition of the importance of
patient perspectives in research to improve patient decisionmaking and health outcomes, patient engagement in research
is an increasingly critical aspect of the research process. The
HMORN Patient Engagement in Research Scientific Interest
Group (PER SIG) was established to improve the ability
of member organization research teams to effectively and
meaningfully engage patients and other stakeholders in the
continuum of research, from developing appropriate research
questions to disseminating research findings. One of the 2014
goals for the PER SIG was to create an engagement checklist
to guide research teams in planning and recruiting for patient
engagement, and provide best practices for their engagement.
Methods: We created a comprehensive questionnaire
encompassing all aspects of the engagement process,
including prompts for intentionality/justification for
engaging patients, patient roles and stages of participation,
logistical details and planning, human resource issues (e.g.
compensation, contracts), IRB oversight, recruiting, training
for patient and research team members, communication plans,
and engagement monitoring and evaluation. We fielded our
web-based survey to all members of the PER SIG and other
research colleagues with experience engaging patients as
members of research teams.
Results: We received 23 responses to the survey. From the
results and comments provided, we created a draft checklist
of items and practices critical to the engagement process. This
draft was vetted by PER SIG members and discussed at a
monthly PER SIG conference call, then finalized as a “working
draft.” Broader dissemination is currently underway, and
this abstract, leading to further dissemination at the annual
meeting, is one goal of the dissemination plan.
Discussion: Patient engagement in research is a complex
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process requiring thoughtful planning and preparation as
well as continued monitoring and evaluation throughout the
life of the research project. The patient engagement checklist
provides research teams with guidance for each step of the
process, promoting use of best practices and encouraging
meaningful engagement of patients as members of the
research team.
Keywords: patient engagement, patient-centered outcomes
research
D4-2:
Building Infrastructure to Engage Patients, Families
and Members in Research Within a Learning Health
Organization
Jane E. Duncan1
HealthPartners

1

Background/Aims: HealthPartners is the largest consumergoverned nonprofit health care organization in the country,
with a mission “to improve health and well-being in
partnership with our members, patients and community.”
We strive to have members, patients and families (PFM)
experience us as a trusted partner, and have engaged over 30
advisory groups across the enterprise. The HealthPartners
Institute for Education and Research is an integral arm of
the HealthPartners learning health organization. One of the
institute’s key goals is to develop strategy, processes and tools
to engage PFM in all aspects of patient-centered outcomes
research (PCOR).
Methods: Institute leadership prioritized the development
of an infrastructure to support PFM engagement in research.
A stakeholder group of three senior investigators and the
Strategic Programs Manager led the effort to align with the
larger HealthPartners strategy. Other resources included
HMORN’s patient engagement scientific interest group,
the Institute for Patient- and Family-Centered Care, the
Patient-Centered Outcomes Research Institute, and the Park
Nicollet Medical Group, which had recently merged with
HealthPartners. The HealthPartners compliance, legal and
finance teams advised on appropriate security and privacy
training and financial issues. The IRB provided guidance on
appropriate review and approval. Investigator team leaders
were interviewed to identify priorities and gaps. Finally, a
discussion was held with a patient advisory group currently
serving on a PCORI-funded grant led by Dr. Leif Solberg.
Results: By joining the HealthPartners core PFM strategy
team, the institute has access to a full inventory of PFM
partnerships across the enterprise. A defined process and
toolkit were created to recruit, interview and onboard PFM
partners. Formal job descriptions and contract templates
are available. A compliance guide that defines privacy and
security training has been created and approved. Training for
investigators and project managers will be held to share tools
and best practices. The process will be piloted in an upcoming
PCORI submission.
Discussion: Engaging PFM at all levels of the HealthPartners
organization, including Research, is one of our core values.
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By designing tools and practices that have been vetted and
easily adapted, we hope to streamline the process of involving
these valuable partners in research.
Keywords: patient engagement, best practices
D4-3:
Developing a Patient-Facing Report for Delivering
Results After Whole Genome Sequencing
Alanna Kulchak Rahm,1 Janet L. Williams,1 Audrey
L. Fan,1 Heather L. Stuckey,2 Doris T. Zallen,3 Jamie
Green,1 Michele Bonhag,1 Lynn Feldman,4 Michael
Segal,4 Marc S. Williams1
Geisinger Health System; 2Penn State Hershey College
of Medicine; 3Virginia Tech; 4SimulConsult Inc.
1

Background/Aims: Genome sequencing is emerging into
clinical practice, raising a number of issues for delivery
systems. One question is how genomic results can be made
available wherever the patient receives care. The purpose
of this research is to develop a patient-facing genomic
laboratory report with advanced functionality including
point-of-care education and clinical decision support. Report
development utilized providers and parents of affected
patients to provide feedback on the desired report elements
to maximize usability.
Methods: The research team, including a patient investigator
and experts in patient engagement and communication,
developed a draft report. Study participants were parents of
children with undiagnosed cognitive disability undergoing
genome sequencing as part of a larger clinical research
study. Semistructured interviews were conducted to elicit
prior experience with genetic test results and feedback
about the draft report. Based on feedback, subsequent focus
groups were conducted to elicit comments on specific report
elements presenting inheritance and prognostic information.
Recordings of interviews and focus groups were transcribed
and analyzed using the conceptual framework of existential
phenomenology, which favors the interpretation of meaning
through subjective experiences.
Results: Participants endorsed the importance of having a
report created for patients and family. In particular, they noted
desire to read and re-read the report and to have a record
of what was discussed. The draft report was found to be
informative and written at an appropriate level. Focus groups
reviewed and ranked four different options for presenting
prognostic information. Important themes for this specific
information were seeing how the condition may change over
time and information on support and additional action steps
to take.
Discussion: Participants value a report created for them.
The interview and focus group participants are informing
the creation of a report that will be used in the comparative
effectiveness portion of the larger project to provide actual
results of whole genome sequencing.
Keywords: patient engagement, genome sequencing
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D4-4:
Partnering With Patient Advisors in the PORTAL
Clinical Data Research Network
Carmit K. McMullen,1 Maureen H. Rumptz,1 Ameerah
Thomas,2 Julie N. Harris,2 Stephanie R. Prausnitz,2
Carol P. Somkin2
Kaiser Permanente Northwest; 2Kaiser Permanente
Northern California

1

Background/Aims: PORTAL, composed of Kaiser
Permanente, Group Health Cooperative, Health Partners
and Denver Health, is a PCORnet network focusing start-up
efforts on identifying what matters most for patients with
obesity, colorectal cancer and congenital heart disease (three
cohorts) and building capacity to conduct patient-centered
research to address those priorities. This presentation
will describe the Patient Engagement Council (PEC) and
an associated Online Advisor group guiding PORTAL’s
development.
Methods: The PEC is composed of 10 patients representing
each of the cohorts as well as three representatives from
cohort-specific advocacy organizations. PEC members
attend an in-person meeting for orientation/team-building
and subsequently offer guidance through 10 webinars,
emails and conference calls. PORTAL seeks PEC members’
input about how to engage patients in research, identify
research questions and methods that matter to patients, and
facilitate communication between PORTAL and broader
audiences. Eighteen online advisors are being recruited to
help PORTAL establish three cohort-specific online Smart
Patients communities –– where patients and caregivers learn
from each other about the latest science, treatments and
patient concerns. Online advisors work with Smart Patients
to identify key topics and develop early content for the online
communities’ discussion boards.
Results: Eligible members were identified within each
health system through clinical and operational liaisons
and were then interviewed by PORTAL staff. Selected
candidates were invited to join as PEC members or online
advisors. All of the PEC members have been recruited,
completed the orientation, and participated in the first
webinar focused on cohort-specific survey questions/modes
of survey administration. The successes and challenges of
recruitment, hosting in-person and online meetings, and
PEC contributions to PORTAL’s start-up phase will be
presented. Prior to the conference, all 18 online advisors
will have been recruited and completed their work setting
up online communities. The benefits and challenges of
engaging online advisors will be presented and the online
communities will be described.
Discussion: This presentation of the process and initial
outcomes of engaging patients in the development of a large
multisite network will have broad significance as a model for
engaging patients in research network development.
Keywords: patient engagement, patient-centered outcomes
research
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D4-5:
Engaging Patients as Stakeholders to Foster More
Open Communication With Primary Care Providers
Cheryl D. Stults,1 Ellis C. Dillon,1 Amy Meehan,1 Judith
Chuang,1 Ming Tai-Seale1
1

Palo Alto Medical Foundation Research Institute

Background/Aims: The philosophy of the Patient Centered
Outcomes Research Institute (PCORI) is to “do research
differently” by involving patients throughout the research
process. By leveraging an existing resource of a senior “aging
in place” community, we recruited patients to be stakeholders
and help develop an intervention to create more open
communication between primary care providers and patients.
This was one of our initial forays into engaging patients as
stakeholders. We wish to share our experience on the patient
engagement journey.
Methods: A reflexive, qualitative summary of our
observations on the process of engaging patient stakeholders
during all phases of a research study.
Results: Five patient stakeholders, all older retired
individuals, participated through all stages of the research
process, attending regular stakeholder meetings and events
and responding to impromptu requests by email or phone.
Our patient stakeholders were an important part of the
construction of the study materials, a visit companion booklet
and a postvisit survey, and we featured their pictures and
comments on the back of these tools so that study participants
could better relate to their experience. One stakeholder was
a former marketing professional who was instrumental in
helping us formulate and sharpen the language and delivery
of the intervention. When we encountered study recruitment
problems, we held a patient stakeholder meeting to seek
their advice. They provided us with suggestions that we
incorporated into our workflow.
Discussion: Expanding the relationship between patients
and researchers was easier than expected and yielded a great
improvement on the design and conduct of this research study.
Engaging patient stakeholders was not only invaluable for the
researchers but also created a reciprocal relationship. The
researchers were asked by patient stakeholders for guidance in
their own projects, e.g. in one case a patient asked the research
team to help her plan an advance care planning workshop at
a senior center. Our older retired patient stakeholders are not
representative of all patients, but their availability allowed
them to share their cumulative wisdom and insights –– not
only as patients, but also as resourceful professionals –– with
the research team.
Keywords: patient engagement, patient-centered outcomes
research
PS1-15:
A Systematic Review of the Measurement Properties
of the European Organization for Research and
Treatment of Cancer QLQ-BR23 Quality-of-Life
Instrument

Supplement

Janet Mora Marquez,1 Albert J. Farias,1 Cecilia Portugal,1
Erika L. Estrada,1 Aniket A. Kawatkar1
1

Kaiser Permanente Southern California

Background/Aims: The objective of this literature review
was to analyze the measurement properties of the European
Organization for Research and Treatment of Cancer’s
(EORTC) breast cancer-specific quality-of-life questionnaire
(QLQ-BR23).
Methods: A PubMed search was conducted using the search
terms “breast neoplasm,” “quality of life,” and “EORTC”
to identify all the articles using the EORTC QLQ-BR23
questionnaire. The search was limited to studies published in
the English language from 2005 to 2014. Articles were also
searched on HEALTHSTAR and Google Scholar Search and
the websites of organizations like the Centers for Disease
Control and Prevention, the National Cancer Institute and the
EORTC Quality-of-Life group. This study primarily focused
on articles looking solely at measurement properties such as
discriminative and evaluative properties, reliability, validity
and interpretability of the EORTC QLQ-BR23 instrument.
Articles that did not report any measure of reliability, such
as intraclass correlation coefficient or Cronbach’s alpha, were
excluded from the review.
Results: Of the 101 articles obtained from the initial
search, 18 were relevant and 15 met the inclusion criteria.
The QLQ-BR23 instrument had suitable face and content
validity. Of those 15 articles that met the inclusion criteria,
only 6 established support for convergent-divergent validity.
Acceptable convergent-divergent validity was seen in the
body image, sexual functioning, systemic therapy side effects,
breast symptoms and arm symptoms domains. Construct
validity for all domains was supported using the method of
known groups in 3 culturally diverse populations when the
QLQ-BR23 was used as a discriminating tool. Overall, the
instrument exhibited high internal consistency in the diverse
populations. Reliability, interpretability and evaluative
properties were inadequately studied in the published studies.
Discussion: The EORTC QLQ-BR23 instrument is proven to
be valid cross-culturally and readily accepted as having high
internal consistency. Consequently, it is a suitable instrument
for measuring patient-reported outcomes in breast cancer
patients. It has good discriminative properties, but evaluative
properties need more empirical support. Considerations for
future research may include using the QLQ-BR23 module in
studies designed to better assess the instrument’s evaluative
properties.
Keywords: EORTC QLQ-BR23, quality of life
PS1-18:
A Pharmacy Counseling and Postdischarge
Intervention to Improve Initial Adherence for HighRisk Medications
John E. Zeber,1 Disha Shah,1 Angel Trieu1
1

Scott & White Health System
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Background/Aims: Poor medication adherence to potentially
life-saving prescriptions frequently inhibits appropriate
treatment and outcomes, particularly concerning new drugs
following hospital discharge. Yet such initial adherence
signals an opportunity to implement effective patient-centered
care, balancing clinical objectives with patient health beliefs
and other considerations. Within quality improvement efforts
of a pharmacy counseling program for high-risk medications,
we utilized a short adherence questionnaire and follow-up
contact with patients to determine factors associated with
initiating anticoagulant regimens.
Methods: Consecutive adults discharged from Scott &
White Hospital between February and December 2013
receiving new prescriptions for Plavix, Effient, Brilinta,
Pradax, Xarelto or Coumadin were recruited. Per program
guidelines, a pharmacist counseled inpatients concerning their
prescriptions, discussed benefits and side effects, and helped
resolve immediate adherence problems. Individuals were
next administered a validated 3-item Likert instrument as a
brief, proximal screener for adherence propensity targeting
specific barriers on medication trust, perceived effectiveness
and out-of-pocket drug costs. Following consent, participants
were contacted within 3 days to provide demographics and
confirm they filled initial prescriptions, commenced treatment
and intended to remain adherent. If not, self-reported reasons
for not taking medications were solicited. Descriptive and
bivariate analyses documented associations between patient
characteristics, perceived barriers, and upon initial adherence
behavior.
Results: Slightly over half of the 101 patients contacted (96%
response rate) were prescribed Plavix, with other medications
equally distributed; participants averaged 70.1 years, were
60% male, 26% minority and 12% uninsured. The mean
medication trust score was 4.7 (of 6), indicating positive drug
perceptions, as did the 4.8 average for gauging prescription
importance. However, mixed experiences were reported
for personal drug costs (3.6 mean). 94% both filled initial
prescriptions and intended to keep taking them. Minimal
self-reported barriers included costs or forgetting to visit the
pharmacy, yet far greater numbers enthusiastically supported
the counseling program and follow-up contact.
Discussion: While the brief screening instrument did not
identify patients likely to experience adherence problems
(costs excluded), the predischarge counseling program
exemplifies a successful transition engagement as patients
initiate essential treatment. Since prior work demonstrates
that highly activated individuals adopt better self-care
behaviors, including adherence, such educational patientcentered interventions can promote healthier decisions and
better outcomes.
Keywords: medication adherence, transition counseling
PS1-25:
Assessing Current Practices in the Evaluation
and Treatment of Acute Sinusitis: A Comparison
of Primary Care, Urgent Care and Emergency
Department Care
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Adam L. Sharp,1 Marc Klau,1 David Keschner,1 Eric
Macy,1 Tania Tang,1 Ernest Shen,1 Corrine MunozPlaza,1 Michael Kanter,1 Matthew A. Silver,1 Brian
Mittman,1 Michael K. Gould1
Kaiser Permanente Southern California

1

Background/Aims: Acute sinusitis (AS) affects 1 in 7
adults and costs over $5.8 billion annually. As part of the
American Board of Internal Medicine’s Choosing Wisely
campaign, three organizations make recommendations
regarding appropriate sinus imaging and antibiotics for
uncomplicated AS. The extent to which AS recommendations
are followed is unknown; our aim is to measure adherence
with recommendations for AS and to compare AS encounters
in primary care (PC), urgent care (UC) and emergency (ED)
departments.
Methods: A retrospective, observational study of AS
care using structured data from electronic health records,
complemented by more extensive chart review in a smaller
subsample of encounters. All immunocompetent adults
with an initial AS encounter (ICD-9 code 461.x) from 2010
to 2012 were included. Primary outcomes (structured data)
were filled antibiotic prescriptions and the performance of a
face, head or sinus computerized tomography (CT) scan, and
secondary outcomes (chart review) were length of symptoms
and adherence to AS recommendations.
Results: The median age of patients was 46 (interquartile
range: 34–58), 67.5% were female and the mean Elixhauser
comorbidity score was 1.5 (±1.6 standard deviation). Of
152,774 AS encounters (77% PC, 22% UC and 1% ED),
89.2% resulted in a filled antibiotic prescription and 1.1% in a
CT scan. Compared with the PC setting, UC encounters were
more likely to result in antibiotics (adjusted odds ratio [OR]:
1.12, 95% confidence interval [CI]: 1.08–1.17) or obtaining
a CT scan (adjusted OR: 2.4, 95% CI: 2.1–2.7, and ED
encounters were less likely to result in antibiotics (adjusted
OR: 0.57, 95% CI: 0.50–0.65) but more likely to result in a CT
scan (adjusted OR: 59.4, 95% CI: 51.3–68.7). Chart review of
300 encounters resulting in antibiotics determined that 50%
were for symptoms ≤ 7 days (95% CI: 41–58%) and 35% for
symptoms ≥ 14 days (95% CI: 27–44%). Only 29% (95% CI:
22–36%) of encounters resulted in guideline adherent care
(30% PC, 26% UC, 16% ED).
Discussion: Among adults with AS in a large, integrated
health care system, CT imaging is infrequent but antibiotic
treatment is common, even for uncomplicated cases with a
short duration of symptoms.
Keywords: acute care improvement, low-value care
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Background/Aims: Funding agencies like the PatientCentered Outcomes Research Institute (PCORI) are
requiring that health-related research engage patients
in new and more integrated ways, such as employing
patient co-investigators. HMORN researchers have
often engaged patients in an advisory capacity and are
now expanding ways to collaborate. This work builds
on Kaiser Permanente Colorado’s Institute for Health
Research Member Engagement Toolkit and the HMORN
Patient Engagement in Research (PER) Interest Group’s
environmental scan of tools, practices and gaps. The aims
of our project are to: 1) develop a toolkit to recruit, hire
and orient patient researchers and their research teams, and
2) develop patient community forums to solicit ideas about
patient-centered research projects.
Methods: We will conduct semistructured interviews
with PCORI research teams, delivery system partners and
members of the PER Interest Group. Feedback from these
interviews will be used to adapt existing tools or develop
new ones to recruit, hire and orient patient investigators and
their teams. To develop patient forums, we will work with
Group Health’s Governance Services, Communication and
Clinical Improvement and Prevention departments to utilize
existing communication methods and/or create new ones. We
will pilot test and evaluate the usability of the resources with
project teams submitting new grant proposals.
Results: We will present preliminary insights from these
interviews and initial work on forum development. Our
presentation will be aimed at both generating additional
discussion and feedback and helping apprise the field of
practices that are cutting edge in this area of health services
research. Already, Group Health teams working on PCORI
projects have learned valuable lessons about the benefits
of partnering with patient investigators, “They ask great
questions and they have blown our assumptions out of the
water.” We also have learned about important barriers,
“Computer skills or knowledge of human subjects research
should not be assumed.” Our project builds on this experience
to improve our capacity to collaborate with patient research
partners.
Discussion: The HMORN is well-positioned to be a leader in
patient-centered outcomes research. This project builds on the
experience, existing resources and current partnerships within
the HMORN to develop innovative and proactive patient
engagement infrastructure for health research and evaluation.
Keywords: patient engagement, toolkit
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Background/Aims: Successful pragmatic trials require close
partnership between researchers and health care organizations.
We describe the process by which we engaged clinical and
operational leaders from three Kaiser Permanente (KP)
regions to design a trial to test alternative population-based
models for diabetes prevention.
Methods: The study leveraged ongoing efforts in each
region to develop a populationwide approach to diabetes
prevention. Working with clinical leaders from KP Northwest
(KPNW), we designed an initial study that we then took to the
leadership of KP Southeast and KP Hawaii. We also obtained
the endorsement of KP’s national Care Management Institute
(CMI). After submitting a successful letter-of-intent to the
Patient-Centered Outcomes Research Institute, we worked
with our health plan partners to develop a full proposal that is
presently under review.
Results: Throughout the proposal development process, we
consulted key regional and national health plan stakeholders
on various design issues. We also included the KPNW lead
for diabetes management as a full co-investigator and regular
member of our weekly planning meetings. As a direct result
of these interactions, we dropped our initial three-arm design
in favor of a two-arm design because it became clear that our
planned low-intensity arm would likely be obsolete by the time
the grant was funded. We also decided to focus our study on those
at highest risk for progressing to diabetes since this was where
the organization clearly intended to focus its greatest energy.
Finally we leveraged an ongoing demonstration project being
coordinated by the CMI to evaluate an online diabetes prevention
curriculum that was seen as a scalable model for providing a
proven lifestyle change program to our members nationwide.
We incorporated this program into our intervention design and
conducted interviews with patients to better understand their
perspective regarding the overall usefulness of the program and
barriers to participation. To meet the needs of members who
preferred face-face classes, we also partnered with local diabetes
programs in our communities to provide this option.
Discussion: Our process of stakeholder engagement directly
informed the design of the trial and helped to ensure strong
institutional support for the study should it be funded.
Keywords: pragmatic trials, stakeholder engagement

STATISTICAL AND RESEARCH
METHODS
D2-3:
Increasing Efficiency in Creating High-Level
Site Comparisons and Populating Cohort Flow
Diagrams: The “Cohort Diagram” Macro
Heather M. Tavel,1 Nikki M. Carroll,1 Heather S.
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Background/Aims: Understanding how a population is
selected for an analysis is necessary for understanding
potential sources of bias. Searching logs to determine counts
for key steps of the process is cumbersome, and re-ordering a
flow diagram after all data have been collected is problematic.
We developed two tools at Kaiser Permanente Colorado
(KPCO) for capturing counts during cohort creation, one of
which was refined through a Center for Effectiveness and
Safety Research study. These tools are used for comparing
similarities and differences in data flowing from multiple
health plan sites, for quality assurance, and for populating
cohort diagrams for presentations and manuscripts.
Methods: A macro was created with parameters to define
a source data set, an output table to hold counts and a step
description. An alternate and complementary method of
collecting counts was also developed that consists of building
a table at the individual level with Boolean flags for each
criterion used in cohort selection, which is then summarized
into an n-way de-identified frequency table.
Results: The count macro method allows for users to collect
any count at any time during the process. Users also specify
whether to count rows of a table or distinct values of a
specific variable. Multiple output data sets may be used to
capture different data flows, such as one dataset for a cohort
diagram and another to check for other key quality assurance
counts. Tables returned from sites can readily be combined
and compared to assess heterogeneity across sites. The n-way
frequency table method, while CPU-intensive for large cohort
processes, allows for maximum flexibility in the ordering
of a cohort diagram. It also adds an extra layer of quality
assurance, particularly when paired with a cohort diagram
table built using the count macro.
Discussion: These tools have been shared within the KPCO
analytic team to aid in data collection and cohort diagram
development. They are simple to implement, applicable in
distributed data environments and reusable across projects.
Reviewing the tables prior to requesting further data can
prevent data reruns. Other sites and projects will benefit from
increased efficiency by using these tools.
Keywords: quality assurance, programming efficiencies
PD2-10:
Characterizing Longitudinal Patterns of Breast
Cancer Care
Caroline A. Thompson,1 Harold S. Luft1
1
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Background/Aims: Cancers with high rates of survival, e.g.
breast cancer, are often characterized by treatment periods, or
episodes of care, that can continue intermittently for months
or years. The effective beginning of a cancer care episode may
precede the date a patient obtains a definitive diagnosis. The
peridiagnosis phase is often a time of intense resource use that
may involve patients seeking care or physician opinions at
multiple health care organizations. After the initial episode
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of treatment, which may involve multiple interventions and
cycles, routine posttreatment surveillance may continue
indefinitely. Considering the extended length of breast cancer
treatment and follow-up, the electronic health record (EHR)
for one or more organizations may reflect only part of the
long-term care of these patients. In this study we characterize
longitudinal patterns of breast cancer care across two health
care organizations using a linked EHR database.
Methods: We studied a cohort of 13,377 women with evidence
of some breast cancer care, 2000–2013. We distinguished
breast cancer-related treatment from other types of care,
e.g. diagnosis, second opinions, surveillance. We developed
an algorithm to define the customary cancer care periods
(routine screening, peridiagnosis, treatment, posttreatment
surveillance). We determined number of care episodes for
each patient and classified each patient as receiving care at
either or both of the health care organizations.
Results: Care period classification identified a subsample of
7,365 patients who received treatment for breast cancer, the
rest of the cohort were seen only for diagnosis or posttreatment
surveillance. Among those treated, 17% had more than
one treatment episode and 16% of patients sought care at
both organizations. We present details of our classification
algorithms and other key findings.
Discussion: By examining specific components of the cancer
care episode, we can assess whether breast-related services
were provided concurrently or sequentially, and before,
during or after the initial diagnosis period. Categorizing
cancer-related services by purpose and time offers valuable
insights into how care is organized and delivered.
Keywords: electronic health records, care patterns
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Increasing the Efficiency of Presenting Study
Population Descriptive Characteristics: The “Table
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Background/Aims: Basic characteristics of a data set or
cohort are often described using a “Table 1.” Numerous
iterations of this table can be required before the final product
is satisfactory. Reproducing this table multiple times can
become onerous and increases the chance for data entry
errors. Some programmers create their Table 1 through the
output delivery system (ODS) in SAS and some output data
into Excel. A recently funded Center for Effectiveness and
Safety Research project supported us in developing macros to
create a “Table 1” macro that can easily accommodate format
and content changes and output data in either ODS or Excel
format.
Methods: The Kaiser Permanente Colorado analytic team
developed two different macros for creating “Table 1,” one
for frequencies, means and p-value output through ODS into
a pdf or rtf file and one for frequencies and means output
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into an Excel file. We describe the features, advantages and
disadvantages of each macro.
Results: By converting the Table 1 development process
into a macro, we have increased the efficiency of producing
and reviewing the results of descriptive analysis while at the
same time facilitating different examinations of the data.
Both macros have the flexibility to present typical descriptive
statistics, such as frequencies, means and comparative
p-values. Output from ODS produces a table that is ready to
distribute without additional manipulation by the programmer.
However, it can be challenging to set up the macro variables
correctly. An advantage for the Excel output macro is ease of
use, whereas some disadvantages include the time required
to format the spreadsheet after data are exported into Excel
and moving data into the correct fields. These macros are
durable in that they can be applied across multiple projects
and variables can be customized for any Table 1 analysis.
Discussion: These macros increase the efficiency of producing
and reviewing descriptive analyses and reduce errors that can
be introduced from data entry and creating tables de novo.
Future work includes combining the macros so that the user
can choose the preferred output destination.
Keywords: descriptive statistics, macros

(8%, P<0.01). Assuming no underreporting, there was an
87% greater relative odds of admission associated with
schizophrenia (odds ratio: 1.87; 95% confidence interval:
1.08–3.23). In the Bayesian approach, assuming varying
sensitivities, effect sizes were 2–3% lower with credible
interval smaller (reduced by 2–4%) than that observed with
the classical approach.
Discussion: A delayed diagnosis of schizophrenia can lead to
inappropriate treatment and symptom exacerbation, increasing
the risk of hospitalization. In the Bayesian approach, reduced
association between hospitalization and schizophrenia, as
well as other SMIs, was uniformly observed across varying
rates of underdiagnosing, meaning prompt diagnosis should
lead to lower rates of hospitalization. Although effect
sizes may vary across health care systems, the analytical
approach has useful applications in other contexts where
the identification of patients with a given condition may be
subject to underreporting in administrative records.
Keywords: underdiagnosis, Bayesian analysis
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Background/Aims: Schizophrenia is a debilitating serious
mental illness (SMI) characterized by a complex array of
symptoms. Patients tend to seek treatment only intermittently,
contributing to difficulty in diagnosing the disorder. A
misdiagnosis may potentially bias and reduce the validity of a
study based on recorded diagnoses. It also may impact patient
outcomes by delaying receipt of appropriate care. Thus, we
present a statistical model to compare the odds of 1-year
hospitalization among patients with schizophrenia versus
patients with or without other SMIs when schizophrenia is
underreported in administrative databases.
Methods: A retrospective study design examined patients
seeking care during 2010 in one of 19 care-and-coverage
health systems across the United States comprising the Health
Maintenance Organization Research Network (HMORN).
Bayesian analysis was applied to address the problem of
underdiagnosed schizophrenia using a statistical measurement
error model that explicitly evaluated the impact of varying
assumptions about the extent of underreporting. Results were
then compared to a classical multivariable logistic regression
model.
Results: Among 87,806 patients, 7.3% had a SMI, including
114 (1.3 per 1,000) diagnosed with schizophrenia. Admission
was greatest among patients with schizophrenia (14%),
followed by other SMIs (12–13%) and non-SMI patients
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Background/Aims: HMORN institutions are geocoding
their patients in a variety of ways with a variety of tools.
Neighborhood data from the Census Bureau and American
Community Survey can then be used as proxies for data that is
not captured, such as socioeconomic status. We are interested
in understanding how variation across institutions can affect
estimates and variances.
Methods: Descriptive statistics. Comparison of simple linear
models with mixed models (i.e. hierarchical linear models or
latent variable models).
Results: Results are forthcoming.
Discussion: Conclusions to follow.
Keywords: census, geography
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Using HMORN’s Virtual Data Warehouse From
Two Health Systems to Identify Risk Factors for
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Background/Aims: Abdominal aortic aneurysm (AAA) is a
leading cause of death in the United States, often undetected
until rupture. At least 33% of ruptured AAA hospitalizations
are among women, and 22% of AAA-related deaths occur in
nonsmokers, individuals not covered by current screening
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guidelines. Identifying additional risk factors for AAA would
allow for targeted screening of a larger at-risk population. We
conducted a retrospective study of electronic health record and
claims data from the HMO Research Network’s (HMORN)
virtual data warehouse (VDW) in two sites: Geisinger Health
System (GHS) and Essentia Institute of Rural Health (EIRH).
Methods: We used an algorithm that includes CPT and ICD9
codes to classify individuals in the VDW as cases, controls
or excludes. This algorithm had a positive predictive value
of 94% and sensitivity of 100%. We extracted demographic,
behavioral and clinical covariates, including comorbidities
such as peripheral artery disease, diabetes, neoplasms, and
pulmonary, kidney and cerebrovascular diseases. Individuals
were excluded based on age, no visit in 5 years, genetic
conditions or unspecified aneurysm site.
Results: We identified 2,133 AAA cases and 130,289 controls
from GHS and 1,986 cases and 196,534 controls from EIRH.
Risk factors were similar in direction and magnitude of effect
and level of significance across sites, including the novel
association of benign neoplasms with AAA.
Discussion: We leveraged the VDW to efficiently demonstrate
the transportability of an algorithm for identifying AAA
patients, expanding the sample size for studying AAA risk,
and replicating our risk factor findings in a second institution.
This work was funded in part by National Human Genome
Research Institute as both sites are members of the Electronic
Medical Records and Genomics (eMERGE) Network
(U01HG006382 to Geisinger Clinic and U01HG006389 to
Essentia Institute of Rural Health).
Keywords: virtual data warehouse, risk factors

VACCINE EFFECTIVENESS AND
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Background/Aims: Health care-associated infections
(HAI) affect 1.7 million patients and cause 100,000 deaths
annually, yet preventive strategies are only partially effective.
HAI are often transmitted between health care workers and
patients; the sharp increase of antibiotic-resistant organisms
compounds the problem. Fortunately, numerous efforts to
reduce HAI incidence are being adopted, targeting clinical
and environmental cleaning polices. We document current
infectious disease work by investigators uniquely positioned
within Scott & White and nearby Central Texas VA. Our
involvement in several disinfection strategies and research
protocols utilizes evidence-based findings to transform patient
care while reducing unnecessary treatment costs.
Methods: Besides aggressive hand-washing and antibiotic
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stewardship programs at both institutions, ongoing VA
initiatives focus on novel pulsed-xenon ultraviolet ray (UV)
technologies to eliminate patient room pathogens. Supported
by laboratory experiments, this ongoing project examines the
clinical efficacy and cost-effectiveness of portable UV devices,
gauging implementation challenges. Other decontamination
or preventive efforts include air disinfection in operating
suites to target surgical site infections (Scott & White), and
copper-infused room surfaces to thwart microbial build-up in
high-touch areas (VA). A new veterinary medicine partnership
is exploring MRSA transmission via animal contact, a major
facet of rural Central Texas life.
Results: Research and quality improvement findings highlight
potential barriers in bridging technological advances and
health care delivery realties, yet are quite promising. We
found a 99.4% reduction in MRSA microbial counts with
evidence of HAI declines where UV devices are routinely
deployed; other tests suggest these machines work even absent
manual cleaning and without bacteria developing resistance.
Carbapenemase-resistant infections dropped 75% with higher
overall treatment response since Scott & White initiated better
HAI screening, selective antibiotic combination therapies
(e.g. minocycline plus amikacin) and other infection control
precautions.
Discussion: Pragmatic clinical efforts paired with insightful
research simultaneously tackle universal health care system
concerns, as HAI perniciously evolve with containment
strategies. However, mounting evidence provides optimism,
encouraging future collaborative endeavors. Our work
demonstrates a crucial need to involve multiple stakeholders
(clinical leadership, housekeeping, researchers) spurring
practical hygiene programs, educational training and creative
advances to combat HAI. Future efforts will spotlight
implementation and translational progress as we continue
pursuing effective models across multiple health systems.
Keywords: hospital-associated infections, novel technology,
implementation
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Background/Aims: Norovirus is the leading cause of acute
gastroenteritis in the United States and is the leading cause
of medically attended acute gastroenteritis (MAAGE) among
children younger than five years of age. Our primary goal
is to describe the community incidence of MAAGE and the
proportion of MAAGE encounters due to norovirus within
the membership population of Kaiser Permanente Northwest
(KPNW). Our secondary goal is to describe transmission of
norovirus within households.
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Methods: We are conducting a 12-month active surveillance
project in which we identify all KPNW members with
MAAGE-associated health care encounters through daily
electronic abstraction of the electronic health record system.
We are recruiting a sample of this population daily, along
with their symptomatic household members, to complete a
recruitment survey and collect a stool sample for norovirus
testing.
Results: During the four months of our surveillance period,
we identified 6,156 members presenting for MAAGE
(annualized incidence of 413/100,000). We attempted to reach
1,782 (30%) potential participants, 525 (29%) of whom were
ineligible. Of those remaining, 708 (56%) refused and 549
(44%) agreed to participate. Of those agreeing to participate,
453 (83%) provided a sample from which we obtained viral
testing results. Among samples tested, we identified 52 (11%)
positive for norovirus. Norovirus positivity was highest
among those 0–4 years of age (20%) and lowest among
those 65 years or older (6%). Thus far, we have recruited 48
household members, 8 (15%) of whom tested positive for
norovirus; 7 (88%) had the same laboratory results as their
MAAGE-associated household member.
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Discussion: Our observed incidence of MAAGE and
proportion of MAAGE encounters due to norovirus infection
in the KPNW member population over the first four months
of our surveillance period are consistent with results obtained
from other studies using varying methodologies and reinforce
the high burden of MAAGE and norovirus infection within the
community. Our results further support the high transmission
of norovirus infection within households. Importantly,
our project –– with 44% agreeing to participate and 83%
collecting and returning a stool sample –– demonstrates a
model for conducting other community-based studies of acute
infectious diseases within a managed care system.
Keywords: public health surveillance, norovirus
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